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1
Abstract
Eimeria spp. are a highly successful group of intracellular protozoan parasites that develop within
intestinal epithelial cells of poultry, causing coccidiosis. As a result of resistance against anticoccidial
drugs and the expense of manufacturing live vaccines, it is necessary to understand the relationship
between Eimeria and its host more deeply, with a view to developing recombinant vaccines. Like other
members of the Apicomplexan parasites, Eimeria possesses a number of microneme proteins (MICs)
which are deployed at the parasite-host interface during the early stages of invasion. One of these
proteins, EtMIC3, is a lectin consisting of seven tandem microneme adhesive repeats (MAR), which
possess a high affinity for sialylated glycans as shown by cell-based assays and carbohydrate microarray
analyses.
To provide a structural basis for the sialic acid recognition of EtMIC3, the second MAR domain of
EtMIC3 was expressed recombinantly and its structure was determined by Nuclear Magnetic Resonance
(NMR) spectroscopy. NMR titration and chemical shift mapping was carried out to localise the carbohydrate
binding site and inter-molecular NOEs were measured using filtered NOESY experiments. Structural
models of the carbohydrate complexes were subsequently calculated invoking both intermolecular NOEs
and chemical shift-derived distance restraints using the HADDOCK approach.
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Chapter 1
Introduction
1.1 Eimeria and coccidiosis
1.1.1 Eimeria
Coccidiosis is an intestinal disease commonly found in intensively reared livestock, caused by protozoan
parasites belonging to the genus Eimeria within the Apicomplexan phylum [2]. Eimeria tenella is one of
seven species of Eimeria that causes coccidiosis in chickens (others include E. acervulina, E. maxima,
E. necatrix, E. mitis, E. brunetti and E. praecox). It is one of the most economically significant diseases
to the poultry industry worldwide, costing approximately £40 million per annum in the UK alone [3] .
Modern intensive farming where large flocks of chickens are kept in warm environments create an ideal
condition for transmission and outbreak of coccidiosis. The parasites are transmitted by the faecal-oral
route, they invade and multiply in the intestines and cause severe tissue damage at the site of infection,
leading to poor absorption of water and nutrients. Infected chickens typically show symptoms such as
bloody discharge, weight loss and dehydration.
Eimeria exhibit a high degree of host specificity; with few exceptions, each Eimeria species is limited
to a single host species and invades narrowly defined areas within the intestine of the host birds. For
example, E. tenella only invades the caeca of chickens (Caeca are a pair of elongated sacs at the junction
of the small and large intestines which are used to absorb water), whilst E. acervulina only invades the
upper part of the small intestine and E. maxima can invade the entire small intestine.
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1.1.2 Life cycle
Eimeria-infected chickens shed a large amount of oocysts from the faeces into the environment. The
oocysts undergo sporogony where the single cell zygote within the oocyst wall undergoes meiotic
divisions to form sporozoites (Figure 1.1). Each sporulated oocyst contains four sporocysts, each
containing two sporozoites. Once ingested by the host, the oocyst wall is broken by the grinding process
in the gizzard and excystation of the infective sporozoites is aided by trypsin, bile salts and CO2. The
released sporozoites invade by penetrating the intestinal epithelium. The sporozoites of E. brunetti and
E. praecox develop within cells at the site of penetration, whilst others (E. acervulina, E. maxima,
E. necatrix and E. tenella) are transported to the crypt epithelium to undergo asexual reproduction
(schizogony or merogony). The merozoites then break free and are released into the gut lumen, where
they reinfect other epithelial cells beginning further more schizont generations (typically two to five).
Sexual reproduction (gametogeny) follows the last merogonic cycle when merozoites enter cells and
develop into either male (microgametocytes) or female (macrogametocytes). Once a microgametocyte
fertilises a macrogametocyte to form a zygote, it begins to develop into an oocyst. The oocyst is finally
released from its host and shed into the environment to undergo sporogony, completing the cycle when
another host ingests the sporulated oocyst [4, 5, 6].
Figure 1.1: Life cycle of Eimeria tenella. (Edited from United States Department fo Agriculture website
http://ars.usda.gov/).
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1.1.3 Controls against coccidiosis
1.1.3.1 Drugs
Good husbandry and poultry house management strategies are essential elements in the control of
coccidiosis. However, it is very difficult to keep chickens coccidia-free in intensive rearing conditions.
Anticoccidial drugs for the treatment of Eimeria are widely used in the poultry industry [7], particularly
for the production of ‘broilers’ (chickens raised for meat) which are reared for only about six weeks
before slaughter. Prophylactic chemotherapy is generally used in these birds, hence the majority of
broiler chickens around the world are given anticoccidial drugs from the time of hatch until a few days
before slaughter. However, the development of drug resistance [8, 9], the high cost of prophylactic drugs
and consumer concerns about drug residues in food have lead to the demand of alternative anticoccidial
methods. Current ways to reduce the impact of resistance include rotating the use of various anticoccidials
with successive flocks and combining chemical and ionophore treatments [5]. However, no new drugs
have been introduced for many years and legislation has increasingly favoured the use of vaccines over
drugs. Therefore it is expected that the use of vaccine will become more popular in the near future.
1.1.3.2 Vaccines
Chickens develop immunity from natural infection with Eimeria spp. Early vaccine efforts where
chickens were injected with dead parasites, infective tissue or oocyst extracts of Eimeria all failed to
protect chickens from infection [10]. It has been found that the initial asexual developmental stages
where trophozoites multiply within the epithelial cells of intestinal villi is important for the induction
of protective immunity [6]. Live vaccine using wild type or attenuated strains are both effective in
providing protection against Eimeria. Vaccination is particularly important for the egg production sector
of the industry where prophylactic anticoccidial drugs must be withdrawn once hens approach the time
of laying to prevent any carryover of drugs into eggs. It is also advantageous for breeding and free-range
flocks where the birds are kept for a longer period of time. It is also known that the introduction of drug
sensitive, attenuated parasites given in the live vaccine interbreed with wild, native strains, reducing
virulence and drug resistance in local populations [11, 12]. Therefore rotation with the use of live
vaccines helps prolong the useful period of anticoccidial drugs.
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1.1.3.2.1 Wild type vaccine
A small number of virulent parasites of different species of Eimeria are given to the birds orally during
the first week after hatching to induce immunity in the digestive system [6]. However, since the severity
of infection is proportional to the amount of oocysts ingested, a wild-type vaccine has to be administered
very carefully to ensure each bird receives a correct dosage. Uneven uptake of the wild-type parasite by
birds in one flock can lead to outbreak of disease where birds ingest none or small amount of oocysts
in the initial vaccination, and are therefore not immunised. They later become susceptible to severe
infection from exposture to a large number of virulent oocysts shedded by the immunised bird. Many
different approaches are used to administer coccidiosis vaccines to ensure even uptake of wild-type
vaccine, including spraying oocysts onto food and water, or placing oocysts within gels that can be
pecked [13, 14]. Detailed descriptions are reviewed in [15, 16].
1.1.3.2.2 Live attenuated vaccine
The precocious and egg-adapted line of Eimeria are two types of live attenuated vaccines against
coccidiosis. The precocious lines are derived by controlled passage through chickens with repeated
selection for the first oocysts produced during infection [17] (Figure 1.2). This results in loss of one
or two generations of schizogony in the precocious line. Compared with the wild-type strains, the
precocious lines have lower reproductive potential and are significantly less pathogenic whilst maintaining
their immunogenicity [18]. This prevents problems associated with live unattenuated vaccine where
dramatic loss of weight and motility of the host may result. The first commercial vaccine formulated by
eight precocious lines (seven species of Eimeria with two immunologically distinct lines of E. maxima),
Paracox®, was introduced in 1989 to protect breeding and laying flocks [19]. For the egg-adapted line
the parasites are attenuated by serial passage in the chorioallantoic membrane of embryonated eggs,
resulting in a less pathogenic strain. An egg-adapted line for E. tenella, derived after more than 100
passages is included in the Livacox® vaccine [19].
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Figure 1.2: The life cycle of wild type virulent strain (blue arrows) and the precocious line (red arrow) of
Eimeria. The precocious strain has fewer schizogony generations, therefore causing less damage to the host
whilst maintaining their immunogenicity.
1.1.3.2.3 New generation antigenic vaccines
While the use of live vaccines is effective and avoids many problems associated with the use of
anti-coccidial drugs, large scale manufacture of live vaccines is expensive because oocysts have to be
obtained from specified pathogen-free chickens, purified from faeces and formulated to high quality in
specialised commercial facilities within a sterile medium. The vaccine is also strain specific, so different
countries or even regions need to manufacture live vaccines specific to the local Eimeria strains. The
new direction of research is to develop a new generation of vaccine based on recombinant antigens,
so that vaccines are relatively inexpensive to manufacture and have a longer shelf life [20]. However,
selection of relevant antigens and an optimal delivery system is still a challenging step. Attempts using
recombinantly expressed antigens such as parasite surface proteins have had little success because of
the major challenge of providing cross-species immune protection. Several reports showed that DNA
vaccination could be an effective strategy with a suitable antigen [21, 22, 23, 24] . The genome
sequence of Eimeria tenella has allowed some high-throughput proteomic analysis to identify relevant
immunogens [25, 26, 27] . In general a better understanding of the mechanism of parasite invasion and
host immunity against infection is needed for the design of an effective recombinant vaccine.
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1.2 Apicomplexan parasites
Eimeria belong to a large group of parasites within the Apicomplexa phylum, characterised mostly by
their unique apical complex structure (Figure 1.3). There are more than 4000 known species within
the phylum and many of them are causative agents of serious human and agricultural diseases including
malaria (Plasmodium), theileriosis (Theileria), babesiosis (Babesia) and coccidiosis including cryptosporidiosis
(Cryptosporidium parvum), toxoplasmosis (Toxoplasma) and neosporosis (Neospora). Despite their
morphological resemblance and close phylogenetic relationships, Apicomplexan parasites differ significantly
with respect to host range, niches they occupy and their mode of transmission. From the first description
of Eimeria stiedae by Anton van Leeuwenhoek (1632-1723) in the bile of rabbits [28] to the genome
sequences of a number of Apicomplexan parasites [29, 30, 31, 32, 33], there have been enormous
efforts to understand the biology of Apicomplexa. Toxoplasma gondii has been the model organism
of the Apicomplexans because of its amenability to genetic manipulation [34]. Unlike many other
Apicomplexans, T. gondii can be readily cultured in vitro, has a well developed mouse model and
high efficiency of transient and stable transfection. Therefore many aspects of the cell biology of
Apicomplexa, including gliding motility and host invasion mechanisms are best understood from studies
in T. gondii.
Figure 1.3: Phylogenetic tree of Apicomplexa (adapted from [35]). The parasites that are of human medical
importance are coloured in red, whereas those with veterinary importance are coloured in green. Eimeria is
phyogenetically close to the Cryptosporidia, Isospora, Toxoplasma and Neospora species.
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1.3 Mechanism of gliding motility and invasion
1.3.1 Gliding motility
Apicomplexan parasites exhibit a specialised cell invasion mechanism by active penetration into the host
cell. In the absence of pseudopodia, cilia or flagella, they rely on gliding motility for their migration
across biological barriers and host cell invasion [36, 37]. Many Apicomplexan share a characteristic
structure called the apical complex, composed of two specialised secretory organelles, the rhoptries and
micronemes, an apical polar ring and in some case a conoid (Figure 1.4). The apical polar ring functions
as a microtubule organising centre for the subpellicular microtubules, which radiate from the apical end
to about two thirds of the length of the parasite [38]. The conoid has a small cone-shaped structure and
protrudes during invasion. The Apicomplexan pellicle consists of the plasma membrane and an inner
membrane complex (IMC), a network of flattened cisternae containing intramembranous particles which
form a two dimensional particle lattice attached to the underlying subpellicular microtubules [39, 40]
(Figure 1.5).
Figure 1.4: Cartoon depiction of T. gondii tachyzoite and P. falciparum merozoite showing the unique
Apicomplexan organelles. The micronemes (light blue) and rhoptries (beige) are located near the apical end
of the parasite, just behind the conoid structure (taken from [41]).
Gliding motility is based on various surface adhesive proteins linked to an actin/myosin-based molecular
motor complex between the plasma membrane and IMC, called the “glideosome” [42, 43, 44]. Movement
is generated by attachment of the parasite’s surface proteins to host receptors and transmission of
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mechanical force from the motor complex (Figure 1.5). The motive force is generated by the movement
of ATP-driven class XIV myosin A (MyoA) on a short actin microfilament (F-actin) [45, 46]. MyoA is
in complex with the myosin light chain 1, named MLC1 in T. gondii or Myosin A tail domain interacting
protein, MTIP, in Plasmodium [47, 48, 49]. The N-terminal domain of MLC1 serves as a tail for MyoA
and brings the motor to its site of action by association with the C-terminus of the gliding associated
protein 45 (GAP45) [50]. GAP45 is anchored to the plasma membrane by N-terminal acylation and to
the IMC via the C terminus [51]. The pre-complex MyoA-MLC1-GAP45 is anchored to the IMC via
another GAP, the integral membrane glycoprotein GAP50 [50]. GAP50 is firmly immobilized in the
IMC and was proposed to act as a fixed anchor for the motor complex [52]. Recently a fifth component
of the glideosome, GAP40, was identified, the polytopic IMC protein is conserved across the phylum
of Apicomplexa [51], but its function and interaction with the other glideosome proteins are yet to be
published.
Figure 1.5: Current model of the glideosome of T. gondii (taken from [41]). The motive force is generated by
the movement of ATP-driven myosin A (MyoA) on a short actin microfilament (F-actin) which in turn is coupled
to cell-surface TRAP-like proteins/adhesins by the glycolytic enzyme aldolase. Adhesin receptor complexes are
therefore pushed ‘backwards’ propelling the parasite forward and subsequently proteolytically removed at the
posterior end of the parasite.
On the other side of the glideosome, the F-actin associates with the glycolytic enzyme aldolase which
links the complex to the cytosolic domain of transmembrane adhesive proteins on the parasite plasma
membrane, such as T. gondii microneme protein 2 (TgMIC2) and the Plasmodium thrombospondin-related
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adhesive protein (TRAP) family [53, 54, 55]. The extracellular adhesive domains of the protein bind to
their substrates on the host cell plasma membrane and act as anchors for the parasite to move along the
host cell surface. These adhesive complexes move away from the apical end of the parasite towards the
posterior as the parasite moves forward. Eventually the anchors are cleaved by microneme protein
protease 1 (MPP1) [56], an intramembrane serine protease belonging to the rhomboid family [57],
leaving trails on the gliding path which can be visualised easily by using specific antibody staining
(Figure 1.6). The glideosome used by P. falciparum during erythrocyte invasion has also been identified
[58], and homologous proteins involved in forming the glideosome are found in proteomic analysis of
E. tenella [27]. Analysis of other parasite genomes showed that the components of the glideosome
motor complex are conserved across the diverse Apicomplexan genera [55, 59], suggesting a common
molecular mechanism which underlies all Apicomplexan motility.
Figure 1.6: Capping and trailing of EtMIC2 during sporozoite gliding illustrated in [60]. a) Staining of trails
on the MDBK cell surface left by extracellular sporozoites; b) A partially invaded sporozoite (arrowhead) with
nearby trails; c) An attached sporozoite (arrow) and a partially invaded sporozoite (arrowhead) with EtMIC2
(stained) distributed over the host cell surface; d) uninfected cells probed with anti-EtMIC2 antibodies.
1.3.1.1 Actin regulation
Identifying the actin/myosin motor only reveals a static picture of gliding and invasion. Recent efforts
have focused on understanding how polymerisation of actin is regulated. T. gondii actin filaments are
found to be very short and highly dynamic [61, 62, 63]. The repertoire of actin-binding proteins is
relatively small in Apicomplexa compared to that of other eukaryotes [41]. This includes a number of
monomer-binding proteins: profilin [64, 65, 66], actin-depolymerising factor (ADF)/cofilin [67, 68], and
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Srv/cyclase-associated protein (CAP) [69]. The ARP2/3 complex, which is one of the central nucleators
used across eukaryotes, is absent in Apicomplexa. However, it does contain a newly recognised family
of actin nucleators called formins [41]. Formins are known to harness the ability of profilin to couple
ATP hydrolysis to filament assembly, in order to catalyse a fast assembly at the barbed end [70, 71, 72].
Almost no actin-bundling or crosslinking proteins have been identified in Apicomplexa so far [41].
1.3.2 Invasion
The Apicomplexan invasion mechanism is a highly regulated process, with proteins from different
organelles discharged in an orchestrated manner at precise times (Figure 1.7). These include the surface
antigen glycoproteins (SAGs), microneme proteins (MICs) [73], rhoptry neck proteins (RONs), rhoptry
bulb proteins (ROPs) [74, 75] and dense granule proteins (DGs) [76, 36].
Figure 1.7: A working model of Toxoplasma gondii invasion summarised in seven steps (taken from [77]).
Step (1): Host cell recognition and initial attachment using GPI-anchored surface antigens (SAGs). (2):
Calcium-mediated microneme release leads to polarised apical attachment. (3): Rhoptry neck proteins (RONs)
and the microneme-derived Apical Membrane Antigen 1 (AMA1) together form the moving junction, creating an
intimate binding interface with the host cell. (4): Rhoptry proteins (ROPs) are injected into the host cytoplasm.
(5): The parasite actively penetrates the host cell by activating the glideosome, invaginating the host cell plasma
membrane to form the parasitophorous vacuole. Rhomboid proteases (ROMs) appear to be responsible for
cleaving microneme proteins from the posterior end. (6-7): The moving junction is closed and the parasite
separates from the host cell plasma membrane.
23
1.3.2.1 Surface antigen glycoproteins (SAG)
Whilst the parasite glides in between host cells, it ‘searches’ for a suitable cell to invade. Details
of host cell selection mechanism are still largely unknown, but sulphated proteoglycans have been
identified as one of the targets for host cell attachment [78], and several surface antigens of the parasite
were identified to bind to host cells through protein-carbohydrate interactions [79, 80, 81, 82]. The
surface of T. gondii tachyzoites and bradyzoites has an abundant and even distribution of a family of
GPI-anchored surface antigen glycoproteins (SAGs) and SAG-related sequence (SRS) proteins [83, 84].
There are more than 160 SAG or SRS genes in the Toxoplasma genome [85], most of which belong to
the surface antigen 1 (SAG1) or the SAG2 families [86, 87]. Recently a SAG, which is expressed in
sporozoites (sporoSAG) [88] and another family of highly polymorphic GPI-anchored surface antigens
were identified [89]. SAGs and SRSs are involved in the initial attachment of the parasite to the host
cell surface in a reversible, low affinity interaction [77]. Moreover, being expressed on the surface of
the parasite, they are thought to be involved in manipulation of the host immune response against the
parasite. It is now known that T. gondii surface antigens are expressed in a stage-specific manner; the
rapidly dividing tachyzoite stage displays a subset of SRSs, which is different from that displayed by the
encysted bradyzoite stage [90, 91]. This could be because bradyzoite SRSs evolved to facilitate invasion
of different cell types, or the change in expression is necessary to protect the bradyzoites against an
immune response raised against the tachyzoite stage [83]. For example, SAG1 attracts a strong immune
response against the virulent tachyzoites and therefore facilitates the persistence of bradyzoites, which
naturally lack SAG1 [84, 92]. Proteomic analysis in E. tenella has identified 47 SAGs in the merozoite
but only four in the sporozoite [27]. Several crystal structures of SRS proteins, including SAG1 [92, 93],
bradyzoite surface antigen (BSR4) [94] and a SAG2 related surface antigen (SporoSAG) [95] were
published recently. They show significant structural diversity within the SRS superfamily which was
not predicted from their primary sequences [83]. SAGs have also been found in other Apicomplexan
parasites, including E. tenella [96, 27], Plasmodium spp. [97] and N. caninum [98].
1.3.2.2 Microneme proteins (MIC)
After the initial recognition and as soon as a suitable host cell is found, the parasite attaches to the
host surface using its apical end and initiates penetration into the target cell. Microneme proteins
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(MIC) with multiple adhesive domains are deployed at this stage to establish stronger interaction to
the host cell surface [73, 99, 100]. Micronemes are small, spherical organelles that cluster at the
apical end of the parasite (Figure 1.4). The number of micronemes varies between different genera,
species and developmental stages. Those displaying vigorous and extensive gliding or migration activity
generally contain the most micronemes. The secretion of microneme contents is triggered by an increase
in intracellular calcium ion level [101, 102]. Calcium is released from the endoplasmic reticulum
(ER), mitochondria or acidocalcisomes [103, 104] in response to second messenger cyclic ADP ribose
(cADPR) and inositol triphosphate (IP3) signalling [105, 106]. The released calcium activates calcium-dependent
protein kinases such as TgCDPK1 which control microneme secretion [107, 108], but the detailed
mechanism of MIC release is still poorly understood.
1.3.2.3 Moving Junction (MJ)
After the secretion of adhesins from the micronemes, lipids and proteins from the rhoptries are released.
Rhoptries are club-shaped organelles found at the anterior end of the parasite which release their contents
during invasion (Figure 1.4). Rhoptry contents are sorted into discrete subcompartments, either at the
tapering neck (RON proteins) or on the bulbous base (ROP proteins) [109, 110, 111]. RON proteins are
first released as the parasite starts its penetration into the host cell and are involved in the formation of
the moving junction [112]. The process is followed by the release of ROPs which are needed for the
survival of the parasite within the host cell.
The moving junction is a ring like structure formed at the irreversible attachment point between the
parasite and the host cell plasma membrane. This junction between the parasite and host cell moves
towards the posterior pole of the parasite, pulling the host cell membrane with it. Eventually forming
the parasitophorous vacuole (PV), surrounding the parasite within the host cell cytoplasm. The moving
junction seems to act as a molecular sieve that excludes many host and parasite proteins from the two
plasma membranes, leaving only host GPI-anchored proteins [113]. Host cell membrane molecules are
selected based on multiple mechanisms, including raft association, cytoskeletal tethering and molecular
multimerisation [114]. The lipids forming the PV are derived from both the host cell plasma membrane
and the parasite rhoptry [115]. This establishes a nonfusogenic vacuole in which the parasite resides and
divides, and the vacuole does not acidify over time [116, 117, 118].
25
Figure 1.8: Current model of the Toxoplasma moving junction and crystal structure of the TgAMA1/RON2
complex (taken from [119]). The RON complex is proposed to be a parasite-derived receptor which is inserted
into the host cell and binds to AMA1 on the parasite surface. This interaction act as an anchor point for the parasite
to draw against during invasion.
Co-immunoprecipitation studies in Toxoplasma have led to the identification of TgRON2, TgRON4,
TgRON5, TgRON8 and a microneme protein known as the apical membrane antigen (AMA1) in the
MJ [120, 121, 111, 122]. RON2, RON4, RON5 and AMA1 orthologues are found in the genomes
of PV-forming Apicomplexan such as Plasmodium, Toxoplasma, Neospora, Eimeria, Theileria and
Bebesia [123]. However RON8 is only present in coccidian parasites (Toxoplasma, Neospora, Eimeria)
[121]. This shows a broadly conserved function for RON2/4/5 and AMA1 but a more specialized
function for RON8. The current model of the moving junction complex suggests that the RON protein
complex act as a secreted, parasite-derived receptor that is anchored into the host cell plasma membrane
[111, 124, 120, 112] (Figure 1.8). TgRON4/5/8 associate with the cytoplasmic face of the host cell
plasma membrane [120]. The ectodomain of RON2 serves as the receptor on the host surface [125,
126]. Whilst on the parasite plasma membrane, AMA1 acts as a ligand of the RON complex receptor
providing an anchor point for the parasite to draw against during invasion [122]. Both RON2 and AMA1
contain a transmembrane helix domain which spans the parasite or host membrane. The co-structure of
TgAMA1 and RON2 was recently solved by X-ray crystallography [119]. In the complex structure
a 37 residue region near the C-terminus of RON2 binds to a hydrophobic trough of TgAMA1 in a
U-shaped conformation with a large buried surface area and significant shape complementarity. This
resulted in a strong interaction between the two proteins that are likely to allow the MJ to withstand
the sheer mechanical force associated with the parasite moving through the constricted MJ ring (Figure
1.8). A recent paper investigated the function of coccidian-specific RON8 [127]. The author proposed
that RON8 anchors the invading parasite to coccidian specific host cytoskeletal proteins, directing the
parasite toward complete penetration of the host. The specific functions of RON4 and 5 are still largely
26
unknown.
1.3.3 Forming the Parasitophorous Vacuole (PV)
1.3.3.1 Nutrient acquisition
Whilst the parasitophorous vacuole membrane (PVM) protects the dividing parasite from host cell
elimination, it also deprives it of the abundance of nutrients in the host cytosol. GRAs and ROPs are
thought to maintain the PV, ensure nutrient acquisition and the recruitment of the host mitochondria
and ER [128]. The N-terminal domain of ROP2 has a mitochondrial targeting signal and is thought to
recruit host mitochondria to the PVM [129]. GRA3 and GRA5 might be responsible for ER recruitment
because of their ability to bind an ER integral membrane protein called the calcium modulating ligand
(CAMLG) [130]. T. gondii also interferes with host cell low-density lipoprotein (LPL) endocytosis to
obtain host cholesterol [131].
1.3.3.2 Rhoptry bulb proteins (ROP)
In contrast to the conserved roles of RON proteins in the moving junction, most ROPs do not have
orthologs across the genera [111, 132], indicating these proteins are highly adapted to the niche in
which the parasite invades. Currently ROPs are thought to play a role in maintaining the interaction
between host and parasite [74]. Most studies about ROPs have focused on T. gondii and P. falciparum.
So far 24 ROPs have been identified in Toxoplasma [111, 74]. Most ROPs, including ROP2 and the
ROP2-like family, show clear homology to protein kinases [133, 134, 135]. Others are homologous to
phosphatases [136] or proteases [137, 138].
ROPs are released into the host cell during invasion and are targeted to one of three general locations:
the lumen of the nascent PV, the PVM or the interior of the host cell. For example, after release,
ROP1 remains soluble within the PV [139]; Proteins belonging to the ROP2 family are targeted to
small vesicles called ‘evacuoles’ found in the cytoplasm and can fuse with the parasitophorous vacuole
membrane PVM [140]; others such as ROP16 [141] and protein phosphatase 2C-host nucleus (PP2C-hn)
[136] are targeted to the host cell nucleus (Figure 1.9).
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Figure 1.9: Secretion of Toxoplasma rhoptry proteins (TgROPs) to different destinations within the host cell after
invasion (taken from [124]). For example ROP2 and ROP18 are directed to the surface of the parasitophorous
vacuole whilst ROP16 is located at the host cell nucleus.
The majority of European and North American isolates belong to three distinct clonal lines, referred
to as types I, II, and III [142, 143]. The type I strain is the most virulent of all in mice [144]. Using
the F1 progeny from crosses between two strains that differ in their virulence, the parasite loci that are
responsible for the different pathogenicities were mapped [145, 146]. Five virulence loci were identified
and two of them are polymorphic kinases ROP16 and ROP18. They are thought to down regulate the
host innate immune response by altering host transcription [141].
ROP16 is released into the host cell cytosol at the time of invasion and accumulates in the nucleus [141].
It binds to and phosphorylates transcription factors STAT3 and STAT6 via its N-terminal extension
[147, 148], thus enhancing the proimflammatory cytokine interleukin IL-4 and IL-6 production whilst
down regulating the production of IL-12. On the other hand, ROP18 is targeted to the surface of the
parasite-containing vacuole [149]. It has been shown that interference with the innate function of a
immunity-related GTPase (IRG), Irgb6, is a key mechanism by which ROP18 mediates virulence at
an early stage after infection [150, 151]. Recently, the host endoplasmic reticulum-bound transcription
factor ATF6-b was found to bind to the N-terminal extension of ROP18 [152], leading to a proteosome-dependent
degradation of ATF6-b. This shows that ROP18 also targets an ATF6-b-dependent CD8 T cell-mediated
acquired immune response that acts at a later stage after infection.
So far the crystal structures of ROP2 and ROP8 are available [134, 153]. ROP2 has a protein-kinase fold
but is devoid of catalytic residues and does not bind ATP. ROP2 is important for parasite development
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but the details of its function are still unknown [154]. Nevertheless the structures have provided some
insight on the mode of activation and regulation of ROP16 and 18, which are also members of the ROP2
family [145, 146].
1.3.3.3 Dense Granule proteins (GRA)
Dense granule proteins are released into the PV after invasion, including some that associate with or
insert into the PVM [155]. Most of the DG proteins are predicted to be type-I transmembrane proteins.
They are secreted as soluble proteins [156] and some are detected as protein complexes [157]. Following
Toxoplasma invasion, a network of membranous nanotubes called the intravacuolar network (IVN) build
up within the vacuolar space and extend to connect the PVM [158]. It has been proposed that this
network provides structural support for the rosette arrangement of the developing parasite [159], as well
as aiding metabolic exchanges between the parasite and the host cell [155]. GRA2 was shown to induce
the formation of the network [160] and many GRAs (GRA 2, 3, 4, 6, 9, 12, NTPases) are found to be
inserted into the IVN [161, 162, 163, 156, 164]. Other Apicomplexans also contain dense granules but
so far little is known about them [155].
1.3.3.4 Egress from host cells
Parasites exit from the host cell by an actin-based motility process in a similar vein to invasion [165].
However, during egress the parasite has to cross the parasitophorous membrane first and then the host cell
membrane; therefore the parasite must recognise different receptors for egress. Microneme and rhoptry
contents are discharged and a tight junction is formed for the crossing. The parasitophorous membrane
and host plasma membrane are permeabilised a few minutes prior to egress [166, 167]. It has recently
been shown that the T. gondii perforin-like protein 1 (TgPLP1) displays structural features necessary for
pore formation and is essential for rapid egress [168]. During natural egress of T. gondii, accumulation
of the phytohormone abscisic acid (ABA) leads to a rise of the second-messenger cyclic ADP ribose
(cADPR) [169], cADPR controls calcium release and induces parasite egress from the infected host
cell [106]. It has been proposed that the parasite senses potassium levels in its surroundings within
the parasitophorous vacuole. It remains non-motile in the high potassium intracellular environment.
Metabolic or mechanical strain in the parasite-filled host cells could cause potassium to flood out of
the cell, or a rupture of the host cell membrane could cause a drop in potassium concentration, which
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triggers egress from the host [167]. The reduction in the host cell potassium level appears to activate a
phospholipase C activity in T. gondii that, in turn, causes an increase in cytoplasmic calcium in the
parasite, triggering egress. Proteases are also important for Apicomplexan egress [170, 171]; in a
cascade of proteolytic events, P. falciparum late-stage schizonts activate and secrete a subtilisin, PfSUB1
which processes proteases called serine-repeat antigens (SERA) that contribute to merozoite egress
[172, 173, 174]. Another study also suggests that a host calcium-dependent protease called calpains-1,
is required for efficient parasite egress, possibly by acting upon the host cytoskeleton [175].
1.3.4 Proteolytic processing of adhesins
1.3.4.1 Proteolytic maturation
The majority of rhoptry and microneme proteins undergo a series of proteolytic processing events
during biogenesis and after exocytosis [176, 177, 44] (Figure 1.10). Firstly the proteins are subjected
to proteolytic maturation. This process involves signal peptides being removed co-translationally by
signal peptidase during import into the ER, releasing the proprotein. The propeptides are then removed
as the protein transits through the secretory pathway, producing an active protein destined to their
target organelle. The processing events are important in targeting the protein to the correct destination.
The propeptides of TgROP1 and TgROP4 both act as a rhoptry-targeting signal [178, 179]. Similar
roles were shown for the propeptides of TgMIC3, TgM2AP and TgMIC5 [180, 177], which divert
these proteins from the default constitutive pathway to the dense granules. The first epidermal growth
factor (EGF) domain of TgMIC6 was found to be cleaved at the trans-Golgi network [181, 182] but
the significance of this processing is unclear, as deletion of the first EGF domain does not affect the
targeting of TgMIC6 as well as its cargo proteins TgMIC1 and TgMIC4 to the micronemes [181].
Moreover, proteolytic processing is important in masking the active sites of the adhesins, such as
that of TgMIC3 [183]. The carbohydrate binding property of its lectin-like domain remains inactive
until the propeptide is cleaved. It has been also proposed that proteolytic processing is linked to
the specificity of complex formation of microneme proteins along the secretory pathway [44]. Using
various protease inhibitors, mapping proteolytic cleavage sites, and proteomics methods have identified
a number of protease candidates responsible for the processing of adhesins [176]. Two of them have
been proposed to be rhoptry-processing proteases. TgSUB2, a member of the subtilase family of
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serine proteases, is a transmembrane protein localised to the rhoptries and undergoes autocatalytic
processing at its N-terminus [138]. Co-immunoprecipitation experiments showed its association with
TgROP1, and they have a matching proteolytic cleavage site. Another candidate, previously named
toxopain 1, is a cysteine protease identified as a cathepsin B [137]. It is localised to the rhoptries and a
cathepsin B inhibitor delays proTgROP2 processing. Furthermore, inhibiting the expression of toxopain
1 significantly decreased the capacity of the parasites to multiply and invade in vitro [184].
Figure 1.10: Illustration of the endoproteolytic cleavage (middle panel) of three T. gondii microneme protein
complexes (MIC2/M2AP, MIC6/1/4 and MIC8/3) along the secretory pathway and post-exocytosis and surface
trimming and shredding by MPP2 and MPP1 (lower panel) (taken from [176]).
1.3.4.2 Surface trimming
After being secreted, microneme proteins are subject to further proteolytic modifications termed surface
trimming. For example, the N-terminus of TgMIC2 is cleaved at multiple sites up to the beginning of
the A-domain by microneme protein protease 2 (MPP2) [56] (Figure 1.10). The cleaved mature form of
TgMIC2 is activated to bind to intercellular adhesion molecule-1 (ICAM-1) on host cells and facilitates
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transmigration by the parasite [185]. TgMIC4 is also cleaved by MPP2 within its fifth apple domain
[186] and the C-terminal coiled domain of TgMIC2 associated protein (TgM2AP) was found to be
cleaved by both MPP2 and MPP3 [187]. It was proposed that the primary processing of TgMIC2/M2AP
may facilitate its binding to host receptors or activate clustering of the complex with other adhesive
proteins at the attachment junction. The roles of MPP2 and MPP3 have not been identified yet but
MPP2 is thought to be a chymotrypsin-like serine protease or calpain-like cysteine protease based on
partial inhibition by chymostatin and phenylmethanesulfonyl fluoride (PMSF).
1.3.4.3 Surface shedding
The shedding of microneme proteins from the parasite surface is important for the gliding motility and
invasion of the parasite. Microneme proteins form complexes consisting of a transmembrane component,
one example of such is the TgMIC2/M2AP complex [188]. TgMIC2 and PfTRAP are linked to the
parasite cytoskeleton by their short acidic C-terminal cytosolic domain [53]. Following host cell contact,
TgMIC2/M2AP are secreted on the surface of the parasite. The adhesive domains bind to host receptors
and the complex is translocated to the posterior end by the actin-motor complex. As a result, the parasite
body is propelled forward. To maintain forward movement, the parasite must break the interaction of
the adhesin with the host at the rear end. TgMIC2 is cleaved within the transmembrane domain by the
microneme protein protease 1 (MPP1) [42] (Figure 1.10). MPP1 was found to be a common protease for
surface shedding of many microneme proteins including TgMIC6, TgMIC8 and TgAMA1 [182, 122].
The rhomboid (ROM) family of intramembrane serine protease are thought to be likely candidates for
MPP1 [57]. T. gondii possesses six genes encoding rhomboid-like proteins. Four are localised along the
secretory pathway and therefore constitute possible candidates for MPP1 activity (TgROM1, 2, 4, 5).
TgROM3 is not expressed in tachyzoites [189] and TgROM6 is predicted to be a mitochondrial rhomboid
[57]. Subcellular location studies revealed that TgROM1 is expressed in the micronemes, TgROM2 in
the Golgi, TgROM4 is distributed over the entire parasite surface whilst TgROM5 is most abundant
at the posterior end [190]. Knockdown of TgROM1 appears to affect intracellular parasite growth but
not invasion [191]. TgROM4 is involved in maintaining an apical posterior gradient of adhesins which
is necessary for directional motility during gliding and efficient invasion [192]. TgROM5 is the best
candidate for shedding of adhesin-receptor complex, prior to completion of cell invasion because of its
position at the posterior pole of the parasite and its extremely high activity [189] but the exact role of
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ROM5 in processing adhesin complexes is still not precisely defined.
1.4 Microneme proteins
The majority of MICs contain adhesive motifs which are homologous to proteins in higher eukaryotes
(Figure 1.11) [73] . These include the thrombospondin-1 type 1 domains (TSR), von Willebrand A
domain integrin inserted (I) domains, apple/PAN domains, EGF domains, etc. These motifs can be
present in different combinations and multiple copies and each species have their unique repertoire of
MICs [73, 99, 100].
Figure 1.11: List of microneme proteins from Eimeria and Toxoplasma showing their modular nature (edited
from [100]).
1.4.1 Forming complexes
Many MICs are produced as multi-protein complexes in the ER containing a transmembrane protein
as an escorter and one or more soluble proteins [193, 181]. Oligomerisation increases valency and
avidity of the binding to host cell receptors during invasion. So far a few microneme complexes have
been described, including the TgMIC1/MIC4/MIC6 complex [194], TgMIC2/M2AP complex [195],
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the TgMIC3/8 complex [196]and the EtMIC4/5 complex [197] (Figure 1.12). The escorters include a
family of transmembrane proteins in T. gondii, namely TgMIC6, 7, 8 and 9. They contain multiple EGF
domains, a putative transmembrane spanning domain and a short cytoplasmic tail [196]. Escorters from
other species include the thrombospondin-related adhesive protein (PfTRAP) and circumsporozoite-and-TRAP
related protein (PfCTPF) from P. falciparum and EtMIC2 and EtMIC4 from E. tenella [99]. These
escorter proteins ensure the correct trafficking of the protein complex to the micronemes based on the
targeting signals in their C-terminus tails [193]. For example, TgMIC2 is necessary for the proper sorting
of M2AP. In parasites with reduced levels of MIC2, M2AP failed to localise to the microneme, instead
it was transported via the default secretory pathway of T. gondii to the dense granules [198]. Similarly,
the absence of TgMIC6 causes mistargeting of TgMIC1 and TgMIC4 to the dense granules instead
of the micronemes [181]. Moreover, complex formation facilitate correct folding and stabilisation of
the protein during transport. For example, in TgMIC1 knockout parasites, complementation with the
C-terminus of TgMIC1 (TgMIC1-CT) was able to rescue TgMIC6 which otherwise would be retained
in the early secretory compartment [199].
Figure 1.12: Cartoon representation of the model and 3D structures of (left to right) EtMIC4/5, TgMIC1/4/6,
TgMIC2/M2AP complexes and AMA1 from Plasmodium vivax (edited from [100]).
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1.4.2 Eimeria tenella microneme protein 3
1.4.2.1 Identification and biological analysis
EtMIC3 was cloned from a sporozoite cDNA library identified by two monoclonal antibodies raised
against the oocyst stage (accession number: B6VCV4) [200]. It is secreted at the early stages of invasion
prior to the formation of the moving junction. During invasion it was detected at the interface of the
host cell membrane and apical attachment of the parasite interface and remains proximal to the moving
junction complex (Figure 1.13) [1]. Western blot based cell binding assays showed that EtMIC3 was
detected in the cell bound fraction whilst a number of microneme proteins such as EtMIC1, EtMIC2
and EtMIC4 were found in the unbound fraction [1]. Furthermore anti-EtMIC3 monoclonal antibodies
inhibit parasite growth and affect invasion [200]. These results showed that EtMIC3 is one of the key
microneme proteins secreted during invasion to promote efficient cell adhesion and assist the irreversible
apical attachment of the parasite prior to the formation of the moving junction.
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Figure 1.13: Immunofluorescence localisation (left panel) and corresponding differential interference contrast
(DIC, right panel) of EtMIC3 (green) and beta tubulin (red) in invading E. tenella sporozoites. Blue counterstain is
DAPI (4’,6-diamidino-2-phenylindole, a fluorescent stain that binds to DNA). Sporozoite attaches to the host cell
(top panel) causing invagination of the host cell membrane (middle panel) and the sporozoite becomes committed
to invasion with an extruded conoid (bottom panel). EtMIC3 is present at the apical end of the sporozoite
throughout these early invasion stages. The bar represents 1 µm (Taken from [1])
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1.5 Microneme adhesive repeat Containing Protein (MCP)
T. gondii microneme protein 1 (TgMIC1) was the first microneme protein identified that recognises
sialylated glycans via a motif called the microneme adhesive repeat (MAR) [201]. Nine other MAR-containing
proteins were subsequently identified from the genome data of T. gondi, N. caninum and E. tenella [81].
TgMIC1 has a pair of N-terminal MARs that form two distinct subfamilies based on the amino acid
sequence, termed MAR1 and MAR2, followed by a C-terminal galectin-like domain (Figure 1.14) [199].
Most MCPs contain both MAR1 and MAR2 domains [81]. Uniquely, EtMIC3 only possesses the type
I MAR domain [200]. It has seven MAR1 repeats in tandem (1a to 1e), with three identical internal
repeats (1c), followed by one near identical repeat (1d), and three more divergent external repeats (1a,
1b, 1e) (Figure 1.14, 1.15).
Figure 1.14: Domain organisation of EtMIC3, TgMIC1/NcMIC1 and TgMIC13. The different domains are
colour coded: MAR1 domain (blue), MAR2 domain (purple), MAR2 domain “β-finger” (orange), galectin-like
domain (green).
The two types of MAR domains are slightly different in secondary structure and disulphide bond
arrangement (Figure 1.15), in particular, the first a helix and subsequent loop is extended in MAR1
(MAR1 insertion) whilst MAR2 has two extra short b sheets (b-finger) at the C-terminal [201]. Moreover,
the C2-C3 pair in MAR1 is missing in MAR2, but MAR2 has an extra C8-C10 pair at the C-terminal b
sheets.
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Figure 1.15: Sequence alignments for the MAR domain families from EtMIC3 and TgMIC1. The MAR1
insertion and MAR2 unique β finger are indicated. Cysteines are shaded orange and disulphide bond connectivities
are indicated for the MAR domains. Secondary structure elements are indicated above the sequence alignments;
β-strands as arrows and α-helices as cylinders.
1.5.1 Structure of a MAR domain
The crystal structure of TgMIC1 MAR domains revealed a novel fold consisting of a distorted b- barrel
arrangement of five b-strands, which is flanked on one side by an antiparallel helical bundle comprising
one helix from each terminus (Figure 1.16) [201].
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Figure 1.16: Crystal structure of TgMIC1-MARR in complex with α2,3-sialyl-N-acetyllactosamine ([201], PDB
2JHD). The MAR1 domain (left, purple) and MAR2 (right, magenta) domain with the beta-finger (bottom, orange)
are shown and disulphide bonds are displayed in green. In the protein crystal, only the binding site of MAR2 was
occupied with the ligand, the binding site of MAR1 was occupied with an acetate molecule.
1.5.2 MCP as sialic acid binding lectins
Microarray analysis of TgMIC1-MARR showed significant binding signals with terminally sialylated
glycans, with a slight preference for the Neu5Aca-2,3-Gal linkage over the a-2,6 and a-2,8 linkage
[202, 201]. Crystals soaked with a-2,3- and a-2,6-sialyl-N-acetyllactosamine gave largely unchanged
TgMIC1-MARR structures (Figure 1.16). The complex structure revealed the shallow binding pockets
located on the short beta-sheet b5. Binding to host cells was abolished by a double mutant affecting
these binding sites, and single mutants were defective in binding. Mutation studies and NMR titration
experiments using 15N, 13C-Ala/Thr-labelled TgMIC1-NT and various sialyl carbohydrates confirmed
that both MAR domains are active in binding sialic acid [201]. In both binding sites, a conserved
S/TxHxT sequence is present and in MAR2 it forms direct contacts with the sialic acid of the oligosaccharide
ligand.
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1.5.3 Identifying the active MAR domain in EtMIC3
Work by our collaborator Fiona Tomley and Janene Bumstead (Institute of Animal Health) [1], tested
the binding of individual MARs of EtMIC3 to fixed MDBK cell monolayers using enzyme-linked
immunosorbent assay (ELISA). MAR1b, 1c and 1d showed stronger signals than MAR1a and 1e (Figure
1.17). MAR1b, 1c and 1d have identical sequences (TSHLT) at the b5 helix, containing the conserved
S/TxHxT sialic acid binding motif (Figure 1.15). However it is absent in MAR1a and 1e, which could
explain the weaker binding signal. Therefore, MAR1b, MAR1c and MAR1d are regarded as active
domains in cell binding and are good targets for high resolution structural studies.
Figure 1.17: Binding of individual MARs of EtMIC3 to fixed MDBK cell monolayers determined by ELISA.
Signals from MAR1a and 1e are significantly lower than signals from MAR1b, 1c and 1d. Only MAR1b, 1c and
1d repeats contain the sialic acid binding motif (S/TxHxT) for MAR domains. Therefore MAR1b, 1c and 1d, but
not MAR1a and 1e seemed to be active in cell binding through their sialic acid motifs. (Work by Janene Bumstead,
Institute of Animal Health [1])
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1.6 Aim of the project
The development of new generation antigenic vaccines against coccidiosis is needed for the modern
poultry industry. Eimeria tenella microneme protein 3 (EtMIC3) is involved in the host cell invasion
process and is a potential vaccine candidate. High resolution structural information on the newly
classified Microneme Adhesive Repeat (MAR) is limited to the crystal structures of Toxoplasma gondii
microneme protein 1. This project aims to provide high resolution structural information of EtMIC3
to understand its function during cell invasion. The result is valuable for designing glycomimic drugs
against coccidiosis as well as a better understanding of the invasion mechanism of Eimeria tenella.
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Chapter 2
Production of EtMIC3_MAR1b protein
2.1 Introduction
This chapter describes the production of recombinant EtMIC3_MAR1b domain for structure determination
and functional studies. A pure and homogeneous protein sample of high concentration is desirable for
structural analysis. Recombinant over-expression in a bacterial host, i.e. E. coli, is well established and
is usually the host of choice to produce high yields of folded protein. It benefits from fast growth, being
easy to manipulate and the option of isotopic labelling at a relatively low cost. Furthermore, unlike
yeast or other eukaryote expression systems, bacteria recombinant proteins are not post-translationally
modified. Heterogeneous post-translational modification is undesirable for structural studies.
In the parasite, EtMIC3 is an extracellular protein, pairs of cysteines are therefore exposed to an oxidising
environment, forming disulphide bonds. The OrigamiT M strain of E. coli, which has suitable mutations
to facilitate protein folding and formation of disulphide bonds in the reducing environment of the bacteria
cytoplasm, was used to expressed the EtMIC3_MAR1b domain. Furthermore, EtMIC3_MAR1b was
expressed with an N-terminal fusion protein, thioredoxin, to facilitate disulphide bonds formation; and
an N-terminal 6 histidine tag for affinity purification. The expression host and vector is discuss in detail
in the materials and methods below.
The following sections include: The preparation of the expression vector by molecular cloning; recombinant
over-expression of EtMIC3_MAR1b protein; protein purification and preparation of the NMR sample;
lastly, 1D and 2D NMR experiments to evaluate the protein sample.
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2.2 Materials and methods
2.2.1 Cloning
2.2.1.1 Polymerase chain reaction (PCR)
The plasmid DNA of full length EtMIC3 was provided by Professor Fiona Tomley (Royal Veterinary
College, formerly Institute of Animal Health, UK). The EtMIC3_MAR1b domain (residues 152 to 274)
was amplified by PCR. Primers were designed and purchased from MWG Biotech AG (Table 2.1). PCR
reactions were performed on a Mastercycler Gradient (Eppendorf) and conducted using Thermococcus
kodakaraensis (KOD) (Novagen) DNA polymerase (recipe and protocol according to the manufacturer’s
instructions). Amplified PCR products were analysed by 1% agarose gel electrophoresis and a molecular
weight comparison made against 1 kb DNA markers (Promega). Target DNA was purified from the
PCR mixture using a PCR purification kit (Qiagen) or gel extraction kit (Qiagen) according to the
manufacturer’s instructions.
Name Sequence
MAR1a_forward 5’- ggt att gag ggt cgc GCA CGC CGC GAA TCT CTG CAA GAT GCT CTG - 3’
MAR1b_forward 5’- ggt att gag ggt cgc GCG CCA ACG CTT CAG GAG GCT AAC CTG TCC -3’
MAR1b_reverse 5’- aga gga gag tta gag cct TAA GGT ATC TCT GGC GGT GGT GTT GCT TGT GA -3’
MAR1d_reverse 5’- aga gga gag tta gag cct TAC AAT GTG GCC CTC TCC CCC ATT TTG CAT GT -3’
Table 2.1: List of DNA primers. The nucleotides in lower case are the complementary sequences for ligation independent
cloning (discuss in next section), and the nucleotides in upper case are the annealing sequences to the template during PCR.
2.2.1.2 Ligation independent cloning (LIC)
Ligation independent cloning (LIC, Figure 2.1) was used to insert the PCR product into the bacterial
expression vector pET-32b Xa/LIC plasmid (Novagen) (Figure 2.2). LIC does not require the use of
restriction enzymes, T4 DNA ligase or alkaline phosphatase [203, 204]. Instead, sequence-specific
overhangs are incorporated into the target clone and linearised vector which will anneal to form the
final construct. The 5’-end of the primers used in the PCR reaction contain an additional 12 nucleotide
sequence. The 3’ → 5’ exonuclease activity of T4 DNA polymerase removes nucleotides from the 3’
end of the PCR product to generate 5’ single-stranded overhangs that are complimentary to those in
the vector. Treated inserts are then mixed with a linearised vector in a short annealing reaction to yield
plasmid DNA. LIC vector kits were purchased commercially (Novagen) and cloning was performed
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according to the manufacturer’s instructions.
                  M
   G  I  E  G  R  (or any)
5' GGTATTGAGGGTCGCATG                               XXXGGCTCTAACTCTCCTCT 3'
3' CCATAACTCCCAGCGTAC                                  CCGAGATTGAGAGGAGA 5'
                  M
      I  E  G  R  (or any)
TCCGGTATTGAGGGTCGCATG                               XXXGGCTCTAACTCTCCTCT
AGGCCATAACTCCCAGCGTAC                                  CCGAGATTGAGAGGAGA
                M
    I  E  G  R  (or any)
 GGTATTGAGGGTCGCATG                               XXXGG
             GCGTAC                                  CCGAGATTGAGAGGAGA
LIC plasmid
+
T4 DNA pol + dGTP only
LIC Xa insert
TCC                                                      CTCTAACTCTCCTCT
AGGCCATAACTCCCA
Annealing, transformation
TARGET GENE
PCR
TARGET GENE
TARGET GENE
recombinant plasmid
ATG
TAC
TARGET GENE
stop
TAG
TGA
TAA
start
M
(or any)
CCGAGATTGAGAGGAGA 5'
Xa
Xa
stop or read through
  G  I  E  G  R
5'GGTATTGAGGGTCGC
Figure 2.1: Ligation independent cloning. The 5’-end of the PCR primers are designed with an additional 12 nucleotide
sequence. With the presence of dATP in the reaction mixture, the 3’→ 5’ exonuclease activity of T4 DNA polymerase removes
nucleotides until it reaches the first guanine, producing the complementary sticky ends with the vector for annealing. (Figure
taken from Novagen LIC cloning user manual)
2.2.1.3 pET-32 vector
Correct formation of disulphide bonds are important for the folding of disulphide bond-containing
proteins. However, the reducing environment in the bacterial cytoplasm is unfavourable for disulphide
bond formation. EtMIC3_MAR1b has 8 cysteines which are expected to form 4 pairs of disulphide
bonds. To reduce the chance of misfolding and promote disulphide bond formation, EtMIC3_MAR1b
was expressed with a fusion protein, thioredoxin. The thioredoxin is encoded at the N-terminal side of
the MAR1b domain in the pET-32 vector. Thioredoxin contains two redox-active cysteine residues,
and in its oxidized form directly catalyses disulphide bond formation in the cytoplasm [205]. At
the C-terminus of thioredoxin is an N-terminal 6 residue polyhistidine tag (6 His) to allow protein
purification by Ni-affinity chromatography, and a factor Xa cleavage site directly upstream of the inserted
construct. Factor Xa is a serine endopeptidase which recognises a unique protein sequence : -Ile-Glu-Gly-Arg-↓,
allowing cleavage of the N-terminal thioredoxin and 6 His tag to produce the EtMIC3_MAR1b sample
with no additional residues.
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Sph I(1022)
EcoN I(1082)
Mlu I(1547)
Bcl I(1561)
BstE II(1728)
Apa I(1758)
BssH II(1958)
Hpa I(2053)
PshA I(2392)
Psp5 II(2654)
Bpu10 I(2754)
Tth111 I(3393)
Bst1107 I(3419)
Sap I(3532)
BspLU11 I(3648)
AlwN I(4064)
Ahd I(4541)
Bsa I(4602)
Pst I(4786)
Pvu I(4911)
Sca I(5021)
Dra III(5684)
Bpu1102 I(80)
Xho I(158)
Ava I(158)
Eag I(166)
Not I(166)
Hind III(173)
Sal I(179)
Sac I(190)
EcoR I(192)
BamH I(198)
EcoR V(206)
Nco I(211)
BseR I(235)
PinA I(257)
Kpn I(264)
Bgl II(267)
Nsp V(294)
pET-32 Xa/LIC
(5926bp)
Figure 2.2: Vector map of pET-32b Xa/LIC. This vector is designed to allow ligation independent cloning (LIC), and
expression of a fusion protein with N-terminal thioredoxin, 6xHis-tag, and optional C-terminal 6xHis tag which was not
included in the EtMIC3_MAR1b vector by placing a stop codon after the EtMIC3_MAR1b coding sequence. (Figure taken
from Novagen pET-32 cloning user manual)
2.2.1.4 Transformation
The plasmid was transformed into super-competent cells NovaBlue GigaSingles™ (Novagen) using
a standard heat-shock method. Approximately 5 ml of the annealed plasmid was added to 50 ml of
NovaBlue GigaSingles™. The mixture was gently mixed and incubated on ice for 5 minutes. The tube
was heated for 30 seconds in a 42 ºC water bath and returned to ice for 2 minutes. 250 ml of SOC
medium was then added to the tube and 50 ml of cells spread onto LB agar plates containing 50 mg/ml
carbenicillin (Sigma) for incubation at 37 ºC overnight.
2.2.1.5 Plasmid preparation
A single colony from the transformation was inoculated into 5 ml LB medium containing 50 mg/ml
carbenicillin and incubated overnight with shaking. The plasmid vectors were purified from the overnight
cultures using a Miniprep kit (Qiagen). The plasmids were sequenced by primer extension (Cogenics)
using the T7 promoter primer.
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2.2.2 Protein expression
2.2.2.1 Expression host
OrigamiT M B (DE3) pLysS E.coli (Novagen) cells were selected for the expression of disulphide bond-rich
EtMIC3. The OrigamiT M strain has mutations in both the thioredoxin reductase (trxB) and glutathione
reductase (gor) genes, which prevents disulphide bond reduction in the cytoplasm. The thioredoxin
fusion tag from the pET-32 vector further enhances the formation of disulphide bonds of the expressed
protein [205]. The B strain of OrigamiT M is derived from a lacZY mutant of the BL21 strain which
is deficient in both lon and ompT proteases [206], minimising degradation of the recombinant protein.
DE3 denotes that the host is a l lysogen with the T7 RNA polymerase gene under lacUV5 promoter
control. This allows induction of protein expression by IPTG via production of T7 RNA polymerase
which directs the expression of the target gene located downstream of the T7 promoter in the pET
vector. The pLysS strain expresses T7 lysozyme, a natural inhibitor of T7 RNA polymerase. This
further minimizes the basal expression of potentially toxic gene products before induction. The trxB and
gor mutations were selected by kanamycin and tetracycline, respectively, whilst the pET plasmid was
selected by carbenicillin.
2.2.2.2 Protein expression
Preliminary trial expression and solubility was performed by Dr. T. Blumenschein (University of East
Anglia). The optimised protocol for expression of 0.5 L of culture in 2 L fluted shake flask is as follows:
A single colony picked from a freshly transformed agar plate was inoculated into a 10 ml LB starter
culture containing carbenicillin (50 mg/ml), tetracycline (12.5 mg/ml) and kanamycin (15 mg/ml) for
incubation at 37 ºC overnight. The starter culture was then used to inoculate 0.5 L of sterilised LB
medium containing the antibiotics in a 2L fluted flask. The culture was grown at 37 ºC for several hours
until an optical density (O.D.) at 600 nm of 0.5 was reached. Protein expression was induced by the
addition of Isopropyl-b-D-thiogalactopyranoside (IPTG) (Melford) to a final concentration of 0.5 mM.
Following induction with IPTG the cells were incubated overnight at 30 ºC in a shaking incubator at 200
rotations per minute (rpm). The culture was harvested the next morning by centrifugation at 5000 g for
10 minutes. The cell pellets were used immediately or flash frozen in liquid nitrogen and stored at -80
ºC until required.
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2.2.2.3 Production of isotopically-labelled protein
For expression of isotopically 15N and 13C labelled EtMIC3_MAR1b, the bacterial culture was grown in
M9 minimal media containing 15N-ammonium chloride (0.07%) and 13C-glucose (0.2%) (see Appendix).
A 10 ml LB overnight starter culture was used to inoculate 0.5 L of minimal media in a 2 L fluted flask.
The expression protocol follow the one described above for unlabelled protein.
2.2.2.4 Cell disruption
The cell pellet was resuspended with 30 ml of binding buffer (50 mM Tris-HCl, pH 8, 300 mM NaCl).
One EDTA-free protease inhibitor cocktail tablet (Roche) and DNaseI (final concentration 6 mg/ml) were
added to the suspension and the cells were lysed using a French Press (SLM Instruments) or a Constant
Systems TS series cell disruptor. The lysate was centrifuged at 15,000 g for 30 minutes at 4 ºC to remove
cell debris.
2.2.3 Protein purification
2.2.3.1 Nickel affinity chromatography
Fusion proteins (thioredoxin-6 His-EtMIC3_MAR1b) were initially purified by nickel affinity chromatography.
The clarified lysate supernatant was loaded onto a 5 ml polypropylene column (Qiagen) packed with
Ni-NTA HisBind resin (Novagen) pre-equilibrated with binding buffer. The resin was washed with 5
column volumes of binding buffer (50 mM Tris-HCl, pH 8, 300 mM NaCl), followed by three washes
of 5 column volumes of wash buffer (containing 5 mM, 10 mM and 15 mM imidazole; see Appendix).
Finally, the protein was eluted with 10 column volumes of elution buffer (containing 250 mM imidazole).
Samples of all fractions were taken for analysis by SDS-PAGE electrophoresis. The eluate was then
dialysed with a 3500 Da MWCO membrane (Spectrum) against 4 L of Factor Xa cleavage buffer (50
mM Tris-HCl, pH 8, 100 mM NaCl, 5 mM CaCl2) overnight at 4 ºC.
2.2.3.2 Factor Xa cleavage and removal of fusion partner
After buffer exchange, the fusion protein was concentrated to 5 ml and cleaved using Factor Xa (Novagen)
at concentration of 1 unit of enzyme per 50 mg of protein. The reaction was incubated at room temperature
overnight on a roller mixer. Completion of the reaction was verified by SDS-PAGE and the reaction was
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terminated with 1 mM of the serine protease inhibitor phenylmethanesulfonylfluoride (PMSF). Factor
Xa was removed from the cleavage mixture by affinity chromatography using XarrestT M agarose resin
(Novagen).
Once the fusion protein was cleaved, the thioredoxin-6 His tag was removed by a second nickel affinity
chromatography step. The reaction mixture was loaded onto Ni-NTA resin pre-equilibrated with 5
column volumes of binding buffer (50 mM Tris-HCl, pH 8, 300 mM NaCl) and allowed to pass through
the column three times. The EtMIC3_MAR1b domain in the flow-through fraction was collected and
concentrated to 1 ml for further purification by size exclusion chromatography.
2.2.3.3 Size exclusion chromatography
Size exclusion chromatography was performed using an ÄKTAT M FPLC System (GE healthcare) using
a HiLoad 16/60 Superdex S75 gel filtration column (GE healthcare). The column was pre-equilibrated
in gel filtration buffer (50 mM Tris-HCl, pH 8, 300 mM NaCl). Elution fractions were collected
and analysed by SDS-PAGE; fractions containing EtMIC3_MAR1b domain were pooled and buffer
exchanged into the requisite buffer for experimental analysis.
2.2.3.4 NMR sample preparation
The purified protein sample was concentrated using a Vivaspin 20 centrifugal concentrator with 3500
kDa MWCO (Sartorius) and buffer exchanged into NMR buffer (20 mM NaPO4, pH 6.5, 50 mM
NaCl). The sample was finally concentrated to about 1 mM. Protein concentration was determined
using UV spectroscopy by measuring the absorbance at 280 nm. The concentration was calculated using
Beer-Lambert’s Law, A = ε ·c · l , where A is the absorbance, ε is the extinction coefficient, l is the light
path length and c is the protein concentration. The theoretical extinction coefficient was calculated using
the ProtParam tool from the ExPASY Proteomics Server (http://www.expasy.ch/tools/protparam.html
[207]).
Protease inhibitor cocktail (Roche) was added to reduce proteolysis and sodium azide (Sigma) to prevent
microbial contamination. For most samples D2O was added to 10 % of the total volume for the lock
signal during NMR experiments. A total sample volume of 0.5 ml was placed in a 5 mm NMR tube.
Where total solvent suppression was preferred, such as in the 13C-NOESY-HSQC and (H)CC-TOCSY
experiments the sample was lyophilised and reconstituted into 100 % D2O.
48
2.2.4 NMR experiments
2.2.4.1 NMR data acquisition, processing and analysis
1D and 2D 1H-15N HSQC NMR experiments were acquired on a Bruker DRX500 MHz magnet equipped
with a TXI cryoprobe. 1D NMR data were processed using Bruker TopSpin 1.3 (Bruker Biospin Ltd)
and 2D experiments using NMRPipe [208]. Data analysis was performed in NMRView 5.0 (One Moon
Scientific, INC [209]).
2.3 Results
2.3.1 Cloning
The PCR of EtMIC3_MAR1b was successful and the amplified product migrated to the expected molecular
weight when analysed by 1% agarose gel electrophoresis (Figure 2.3). The amplified construct was gel
purified, T4 DNA polymerase treated to generate 5’ single-stranded overhangs and annealed with the
pET-32 Xa/LIC vector. The ligated vector was then transformed into NovaBlue GigaSingleT M E.coli
cells. DNA sequencing results confirmed the correct construct was cloned.
Figure 2.3: PCR of EMIC3_MAR1b. The PCR products were analysed by 1% agarose gel electrophoresis. The amplified
EtMIC3_MAR1b (thickest band) migrated to the expected molecular weight at 370bp.
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2.3.2 Purification
2.3.2.1 Protein expression
Soluble expression was achieved for EtMIC3_MAR1b in OrigamiT M(DE3) for expression overnight at
30 ºC. About 10 mgs of purified protein could be obtained per litre of LB culture and about 8 mg of
labelled protein in minimal media.
2.3.2.2 Ni-affinity chromatography
The thioredoxin- 6 His- EtMIC3_MAR1b fusion protein was purified by Ni-affinity chromatography
(Figure 2.4). To minimise non-specific binding, the Ni-NTA resin was washed extensively with buffer
and up to 15 mM imidazole (at 20 mM imidazole the protein began to elute from the resin). The
SDS-PAGE showed the fusion protein ran at about 33 kDa and fully eluted at 250 mM imidazole. The
molecular weight of EtMIC3_MAR1b only is 13.2 kDa and the thioredoxin- 6 His tag is about 18 kDa.
Figure 2.4: Fractions from the Ni-affinity purification of the recombinant fusion protein (thioredoxin-6
His-EtMIC3_MAR1b) analysed by SDS-PAGE. Small amount of the fusion protein (33 kDa band) was eluted from the column
in the wash step with 20 mM imidazole (lane 5) and the rest was fully eluted in the 250 mM imidazole fraction (lane 6).
2.3.2.3 Fusion protein cleavage and gel filtration
Following dialysis into Factor Xa cleavage buffer overnight at 4 ºC, Factor Xa was used to cleave the
fusion protein. After cleavage, the thioredoxin-6 His tag was captured with a second nickel-affinity
chromatography step. EtMIC3_MAR1b remained in the flow through fraction and was concentrated for
the final purification by gel filtration (Figure 2.5). The UV profile at 280 nm of the gel filtration showed
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the homogeneity of the sample. One major sharp peak was observed, eluted at the volume corresponding
to the molecular weight of monomeric EtMIC3_MAR1b. Fractions under the largest peak were pooled
and buffer exchanged into NMR buffer, the sample was then concentrated to 0.5 ml, at a concentration
of approximately 500 mM.
Figure 2.5: Gel filtration profile of EtMIC3_MAR1b. The monomeric EtMIC3_MAR1b eluted from the column in a single
sharp peak which was confirmed by SDS-PAGE. The lower molecular weight impurities were excluded after this purification
step.
2.3.3 Preliminary NMR
2.3.3.1 1D 1H experiment
The 1D 1H NMR spectrum of EtMIC3_MAR1b was characteristic of a folded protein (Figure 2.6).
The ring-current shifted methyl peaks at around 0 ppm are often the result of sidechain methyl groups
of hydrophobic amino acids such as valine, leucine and isoleucine coming into close proximity above
or below aromatic rings. This can occur within the hydrophobic core of folded proteins. The amide
protein region between 6.5 to 11 ppm was also well dispersed, with peaks present above 9 ppm, which
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is characteristic of a tertiary structured protein. The line-widths of the peaks are commensurate with the
expected molecular weight. The recombinant expression of the EtMIC3_MAR1b domain has successfully
produced a folded protein sample, and the sample buffer seemed suitable for the protein.
Figure 2.6: 1D1H spectrum of EtMIC3_MAR1b recorded with excitation sculpting water suppression [210]. The presence
of ring-current shifted methyl peaks (around 0 ppm) and a well dispersed amide proton region (6.5 -11 ppm) suggests MAR1b
is folded.
2.3.3.2 2D 1H-15N Heteronuclear Single Quantum Coherence (HSQC) experiment
The 2D 1H-15N HSQC experiment is frequently used in protein NMR. It correlates the 1H and 15N
chemical shifts in a 2D spectrum, which contains a peak for each unique proton attached to a labelled
15N. The peaks in the 1H-15N HSQC spectrum are mainly the backbone amides of all amino acid residues
of the protein (except proline) as well as some sidechain amide and amine groups. These include the
tryptophan sidechain Ne-He groups and asparagine/glutamine sidechain Nd-Hd2/Ne-He2 groups. The
arginine Ne-He peaks can also be visible, but the Ne chemical shift is usually outside the region recorded,
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therefore the peaks appear at a folded/aliased position. The arginine Nh-Hh and lysine Nz-Hz groups
are usually not visible because they tend to be surface exposed and exhibit solvent exchange, however
they may be visible if they are buried or under solution conditions of slow intrinsic exchange.
Figure 2.7 shows the 1H-15N HSQC spectrum of EtMIC3_MAR1b. The peaks are well dispersed and
not crowded at the centre of the spectrum, this again suggests the presence of structured protein. There
are approximately 150 peaks, which roughly matches the number of amides and sidechains expected for
EtMIC3_MAR1b, and no obvious doubling of peaks is observed which indicates that the sample was
homogenous.
Figure 2.7: The 2D 1H-15N HSQC spectrum of EtMIC3_MAR1b. The peaks are well dispersed and there is little overlap
in the middle of the spectrum, between 7.5 to 8.5 ppm, which would indicate unstructured protein. Peaks between 6.5 and 7.5
ppm and 8.5 to 10 ppm, indicate the presence of structured protein. Several weak peaks present in the spectrum were later
found to be residual thioredoxin in the sample.
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2.4 Conclusions
The second MAR domain of Eimeria tenella microneme protein 3 (EtMIC3_MAR1b) was cloned,
expressed and purified. By expressing the protein in the E.coli OrigamiT M strain and as a fusion protein
with thioredoxin, the disulphide rich EtMIC3_MAR1b domain was successfully expressed as a folded
and structured protein. The result of a folded protein also indicates that the domain boundary designed
for the MAR1b domain was not interrupting any secondary structure and was likely to be predicted
correctly. The protein could be purified and was soluble in concentrations in excess of 500 mM and in
low salt and buffer conditions, of about 45 mM NaCl and 18 mM NaPO4 after dilution with 10% D2O.
These properties should enable collection of high quality NMR data with high signal-to-noise ratios.
The 1D and 2D 1H-15N HSQC spectra showed features of a folded and structured domain, including the
presence of ring-current shifted methyl peaks and a dispersed amide region. All in all, EtMIC3_MAR1b
was shown to be a suitable target for structural determination, which is discussed in the next chapter.
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Chapter 3
Structure determination of apo
EtMIC3_MAR1b
3.1 Introduction
The recombinantly expressed EtMIC3_MAR1b domain was shown to be a good target for structural
analysis in the previous chapter. In general X-ray crystallography is widely used to determine protein
structure [211]. However, low-affinity protein-carbohydrate complexes are not ideal for co-crystallisation,
and glycan ligands are highly flexible, which can also pose problems. NMR spectroscopy is a useful
alternative for studying lectin-carbohydrate interactions. It is indispensable for the determination of 3D
structure and conformation of complex oligosaccharides [212] and is particularly suitable for detecting
interactions in solution. The EtMIC3_MAR1b domain is suitable for NMR structural analysis. It is
monomeric, highly soluble and stable in solution. Moreover, at 13.2 kDa, it is within the size limit for
conventional triple resonance NMR experiments for structural characterisation. On the other hand, initial
crystallisation screens were set up for EtMIC3_MAR1b, but no hits were obtained. The domain seemed
to be highly soluble, as no precipitation was observed even at concentration as high as 100 mg/ml.
Therefore, NMR was pursued further for the structure determination of the EtMIC3_MAR1b domain.
The following chapter discusses the resonance assignment, structure calculation and the analysis of the
apo structure of the EtMIC3_MAR1b domain determined by NMR. First of all, an introduction to the
structural determination by NMR is given below.
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3.1.1 Resonance assignments
3.1.1.1 MARS
MARS is a program for automatic backbone assignment. Chemical shifts of the backbone atoms
are inputted into MARS as a pseudo-residue list. The program identifies the amino acid types of
pseudo-residues based on the relationship between amino acid type and 13Cα , 13Cβ and 13Cγ chemical
shifts. It links sequential pseudo-residues into segments using an all to all approach, where only
connectivities not in agreement with experimental intra- and inter-residual chemical shifts are removed,
therefore accepting all matching shifts within the tolerance set for the individual nuclei. Next, it
maps pseudo-residue segments onto the primary sequence by comparing the experimental 13Cα and
13Cβ chemical shift with a theoretical chemical shift value obtained for each residue from a statistical
analysis, with neighbour residue effects and secondary structure influences taken into account. The
program minimises assignment errors by simultaneously optimising the local and global quality of the
assignment, and outputting the assignment of each residue with a confidence score.
3.1.1.2 Chemical Shift Index (CSI)
After backbone assignment, secondary structure of the protein can be predicted using the Chemical Shift
Index (CSI). CSI is based on the observation that the 1Hα , 13Cα , 13Cβ and 13C’ NMR chemical shifts
are correlated with the protein secondary structure the amino acid residues are contained in [213]. In
particular, it has been found that the 1Hα and 13Cβ chemical shift of all 20 naturally occurring amino
acids experiences an up-field shift (with respect to the random coil value) in a helical conformation and
down-field shift when in a b-strand extended conformation. The opposite phenomenon is observed for
13Cα and 13C’, where a down-field shift is experienced when they are located in helices and an up-field
shift when they are located in b-strands [214, 215]. The deviation (either up-shift or downshift) from
the chemical shift for random-coil defines the chemical shift index for each residue in the protein. Local
clusters of three or four non-coil residues with respect to the primary sequence are then assigned regions
of helical or b-strand structure. For example, a contiguous stretch of chemical shift assignments for 13Cα
nuclei which consistently fall below those expected for random coil can be used as a sufficient indicator
for the presence of b-strand secondary structure.
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3.1.2 NMR-derived restraints for structure calculation
A number of NMR-derived restraints were used for structure calculation of EtMIC3_MAR1b. These
include the NOE-derived restraints, dihedral angle restraints from chemical shifts and disulphide and
hydrogen bond restraints. The NOE and dihedral angle restraints are discussed in the following section.
The NOE arises due to dipolar coupling (through space) between nuclei, only spins which are close
in space demonstrate this effect. The NOE-derived distance restraint is based on the relationship that
the intensity of the NOE cross-peak is proportional to the distance between two interacting 1H spins
and hence forms the basis of structural calculations. The NOESY (nuclear Overhauser enhancement
spectroscopy) experiment is commonly used to detect NOE signals. It measures the NOE build up during
a short mixing time (e.g. 100ms) and provide information of relative proximity of protons, typically less
than about 6 Å apart.
3.1.2.1 TALOS
The backbone angle prediction program TALOS [216, 217] was used to generate the backbone f and
y torsion angles restraints. It has been mentioned in the CSI section that chemical shifts of backbone
atoms in proteins are sensitive to local conformation, and homologous proteins show similar patterns
of secondary chemical shifts. The inverse of this relation is used in TALOS to search a database for
triplets of adjacent residues with secondary chemical shifts and sequence similarity which provide the
best match to the query triplet of interest. The database contains 1Hα , 15N, 13CO, 13Cα , 13Cβ chemical
shifts for 200 proteins for which a high resolution X-ray structure is available. TALOS searches this
database for 10 triplets sequences which have the closest similarity in secondary chemical shift and
amino acid sequence to those of the query sequence. If the central residues in these 10 triplets exhibit
similar f and y backbone angles, their averages can reliably be used as angular restraints for the protein
whose structure is being studied.
3.1.3 Structure calculation using ambiguous distance restraints
The ARIA (ambiguous restraints for iterative assignment) protocol was used for the assignments of NOE
cross-peaks [218, 219]. ARIA assigns NOEs using a combination of ambiguous distance restraints
(ADRs) and an iterative assignment strategy by first deriving all possible assignments for each peak
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by matching a list of chemical shifts with the NOESY peak list. Peak volumes are converted into
distance restraints, using the r−6 relationship. Ambiguous assignments are converted into ADRs, so
all assignment possibilities contribute to the target distance [220]. An initial ensemble of structures is
calculated using any unambiguous, including manual, assignments and the ADRs. In each new iteration,
this structural ensemble is sorted according to their total energy, and the lowest energy structures are
chosen. The ADRs are analysed for restraint violations in the chosen lowest energy structures, and any
restraint that is systematically violated is removed. A new set of structures is then calculated. After a
few iterations, the structural ensemble and the dataset should converge. Manual inspection of the lists
of rejected restraints after each ARIA run helps eliminate errors in the NOESY peak lists such as peaks
from noise or artefacts from the spectra, or any chemical shift mis-assignments. The structures from
initial ARIA runs can help additional manual assignments if necessary, which could be added to the next
ARIA run until a final set of structures of the best possible quality is achieved. Finally, the calculated
structure is refined in explicit water [221] to reduce artefacts such as unrealistic side-chain packing and
unsatisfied hydrogen bond donors and acceptors as a result of simplified treatment of non-bonded forces
and missing solvent contacts during structure calculation.
Structure calculation by ARIA is incorporated in the CNS (Crystallography & NMR System) suite [222,
223]. The experimental-derived distance restraints are incorporated into a target function:
E = wconEcon+wexvEexv+wexpEexp
where Econ describes covalent geometry including bond lengths, bond angles, planarity and chirality.
Eexv is a repulsive function that prevents atoms from overlapping and Eexp is the experimentally-derived
distance restraints including NOEs, dihedral angles and hydrogen bonds. The minimisation for the target
function involves a sequence of simulated annealing (SA) stages and is described in detailed in [220].
3.2 Materials and methods
3.2.1 Sample preparation and NMR experiments
A uniformly 13C,15N labelled sample of EtMIC3_MAR1b was prepared as described in (Chapter 2).
A summary of the experiments recorded and their acquisition parameters is listed in Table 3.1. All
experiments, except the NOESY experiments, were acquired on a Bruker DRX500 MHz magnet equipped
with a TXI cryoprobe. The NOESY experiments were acquired on a Bruker Avance II 800 MHz magnet
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with a TXI cryoprobe. The sample temperature was set at 303 K and the NOESY experiments were
recorded with a mixing time of 100 ms. All spectra were referenced to the resonance frequency of the
water peak in the direct proton dimension and the indirect dimensions were referenced using frequency
ratios [224].
Experiment Nucleus Complex points Spectral width (Hz) Field strength (MHz)
HSQC 1H 1024 6510.42 500
15N 100 1520.68
HNCACB 1H 512 6510.42 500
15N 37 1520.68
13C 53 8333.33
CBCA(CO)NH 1H 512 6510.42 500
15N 37 1520.68
13C 55 8333.33
HN(CA)CO 1H 512 6510.42 500
15N 36 1520.68
13C 55 1666.67
HNCO 1H 512 6510.42 500
15N 36 1520.68
13C 55 1666.67
HBHA(CBCACO)NH 1H 512 6510.42 500
15N 37 1520.68
1H (indirect) 90 3001.20
H(C)CH-TOCSY 1H 512 6250 500
13C 32 4401.41
1H (indirect) 128 4752.85
(H)CCH-TOCSY 13C 120 8810.57 500
13C (J-coupled) 32 3144.65
1H 512 6250
(H)CC(CO)NH 1H 512 6510.42 500
15N 38 1520.68
13C 100 11947.43
(HB)CB(CGCD)HD 1H 1024 6265.66 500
13C 26 3144.65
(HB)CB(CGCDCE)HE 1H 1024 6250 500
13C 26 3144.65
15N NOESY-HSQC 1H 1024 10416.67 800
15N 40 2433.09
1H (indirect) 140 10416.67
13C NOESY-HMQC 1H 1024 10000 800
13C 44 14084.51
1H (indirect) 148 10000
Table 3.1: List of parameters used in all NMR experiments for EtMIC3_MAR1b. All spectra were recorded at
303K.
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3.2.2 Chemical shift assignments
3.2.2.1 Sequential backbone assignment
Cross-peaks from the HNCACB, CBCA(CO)NH, HN(CA)CO, HNCO spectra were picked manually
using NMRView (One Moon Scientific, Inc.) and an in-house module was used to generate a pseudo-residue
(PR) list with the chemical shifts of 1HNi ,
15Ni, 13COi, 13Cαi ,
13Cβi ,
13C’i−1, 13Cαi−1 and
13Cβi−1 [225].
Automatic backbone assignments were performed using MARS [85]. The PR list, amino acid sequence,
secondary structure prediction data from PSIPRED [226], fixed assignment file listing the glycine PRs
and disulphide bond table listing all cysteine residues were inputted into MARS. The programme was
run with a maximum length of PR fragments of 5, 0.25 ppm tolerance for 13C’ and 0.5 ppm tolerance
for 13Cα and 13Cβ .
3.2.2.2 Secondary structure analysis
The backbone assignment was analysed using the Chemical shift index (CSI) to determine the secondary
structure of EtMIC3_MAR1b [213, 214, 215], as implemented in NMRView.
3.2.2.3 Sidechain assignment
The sidechains resonances were assigned using the HBHA(CBCACO)NH, H(C)CH-TOCSY, (H)CCH-TOCSY,
(H)CC(CO)NH and the 15N- NOESY-HSQC and 13C- NOESY-HMQC spectra in NMRView with an
additional graphical tool [227]. Additionally, the (HB)CB(CGCD)HD, (HB)CB(CGCDCE)HE were
used for aromatic sidechain assignments.
3.2.3 NMR-derived restraints for structural calculation
3.2.3.1 NOE-derived restraints
NOE cross-peaks from the 15N- and 13C-separated NOESY spectra of EtMIC3_MAR1b were picked
automatically by NMRView and the peak list was checked manually to remove any peaks due to noise
or artefacts. Since the 13C NOESY spectrum was recorded in D2O buffer, the protein amides in the
sample were only partially protonated. Therefore the intensity of the NOEs peaks to these amide peaks
cannot be used as distance restraints in the structural calculation. Hence peaks below 8 ppm in the 13C
NOESY peak list were removed.
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3.2.3.2 Dihedral angle restraints from chemical shifts: TALOS+
TALOS+ was used to generate a set of dihedral angle restraints, only the angles which were classified as
unambiguous by the programme were used in structural calculation. The minimum error of all dihedral
angles was set to 25° or two standard deviations of the prediction, whichever was greater.
3.2.3.3 Disulphide bond and hydrogen bond restraints
Four disulphide bonds were imposed between cysteines C12 - C50, C20 - C28, C65 - C75, and C69
- C105 according to the expected pattern for a type-I MAR domain only after it was confirmed by
observation of NOE peaks across the disulphide bonds. At later stages of the refinement, hydrogen
bonds were imposed on the two helices (from residues Thr 3 - Ser 22 and Glu 92 - Lys 101) between
the backbone N-H group to the C=O group of the amino acid four residues earlier, and on the first and
second b sheets in the anti-parallel arrangement (between the backbone N-H and C=O groups of residues
Tyr 33 and Tyr 51; and Arg 35 and Arg 49).
3.2.4 Assignment of NOE cross-peaks and structure calculation
3.2.4.1 ARIA (ambiguous restraints for iterative assignment)
Input files included the protein sequence, 15N-, 13C- NOESY peak lists, chemical shift assignments,
TALOS+ derived dihedral angles, list of disulphide bonds and hydrogen bonds. The frequency window
tolerance for automatic NOE assignment was set to 0.05 ppm for direct and indirect proton dimensions,
0.3 ppm for 15N and 1 ppm for the 13C dimensions. All other parameters were set as default.
3.3 Results
3.3.1 Sequential backbone assignment
Approximately 80% of backbone assignments were achieved in the initial MARS run. The regions of
missing assignment or assignments with low reliability were checked manually. Some of these missing
assignments were due to missing peaks, mistakes in peak picking, or difficulties in distinguishing
overlapping peaks from different spin systems in crowded regions of the spectra. MARS was re-run
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with corrected peak lists and several manual assignments iteratively to improve the assignment. The rest
of the backbone connectivities were confirmed manually (Figure 3.1).
Figure 3.1: Representative strips of the CBCA(CO)NH (Left) and HNCACB (Right) spectra. Positive peaks are
shown in black and negative peaks are shown in red.
Two regions were missing in the backbone assignment. First of all, Gln 114 to Pro 123 at the C-terminus,
thought to be a linker between the two MAR domains with no predicted secondary structure (PSIPRED).
Secondly, Gly 82 to Ser 92 which spans the predicted 5th b-sheet and is predicted to be the binding site
for the carbohydrate ligand according to the TgMIC1_MARR crystal structure. Excluding prolines,
other missing assignments include Gly 29, Ser 41 and Ser 42, which are predicted to be in loop regions.
Many resonance peaks were missing from the spectra in these unassigned regions, possibly due to their
dynamics in solution causing severe peak broadening, or rapid exchange of the backbone amide with the
solvent in solvent exposed regions and hence are not detectable in the spectra. Subsequent pH titration
experiments showed extra peaks present at lower pH (pH 5) which could be assigned to the 5th b-sheet
(section 5.3.1).
An annotated 15N-HSQC showing all backbone and sidechain amide resonance assignments is provided
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in Figure 3.2.
Figure 3.2: 1H-15N HSQC of EtMIC3_MAR1b. Backbone amide resonances are labelled with assigned residue
number.
3.3.2 Secondary structure analysis
The CSI predicts EtMIC3_MAR1b consists of 2 a helices and five short b sheets connected by quite
extensive loop regions (Figure 3.3). This prediction compares well with the secondary structure of a
type I-MAR domain (Chapter 1, Figure 16). The prediction for the C-terminal proline-rich region (Thr
114 to Pro 123) is poor due to missing assignments.
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Figure 3.3: Secondary structure analysis of EtMIC3_MAR1b using the Chemical shift index (CSI) based on
the1Hα , 13Cα , 13Cβ , 13C’ chemical shifts. Secondary chemical shifts indicative of helical and sheet regions are
indicated by red and blue lollipops respectively. Those within the random coil shift range are shown with grey
circles, missing assignments are shown with an empty grey line and the consensus secondary structure is shown
underneath.
3.3.3 Sidechain assignment
Sidechain assignments of the backbone assigned regions of EtMIC3_MAR1b were completed to approximately
95%. An example of an assigned sidechain (Leu 21) is shown in Figure 3.4. The sidechains of five
aromatic residues were fully assigned with the exception of CHz of Phe 58. Sidechain amides of
arginine, lysine, asparagine and glutamine were partially assigned and missing assignments include
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NHe of Gln 14, 43 and 94; NHe of Arg 76, 89; NHh of Arg 10, 49, 76, 89; NHd of Asn 103 and NHz of
all lysine residues.
The Cα and Cβ resonances of all cysteine residues were characteristic of the oxidised form [228]. Long
range NOEs across the disulphide bonds were observed, confirming the pairing of the cysteines in the
folded protein.
Resonances assigned to chemical shifts more than 3 standard deviations from the average deposited in
the Biological Magnetic Resonance Databank (BMRB) for the same atom type are listed in Table 3.2.
The ring current shift effect is one possible reason for at least some of these outliers. This is discussed
in the context of the structure in section 3.7.1. The reasons for unusual chemical shifts for Arg 35 Hd,
Hh, Arg 49 Hd and Arg 89 Hd, could be that they are not solvent exposed, this is certainly the case for
Arg 35 (discuss below). The full set of resonance assignments of EtMIC3_MAR1b have been deposited
in the BMRB under the accession number 16233 [229].
Residue Atom RMRB Average BMRB s.d. Assigned Shift
A34 Hα 4.26 0.44 5.887
R35 Hδ2 3.12 0.24 3.981
R35 Hη21 6.79 0.41 8.430
Y36 Hβ 2.87 0.38 0.177
K38 NH 8.19 0.62 10.618
N40 Nδ2 112.85 2.41 122.29
K46 Hβ3 1.76 0.26 -0.026
K46 Hγ2 1.38 0.26 0.597
R49 Hδ2 3.12 0.24 2.393
Y51 Hε1 6.71 0.23 5.889
Y51 Hε2 6.71 0.24 5.889
L56 Hβ3 1.55 0.36 -0.051
L56 Hγ 1.51 0.34 -0.19
L56 Cγ 26.73 1.28 22.228
G77 Hα3 3.91 0.38 1.957
R89 Hδ3 3.11 0.25 2.312
Table 3.2: A list of resonances of EtMIC3_MAR1b which has an assigned chemical shift value of more than 3
standard deviation from the average value in the BMRB for the same atom type.
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Figure 3.4: Representative sidechain assignment strips. The sidechain proton strips of Leu 21 from the
HCCH-TOCSY spectrum are shown, the same resonance pattern is observed for all the strips of the same amino
acid sidechain.
An unusual feature in the resonance assignment was the observation of two amino peaks at 76 ppm;
7.3 and 8.3 ppm in the 1H-15N HSQC recorded with wide spectral width in 15N. They were assigned to
the Hh resonances of Arg 35 based on NOEs to other sidechain protons of Arg35 (Hg, Hd2, Hd3 and
He). The Arg 35 He was assigned based on intra-residue NOEs to sidechain protons (Hg, Hd2 and Hd3)
and NOEs to other residues after the initial structure was determined. The signal of these exchangeable
amino protons are usually not observable when the sidechain is solvent exposed at room temperature
and near-neutral pH. The observation of these peaks indicates that the sidechain of Arg 35 is possibly
buried within the hydrophobic core of the protein. This is discussed in the context of the structure in
section 3.3.7.2.
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3.3.4 NMR-derived restraints for structure calculation
3.3.4.1 NOE-derived restraints
Automatic peak picking of the NOESY spectra generated 2 peak lists, after manually removing peaks
due to noise and artefacts thoroughly, the resulting 15N and 13C- NOESY peak lists contained 2114 and
3152 peaks respectively.
3.3.4.2 Dihedral angle restraints from chemical shifts: TALOS+
A total of 224 TALOS-derived dihedral angles ( total φ andψ) were included in the structural calculation.
The C-terminal residues Lys 108 to Ala 116 were classified as dynamic and residues Thr 117 to Pro 123
have no prediction because of missing assignments. 14 other residues (Cys 12, Gly 23, Gly 29, Lys
38, Gln 44, Thr 45, Lys 46, Ile 52, Phe 58, Ser 59, Asp 63, Gly 64, Ser 80, Thr 84) were flagged as
ambiguous and therefore not used for structural calculation. Excluding these regions and the first residue
Ala 1, predictions for the rest of the residues were classified as good and were implemented in ARIA.
3.3.5 Assignment of NOE cross-peaks and structure calculation
A total of 10 rounds of ARIA was carried out. NOE and dihedral violations from initial runs were
improved by removing peaks due to noise and artefacts in the NOESY peak list. A couple of chemical
shift mis-assignments causing large violations in all structure were investigated and corrected. Furthermore,
a bend in the first helix in the initial structure was corrected after the sidechain Hh and He of Arg 35
were assigned. (See section 3.3.7.2)
Using the initial structure, 22 hydrogen bonds within the two helices and 3 pairs of hydrogen bonds
between the antiparallel b sheets were identified and included as restraints in the structure calculation in
later runs of ARIA calculation. Pairs of disulphide bonded cysteines confirmed by manually assigned
NOE peaks were also used in the later stages of calculation. In the final round of ARIA, 0.5±0.5 NOE
violations above 0.5 Å and 4±2 dihedral violations above 5 Å in the 10 lowest energy structures. Figure
3.5 shows the cartoon representation of the lowest energy structure of EtMIC3_MAR1b after the final
round of ARIA. As mentioned above, the unassigned C-terminal region is likely to be flexible in solution.
There were no distance restraints for this region and as such it was represented in many conformations
in the calculated structures. This region is therefore not shown in Figures 3.5 to 3.6 for clarity of the
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diagrams.
The EtMIC3_MAR1b domain contains a number of distorted b-sheets, flanked on one side by an
anti-parallel helical bundle comprising one helix from each terminus, characteristic of the MAR domain
identified in TgMIC1 [201]. The first a-helix (a1) comprises residues Leu 4 - Ser 22 followed by five b
strands encompassing residues Ile 32 - Asp 37 (b1) , Glu 47 - Ile 52 (b2), Ser 61 - Val 66 (b3), Met 72 -
Arg 76 (b4), His 86 - Thr 88 (b5), and the second a-helix spans residues Glu 92 - Asn 103 (a2).
Eight cysteines in conserved positions form four pairs of disulphide bonds in an arrangement unique to
the MAR1 subfamily (Figure 6). Three of them (C12 - C50, C65 - C75, C69 - C105) stabilise the core
structure, whilst C20 - C28 stabilises the first a-helix and subsequent loop (MAR1 insertion), which is
significantly longer in the MAR1 subfamily [201].
Figure 3.6 shows the ensemble of 10 lowest energy structures following water refinement in the last
round of ARIA calculation, showing good convergence between models, with an RMSD of 0.22±0.04
Å over backbone atoms and 0.60 ±0.06 Å over all heavy atoms within secondary structures. Detailed
statistics for the structure are listed in Table 3.3 and a breakdown of the restraints is listed in Table 3.4.
A total of 2962 restraints were used for the structure calculation including 1995 unambiguous and 713
ambiguous NOE-derived restraints.
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Figure 3.5: The solution structure of Eimeria tenella microneme protein 3_MAR1b domain (showing residues
Ala1 to Thr106) in four projections. The two helices (α1 and α2) are shown in green and five b-sheets (β1-5) are
shown in orange. Four disulphide bonds are shown in yellow.
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Figure 3.6: Backbone traces of the 10 lowest structure ensemble of EtMIC3_MAR1b.
RMSD from experimental restraints
Distance (Å) 0.049±0.002
Dihedral angle (º) 1.38±0.11
RMSD from idealised covalent geometry
Bonds (Å) 0.0064±0.0001
Angles (Å) 0.72±0.02
Improper (Å) 2.09±0.07
Coordinate RMSD Coordinate RMSD (Å)
Backbone atoms in secondary structure 0.22±0.037
Heavy atoms in secondary structure 0.60±0.064
Energies (kcal ·mol−1)
Etotal -4031.66±120.84
ENOE 330.47±32.97
Ebond 73.89±1.90
Eangle 263.70±11.24
Eimproper 619.11±38.55
Edihedral 653.19±5.82
Evdw -874.45±132.17
Eelec -4767.1±82.98
Table 3.3: Structural statistics of EtMIC3_MAR1b 10 lowest energy structure ensemble.
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Experimental restraints
NOE-derived 2708
Ambiguous 713
Unambiguous 1995
Intra-residue 726
Sequential 307
Medium range (1> |i− j| ≤ 4) 329
Long range (|i− j|> 4) 633
TALOS-derived dihedral angles (φ and ψ) 224
Hydrogen bonds 30
Total number of restraints used 2962
Table 3.4: Experimental restraints used for structure calculation of the EtMIC3_MAR1b domain.
3.3.6 Structural validation
The EtMIC3_MAR1b was submitted to the Protein Structure Validation Suite (PSVS) (http://psbs-1_3.nesg.org).
The built-in module Procheck [230] gave a Z-score of -2.16 when only phi/psi angles are included, and
a Z-score of -3.84 when all dihedral angles are included. The Ramachandran plot [231] of the structure
ensemble is shown in Figure 3.7. It shows that 82.3% of the residues fall within the most favoured
regions, 17.7% in additionally allowed regions and none in generously allowed and disallowed regions.
Several residues at the C-terminus are either in the generously allowed or disallowed regions, but this
region is poorly defined by the NMR data and is likely to be unstructured.
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Figure 3.7: Ramachandran plot of the 10 lowest energy structures of EtMIC3_MAR1b. Glycine residues are
shown as triangles, residues in unfavourable regions are shown as red squares.
3.3.7 Structure features and analysis
3.3.7.1 Ring-current shifted residues
Using the calculated structure of EtMIC3_MAR1b, majority of the atoms with unusual chemical shifts
listed in Table 3.2 are in close proximity of aromatic rings, therefore are likely to be affected by ring
current shifts (Figure 3.8). Of these Ala 34 Ha is also located within a b sheet which presumably
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contributes to its down-field shift (5.89 ppm). Lys 46 Hb and Hg are likely to be shifted by Tyr 36,
although the low Hg shifts is not consistent with the position entirely, suggesting the sidechain position
may be slightly different from that calculated. A couple of unusual shifts are in the hydrophobic core of
the protein (R 35 Hh and N 40 Nd), therefore are likely to be influenced by restricted motion, unusual
chemical environment and hydrogen bonds, etc. The details of R35 is discussed below.
Figure 3.8: Ring current shifted atoms in the structure of EtMIC3_MAR1b.
3.3.7.2 Internal Arg 35 sidechain
The structure revealed that Arg 35 is indeed buried within the hydrophobic core of the protein. Apart
from the intra-molecular NOEs from the He atom to the neighbouring Hd and Hg, a number of inter-molecular
NOEs were identified for Arg He (Figure 3.9a). This includes NOE cross peak to Gly 77 Ha, Leu 56 Hg
and Tyr 33 Ha shown in the 15N- NOESY strip in Figure 3.9a, the NOE interactions are shown in the
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structure of EMIC3_MAR1b in Figure 3.9b.
The structure of EtMIC3_MAR1b also revealed that the sidechain guanidino group (NHe, NHh) of
Arg 35 is coordinated by several salt bridges with the backbone carbonyl of Gly 62 and the sidechain
carboxylate groups of Asp 37 and Ser 78 (Figure 3.9c). This presumably reduces the proton exchange
rate with solvent and hence explains why it was visible in the 1H-15N HSQC spectrum. The Arg
guanidino group thus appears to constitute a structural feature of the EtMIC3 MAR domain. The large
number of NOEs associated with the NHe group meant that prior to assignment structure calculations
did not converge properly.
Figure 3.9: a) 15N-NOESY strip of Arg 35 Hε. Intra-residual NOE peaks are labelled in black and inter-residual
NOE peaks are labelled in red. b) The inter-residual NOE interactions of Arg 35Hε shown in (a) represented in
the structure of EtMIC3_MAR1b. c) Buried sidechain of Arg 35, Gly 62, Asp 37 and Ser 78 are represented as
sticks and coloured in purple and light blue. The dotted yellow lines indicate potential charge-based or hydrogen
bonding interactions between the NHε and NHη groups of Arg 35 and backbone carbonyl of Gly 62 and the
sidechain carboxylate groups of Asp 37 and Ser 78. (Protons are not shown)
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3.4 Discussion
3.4.1 Comparison with TgMIC1/ MAR1 vs MAR2
Despite a sequence identity of only 28%, the structure shows remarkable resemblance to the MAR1
domain of TgMIC1 (PDB code 2JH1) and these superimpose with an overall RMSD of 1.73 Å over
all backbone atoms (Figure 3.10, left). The loop regions did not align very well in the two structures.
In particular, the loop following the 3rd and 4th b sheet is longer in TgMIC1 MAR1. This loop is
poorly defined in the crystal structure [201]. A comparison of the structure with that of MAR1 and
MAR2 of TgMIC1 reveals that EtMIC3_MAR1b contains a prominent extension to the first helix and
subsequent loop, which is stabilised and pinned together by an extra disulphide bond, exclusive to the
MAR1 subfamily (Figure 3.10, right). However, EtMIC3_MAR1b superimposes with an RMSD of
0.947 Å with the MAR2 domain from TgMIC1 (PDB code 2JH1) outside of this region. Hence EtMIC3
resembles the expected MAR1 family but outside of the first helix, it is closer structurally to the MAR2
of TgMIC1.
The carbohydrate binding site at the 5th b sheet of EtMIC3_MAR1b seemed to align better with TgMAR2
than TgMAR1 (Figure 3.11). A His and Thr residues are conserved in all the binding sites. The Leu in
between the His and Thr in EtMIC3_MAR1b is substituted by a Tyr in TgMAR2 and a Ala in TgMAR1.
The orientation of all the sidechains are very similar in the EtMIC3_MAR1b and TgMAR2 alignment,
but for the TgMAR1 alignment the position of the His and Thr are most similar.
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Figure 3.10: Superposition of EtMIC3_MAR1b (Green) with TgMIC1 (PDB code 2JH1) MAR1 domain (Left,
blue) and MAR2 domain (Right, magenta). The ligand binding sites are labelled with a red arrow. In the MAR1
domain alignment (left diagram), the extended loop in TgMIC1 is indicated. In the MAR2 domain alignment, the
position of the extended first helix labelled ’MAR1 insertion’ is shown. Disulphide bonds are shown in yellow.
Figure 3.11: The alignment of the sidechains of the residues at the ligand binding site of EtMIC3_MAR1b
(green) and the MAR domains of TgMIC2 (MAR1 shown in blue and MAR2 shown in magenta). The residue
numbers of EtMIC3_MAR1b are labelled on the left and TgMIC1 on the right.
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3.5 Conclusion
The solution structure of EtMIC3_MAR1b was solved by NMR spectroscopy. Despite low sequence
identity, the MAR domain seems to have a high degree of structural conservation across the two Apicomplexan
species, T. gondii and E. tenella. This result is intriguing because although both proteins are known
to bind sialic acid-terminated carbohydrates, they have unique specificity towards different types of
oligosaccharide ligands (section 4.2.1) as Toxoplasma gondii and Eimeria tenella have different host
and tissue tropism. To investigate this further, the structural basis of the binding of EtMIC3_MAR1b
to its carbohydrate ligands needs to be explored in more detail. This will be discussed in the following
chapters.
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Chapter 4
Studying EtMIC3-glycan interactions by
NMR
The NMR structure described in the previous chapter has shown that the EtMIC3_MAR1b has a MAR
domain structure similar to the ones in TgMIC1. In order to confirm the function of EtMIC3 as a sialic
acid binding protein and to characterise the glycan specificity of EtMIC3, biochemical experiments
were conducted in collaboration with Janene Bumstead (Institute of Animal Health) and glycoarray
experiments were done in collaboration with Yan Liu (Imperial College London) using recombinant
EtMIC3 protein. Based on these results, NMR experiments were carried out to confirm the interaction
and explore the structural basis of the interaction.
4.1 Studying protein-ligand interaction by NMR
NMR spectroscopy is widely used as a tool for studying biomolecular interactions. Distance and
orientational restraints derived from measuring nuclear Overhauser effects (NOEs) and residual dipolar
couplings (RDCs) of the protein-ligand complex can be used for structure determination, but this can
be lengthy and complicated. On the other hand, methods such as mapping chemical shifts from NMR
titration data, Saturation Transfer Difference (STD) and relaxation experiments can be used to identify
ligands and determine the binding interface of biomolecular complexes. The following sections give a
brief background of various NMR techniques that are commonly used in determining the protein-ligand
interactions; the methods, results and discussion of the EtMIC3_MAR1b-ligand characterisation is
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presented afterward.
4.1.1 Chemical shift mapping
The perturbation of chemical shifts as a result of complex formation provides a sensitive tool for
identifying protein binding sites. The chemical shift mapping method is especially useful for studying
weak or transient complexes that can be very difficult to study by other experimental techniques. The
1H-15N HSQC is commonly used for chemical shift mapping because of its sensitivity and resolution.
The spectrum of the 15N labelled protein is monitored as increasing amounts of unlabelled ligand is
titrated in. The protein is presumed to be saturated when the resonance peaks no longer change with
increasing ligand concentration. The changes in 1H-15N chemical shift can be used to localise the
binding site where the proximity of the ligand perturbs the peaks of the residues at the binding interface.
On the other hand, addition of the ligand may induce conformational changes, causing chemical shift
changes in more remote parts of the protein.
4.1.2 Effect of Chemical exchange on the NMR signal
Chemical exchange refers to the process in which a nucleus exchanges between different environments
in which its NMR parameters differ. In the context of this chapter, the chemical exchange refers to the
binding of EtMIC3_MAR1b with the carbohydrate ligands on the chemical shift timescale (ms).
The binding of a ligand (L) to a protein (P) can be described as a second-order exchange process, where
P+L
 PL
and k f is the rate of the forward (association) reaction, and kr is the rate of the reverse (dissociation)
reaction, and the rate of chemical exchange kex is defined by
kex = k f [L]+ kr
The chemical exchange between e.g. EtMIC3_MAR1b in its bound and unbound form can be monitored
by the chemical shift (υ) differences between the two species. Three exchange regimes which can be
defined are:
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1. Slow exchange: kex| υP−υPL |
2. Intermediate exchange: kex ∼| υP−υPL |
3. Fast exchange: kex| υP−υPL |
Where υP−υPL is the frequency difference between a NMR signal of the free and bound state [232]. The
exchange regime of the protein-ligand complex dictates the quality of the resulting NMR spectra as well
as the experiments that are suitable for studying the complex. Complexes in either slow or fast exchange
can be readily studied by NMR but due to line broadening effects, intermediate exchange processes may
be more difficult to study before saturation is reached (Figure 4.1). Therefore it is important to establish
the exchange regimes of the biomolecular complex of interest before deciding which NMR experiments
are used to characterise the complex.
4.1.2.1 Slow exchange
If the rate of exchange between the bound and unbound state is slow compared to the differences in
chemical shifts of the two species, kex | υP−υPL |, the frequency of each environment is sampled
before exchange. Therefore the spectrum contains two signals representing a superposition of the
individual signals, and the intensities of the signals would represent the relative amounts of each species.
The slow exchange regime is usually observed for tightly bound complexes with a dissociation constant
(Kd) of less than 0.5 mM [232].
4.1.2.2 Intermediate exchange
If the rate of exchange between the two states is comparable to the differences in chemical shifts of
the two species, kex ∼| υP−υPL |, the protein resonance broadens significantly as ligand concentration
increases until it disappears when the total ligand concentration is approaching 50% saturation. The
protein signal reappears at closer to saturation of the binding site.
4.1.2.3 Fast exchange
If the rate of exchange between the two states is fast compared to the differences in chemical shifts of the
two species, kex| υP−υPL |, the spectrum contains a single signal and the chemical shift is a weighted
average of the chemical shifts of the two states. The protein resonance does not change significantly in
80
intensity or line-width, but the chemical shift changes continuously as the ligand concentration increases.
Fast exchange is commonly observed for many signals perturbed in weakly bound complexes with Kd
higher than 100 mM [232].
Figure 4.1: The spectra of the interacting molecules A and B in different chemical exchange regimes (Slow,
intermediate and fast) in the NMR chemical shift timescale. The spectra in both slow and fast exchange regime
gives sharp peaks whilst severe line broadening occurs when is complex is in intermediate exchange. (Figure
taken from [232])
4.1.3 Structure determination from NMR restraints
If the protein-ligand complex is in slow exchange, i.e. the protein binds strongly to the ligand, structure
determination is possible based on inter-molecular NOEs obtained from isotope filtered experiments.
The structure of the protein in its bound form can be determined by standard multidimensional heteronuclear
NMR experiments with suppression of resonances arising from the ligand if required. This can be
achieved with an isotope-editing experiment which selects for the 15N and 13C- bound proton resonances.
The resonances of the bound ligand can be assigned using isotope-filtered experiments which remove
the resonances of the labelled protein. Finally, experiments such as the 3D 13C F1-filtered, F3-edited
NOESY-HSQC can be used to reveal the intermolecular 1H- 1H NOE interactions across the complex
interface. These intermolecular NOE signals can then be used as distance restraints for structure calculation.
4.1.4 3D Filtered-NOESY
The 3D 13C F1-filtered, F3-edited NOESY-HSQC experiment includes isotope filtering and editing in
each of the two proton dimensions, thus the cross-peaks represent exclusively intermolecular 1H-1H
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NOE interactions across the complex interface. A third dimension is used to separate resonances
according to the chemical shifts of the attached 13C. This third dimension allows the direct assignment
of the intermolecular NOE peaks to the binding interface of the protein, provided the 13C assignment of
the protein in the bound-state is available (discussed in the next chapter).
Isotope filters in the experiment have to be tuned to the J-coupling because any in-phase heteronuclear-bound
proton resonance is unaffected by the filter [233, 234]. 15N backbone amides have a relatively uniform
1JHN coupling constant of around 90 Hz. However, 13C has a large range of 1JHC for different types of
C-H group, ranging from about 125 Hz for aliphatic methyl groups to 220 Hz for the imidazole group of
histidine. The large bandwidth of 13C at high-field spectrometers also requires attention because it can
compromise filter performance through offset effects.
The pulse sequences presented by Zwahlen et al. in [233] incorporate adiabatic frequency-swept carbon
inversion pulses based on the observed linear correlation between the value of 1JHC and 13C chemical
shifts for both protein and RNA. The filter element replaces the conventional 13C inversion pulse by a
pulse whose frequency is swept adiabatically during the filter delay, such that the inversion of 13C spins
occurs at a suitable time for both offset and the 1JHC.
4.1.5 Detecting interactions by other methods
If the chemical exchange of the protein-ligand complex is fast, protein-ligand intermolecular NOEs may
not be measurable. In this regime, experiments based on saturation transfer or transferred NOE can
be used to identify ligands and determine structural characteristics of the ligand in its bound form. A
number of experiments are briefly described below:
• Saturation transfer difference (STD) experiments are based on transfer of saturation from the
protein to the bound ligands or vice versa by intermolecular spin diffusion. Subtracting a spectrum
in which the protein is saturated from one without protein irradiation produces a difference spectrum
which only contains signals from the ligand whilst the non-binding compounds cancel out. The
STD experiment allows screening and fast identification of ligands from a mixture of compounds.
It is best suited to large molecular weight protein and small ligands and the protein should not be
smaller than about 10 kDa for it to be effectively saturated by spin diffusion. STD experiments
can also be used for epitope mapping by identifying the relative saturation received by different
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parts of the ligand. This has been applied to study the functional groups involved in several
protein-carbohydrate complexes [235, 236].
• The transferred NOE method is used to measure intra-molecular NOEs of the ligand in the bound
form, commonly by recording 2D 1H-1H NOESY experiment of the complex in excess of the
ligand. This method is based on the phenomenon that the rate of build up of the NOE is approximately
proportional to the correlation time. Free ligands exhibit weak positive NOE signals. Once
the ligand is bound to the protein, because of the slow tumbling rate, the ligand exhibits strong
negative NOE signals [237, 238]. These are detected on the ligand in the free state if the exchange
rate is fast enough.
4.2 Biochemical and glycoarray data
Cell binding assays (Figure 4.2) carried out by Janene Bumstead, Institute of Animal Health, showed
that binding of EtMIC3 to host cells was effectively inhibited after treatment with neuraminidase which
strips cell surface sialic acid residues, or in the presence of fetuin, a sialylated glycoprotein derived
from bovine fetal serum, which would compete with sialyl oligosaccharides on the cell surface for
MIC3 binding [1]. This shows that EtMIC3 binds to host cell via interaction with sialic acid. Moreover,
dose-dependent inhibition of sporozoite invasion was observed following treatments with a2,3-sialylated
gangliosides GD1A and GT1B and with a2,3-sialyllactose, in contrast to treatment with fetuin, NANA
or a2,6-sialyllactose which did not cause significant inhibition of sporozoite invasion (Figure 4.3). This
indicate that a2,3-linked sialyl glycans present on the MDBK cell surface are the dominant ligands of
EtMIC3.
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Figure 4.2: Western blot analysis of EtMIC3 within cell bound (CB) or unbound (UB) fractions of a sporozoite
lysate in the presence of neuraminidase (top), fetuin or asialofetuin (bottom). Treatment with neuraminidase at
0.25 units/ml or fetuin at 100 μg/ml effectively inhibited binding of EtMIC3 to host cells. (Work by Janene
Bumstead, Institute of Animal Health [1])
Figure 4.3: Invasion assay on freshly excysted sporozoites of E. tenella after incubation with varying
concentrations of sialylated molecules. The number of successfully invaded parasites decreased after incubation
with GD1A, GT1B and α2,3-sialyllactose, but fetuin, NANA or α2,6-sialyllactose did not cause significant
inhibition. This indicate that α2,3-linked sialyl glycans present on the MDBK cell surface are the dominant
ligands of EtMIC3. (Work by Janene Bumstead, Institute of Animal Health [1])
Furthermore, chicken intestine histology analysis showed that EtMIC3 bind abundantly to epithelial
cells of the caecum where a high level of a2,3-sialylated glycans are present, shown by staining with
a2,3- specific lectin Maackia amurensis hemagglutinin (MAAII) (Figure 4.4).
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Figure 4.4: Histology analysis of carbohydrate presentation within chicken intestine. Alkaline phosphatase
staining of histological sections of chicken intestinal tissue derived from the upper, mid and lower intestine and
the caecum following incubation with plant lectins Sambucus Nigra agglutinin (SNAI) or Maackia amurensis
hemagglutinin (MAAII), with recombinant EtMIC3_MAR5 protein or with control protein (thioredoxin). SNAI
exhibit high affinity towards some ligands with α2,6-linked sialic acid [239]; on the other hand, MAAII binds to
ligands with α2,3-linked sialic acid [240]. EtMIC3 and MAAII bind abundantly to epithelial cells of the caecum,
indicating that the preferred binding site of EtMIC3 is in the region of the intestine that expresses a high level
of α2,3-sialylated glycans. (Experiment by Janene Bumstead, Institute of Animal Health; EtMIC3_MAR5 and
thioredoxin produced by Livia Lai [1])
4.2.1 Glyco-microarray data
To assess the carbohydrate binding specificity of EtMIC3, carbohydrate microarray analysis [241, 242]
was carried out by Liu Yan, Imperial College London. Experiments were performed with recombinant
proteins consisting of five MAR domains (1b-1c-1c-1c-1d) collectively referred to as EtMIC3_MAR5.
The recombinant protein also carries a N-terminal thioredoxin fusion and a 6 His tag. For comparison,
EtMIC3_MAR5 was analysed in parallel with the N-terminal MAR repeats of T. gondii MIC1 (TgMIC1-MARR).
Protein samples were produced by Livia Lai.
The microarray binding assays were performed essentially as described in [201, 81]. In brief, the arrayed
slides were blocked for 1 hour with 1% w/v bovine serum albumin (Sigma) in Pierce Casein Blocker
solution (casein/BSA). TgMIC1-MARR was precomplexed with mouse monoclonal anti-polyhistidine
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and biotinylated goat anti-mouse IgG antibodies (Sigma) in a ratio of 1:2.5:2.5 (by weight) and overlaid
onto the arrays at 40 µg/ml. For the analysis of EtMIC3-MAR5, precomplexation was not required.
The protein was tested at 40 µg/ml, and followed by overlay with anti-polyhistidine and biotinylated
anti-mouse IgG antibodies (10 µg/ml, precomplexed in a ratio of 1:1). Binding was detected using
Alexa Fluor 647-conjugated streptavidin (Molecular Probes). Microarray data analysis and presentation
were carried out using dedicated software [243].
Similar to TgMIC1_MARR, the binding of EtMIC3_MAR5 was to sialylated probes in the arrays, and
no binding signal was observed with probes that lack sialic acids. The intensities of binding signals
of EtMIC3 elicited with a2,3- and a2,6-linked sialyl sequences sharing similar backbones and lipid
moieties were comparable (Figure 4.5a). In contrast to EtMIC3_MAR5, the TgMIC1_MARR did show
stronger binding to a2,3 than to a2,6 sialyl sequences in the microarrays, in accordance with previous
findings [201, 244].
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Position Structure 
Fluorescence signal intensities 
EtMIC3-MAR5 TgMIC1 -MARR 
20 NeuAcα-3Galß-4Glc-AO                    6,260                     4,734  
70 NeuAcα-6Galß-4Glc-AO                    5,441                        767  
30 NeuAcα-3Galß-4GlcNAc-AO                 13,499                     8,872  
76 NeuAcα-6Galß-4GlcNAc-AO                 12,298                        906  
37 NeuAcα-3Galß-3GlcNAcß-3Galß-4Glc-DH                 10,945                     4,163  
79 NeuAcα-6Galβ4-GlcNAcβ3-Galβ4-Glc-DH                 16,300                        834  
52 
        Galß-4GlcNAcß-6 
              │       │ 
         Fucα-3       Galß-4Glc-DH 
                      │ 
NeuAcα-3Galß-3GlcNAcß-3 
                10,442                     3,007  
86 
        Galß-4GlcNAcß-6 
              │       │ 
         Fucα-3       Galß-4Glc-DH 
                      │ 
NeuAcα-6Galß-3GlcNAcß-3 
                   7,077   - 
56 
NeuAcα-3Galß-4GlcNAcß-2Manα-6         Fucα-6 
                            │              │ 
                            Manß-4GlcNAcß-4GlcNAc-DH 
                            │ 
NeuAcα-3Galß-4GlcNAcß-2Manα-3 
                11,915                     8,831  
87 
NeuAcα-6Galß-4GlcNAcß-2Manα-6 
                            │  
                            Manß-4GlcNAcß-4GlcNAc-DH 
                            │ 
NeuAcα-6Galß-4GlcNAcß-2Manα-3 
                15,948                        671  
Probe Structure 
Fluorescence signal intensities 
EtMIC3-MAR5 TgMIC1 -MARR 
38 NeuAcα-3Galβ-3GlcNAcβ-3Galβ-4Glcß-C30 18,142  11,580  
39 NeuGcα-3Galβ-3GlcNAcβ-3Galβ-4Glcß-C30  -  11,075  
59 NeuAcα-3Galß-4Glcß-Cer            3,694  4,327  
60 NeuGcα-3Galß-4Glcß-Cer  -  12,526  
89 NeuAcα-6GalNAc-AO            7,328  3,815  
88 NeuGcα-6GalNAc-AO 264  13,982  
Figure 4.5: Features of binding to selected sialyl sequences: a) The selected α2,3-linked and the α2,6-linked sialyl
sequences; b) the selcted NeuAc and NeuGc-terminating sequences. (Experiment by Liu Yan, Imperial College
London; protein samples produced by Livia Lai [1])
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4.2.1.1 EtMIC3 display N-acetylneuraminic acid specificity
The microarray analyses revealed that neither EtMIC3_MAR1b nor EtMIC3_MAR5 bound to sialyl
sequences that terminate in the N-glycolyl form of sialic acids (NeuGc), e.g. probes 39, 60 and 88
in Figure 4.5. This is in sharp contrast to TgMIC1_MARR which gave comparable or even stronger
binding to the NeuGc probes than to their NeuAc analogues (Figure 4.5b). 5-N-acetylneuraminic acid
(Neu5Ac) but not N-glycolyneuraminic acid (Neu5Gc) is expressed in chicken [245, 246], therefore it
is not surprising that EtMIC3 does not bind to NeuGc-terminating glycans. The opposite was revealed
by microarray analysis of the oncogenic virus SV40 for which the primary host monkey, unlike humans,
can synthesize NeuGc [247]. The T. gondii MIC1_MARR recognizes glycans with both NeuAc and
NeuGc forms of sialic acids consistent with its very broad cell tropisms. These differing specificity is
clearly a major factor in the host tropisms of these microbes.
Apart from the specificity of EtMIC3_MAR5 toward different sialic acid forms and linkages, the carbohydrate
microarray analysis have revealed modulation of binding strength in the presence of certain sulphate
modifications of the sialyl oligosaccharide sequences. EtMIC3_MAR5 gave stronger binding to the
3’SiaLex sequence that has a sulphate at position 6 of the GlcNAc residue (6-SU SiaLex, probe 49 in
Appendix Figure 1) than to analogues lacking sulphate on GlcNAc (probe 45 and 47) or having an
additional sulphate group on the galactose (Gal) residue (6,6’-SU SiaLex, probe 51). The important role
sulphation pattern plays in carbohydrate recognition by Neospora caninum MIC1 has been previously
reported in [81]. In that study, strong binding of NcMIC1_MARR to two sulphated SiaLex probes was
observed, both of which have a sulphate group on the Gal residue (as in probes 47 and 51). These
properties of MIC proteins might have implications for tissue tropism. It is worth noting that the greater
binding to 6-SU SiaLex sequence is a feature shared with highly pathogenic poultry influenza viruses
including H5N1 viruses [248, 249]. These viruses also target the chicken intestinal tract.
4.2.2 Summary from biochemical and glycoarray data
In conclusion, the collaborative biochemical and glycoarray studies have shown that EtMIC3 binds to
sialylated carbohydrate on the host surface. In particular it only targets the 5-N-acetyl form of sialic
acid (Neu5Ac) but not the N-glycolyl form (NeuGc). Biochemical data have shown that the a2,3 sialyl
sequence was a more potent inhibitor compared to the a2,6 sialyl sequence; however, no significant
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difference in their binding intensities was observed in the glycoarray. Based on this information, several
Neu5Ac terminating-ligands were selected and their interactions with EtMIC3_MAR1b were characterised
by NMR experiments. This is discussed below.
4.3 Materials and Methods
4.3.1 Ligand titration
The sialyl-ligands tested included: N-acetylneuraminic acid (Neu5Ac), a2,3-sialyl-N-acetyllactosamine
(Siaa2-3Galb1-4GlcNAc), a2,6-sialyl-N-acetyllactosamine (Siaa2-6Galb1-4GlcNAc), a2,3-sialyl-N-acetyllactose
(Siaa2-3Galb1-4Glc), a2,6-sialyl-N-acetyllactose (Siaa2-3Galb1-4Glc). In addition, heparin and heparan
sulphate were also tested.
15N- labelled EtMIC3_MAR1b was prepared in 50 mM NaCl, 20 mM NaPO4, pH 5.5. The carbohydrate
ligands, purchased from Sigma, were dissolved in the same buffer and pH adjusted to 5.5. The ligands
were titrated into the protein sample at several steps up to 20 or 100-fold molar excess and 2D 1H-15N
HSQC spectra were recorded at each step under identical experimental conditions.
4.3.2 Chemical shift mapping
In order to identify the carbohydrate binding site, changes in the 1H and15N backbone amide chemical
shifts of EtMIC3_MAR1b upon binding to a2,6-sialyl-N-acetyllactosamine were measured. The chemical
shift changes were then mapped onto its structure as follows:
The assigned peak lists of the apo and bound 1H-15N HSQC spectra (Chapter 3 for assignment of apo
spectra and Chapter 5 for assignment of bound spectra) were compared and the absolute value of the
changes in backbone amide chemical shifts (| 4δ |) in the 1H and 15N dimensions were measured. The
chemical shift changes were quantified using a combined weighed chemical shift change per residue
[250]. The 4δ for 1H was scaled up 10 times to account for the differences in resonance frequency
between 1H and 15N (ratio of the gyromagnetic ratio of nitrogen and proton is about 0.1). The scaled up
| 4δ | for 1H was then added to the | 4δ | of 15N for each backbone amide. The overall chemical shift
changes were mapped onto the structure of EtMIC3_MAR1b using Pymol (DeLano Scientific), with the
value categorised into 5 levels - from white to red. The flexible C-terminus region (Gln111 to Pro123)
was not included in this analysis.
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4.3.3 Measuring intermolecular NOEs by the isotope-filtered experiment
For intermolecular NOE measurements, 3D 13C-filtered NOESY-HSQC spectra were recorded on the
complexes of EtMIC3_MAR1b using two sialyl-carbohydrate ligands; namely a2,3-sialyl-N-acetyllactosamine,
a2,6-sialyl-N-acetyllactosamine. The experiment was ran on a Bruker AvanceIII 800 MHz spectrometer
equipped with a TXI cryoprobe. A pulse sequence incorporating adiabatic frequency-swept carbon
inversion pulses based on the one presented by Zwahlen et al. [233] was used. Data were processed
using NMRPipe [208] whilst analysis was performed in NMRView 5.0 (One Moon Scientific, INC
[209]).
4.3.4 Sample preparation
13C,15N labelled EtMIC3_MAR1b samples were prepared in 50 mM NaCl, 20 mM NaPO4, pH 5.5.
Since the filtered experiment is less sensitive compared to conventional NOESY experiments, the protein
sample was prepared to higher concentrations of about 1 mM to enhance signal in the spectra. In
different samples, 1 molar ratio of a2,3 or a2,6-sialyl-N-acetyllactosamine was titrated into the protein
sample and saturation was confirmed by monitoring the amide peak shifts of the 1H-15N HSQC spectrum.
For the a2,3 and a2,6-sialyl-N-acetyllactosamine complexes, to ensure no remaining unbound ligand
was present in the sample, the complex was diluted with 20 ml of sample buffer and concentrated in
a centrifugal filter (Vivaspin 5 kDa MWCO, GE healthcare) down to 0.5 ml twice. A further 1H-15N
HSQC spectrum was then recorded to confirm that the protein was still in its bound conformation, i.e. the
washing step had not disrupted the complex. Finally, 10% D2O, protease inhibitor (Complete Cocktail
Tablet, Roche) and sodium azide were added to the samples.
4.4 Results and discussion
4.4.1 Ligand titration
MAR domain-containing proteins (MCPs) are known to bind sialic acid (Introduction, section 1.5.2).
To examine the binding of EtMIC3 to various carbohydrate ligands, a series of NMR ligand titration
experiments were performed.
The 1H-15N HSQC spectra of EtMIC3_MAR1b exhibited significant chemical shift changes for most
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of the amide peaks upon addition of all sialylated ligand (Figure 4.6), which suggested binding to all
sialylated ligands tested. However, no changes were observed when heparin or heparan sulphate were
titrated (data not shown) which indicated no binding to these ligands.
Titration of a2,3-sialyl-N-acetyllactosamine (Neu5Aca2-3Galb1-4GlcNAc), a2,6-sialyl-N-acetyllactosamine
(Neu5Aca2-6Galb1-4GlcNAc), a2,3-sialyl-N-acetyllactose (Neu5Aca2-3Galb1-4Glc) and a2,6-sialyl-N-acetyllactose
(Neu5Aca2-3Galb1-4Glc) showed binding to EtMIC3_MAR1b. In the 1H-15N HSQC spectra, new
amide resonance peaks appeared and increased in intensity as the ligand concentration increased whilst
the unbound protein resonances decreased in intensity. The protein-ligand complex was therefore characterised
as in the slow exchange regime with the free protein and ligand for all resonances. EtMIC3_MAR1b
reached saturation at 1:1 molar ratio with these trisaccharide ligands, whilst no further chemical shift
change was observed when more ligand was added (Figure 4.6).
Figure 4.6: 1H-15N HSQCs of EtMIC3_MAR1b titrated with α2,6-sialyl-N-acetyllactosamine. The spectrum of
the apo protein is shown in black and the protein-carbohydrate complex at 1:1 ratio is shown in red.
The slow exchange regime exhibited by the EtMIC3_MAR1b complexes are unusual for protein-glycan
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interactions. The affinity of most single protein-glycan interactions is generally low (mM to mM)
[232], with overall affinity increased because glycan binding proteins are often oligomeric, multivalent
or membrane-associated which concentrates the protein binding sites. Moreover, some glycans have
multiple binding sites presented along a single chain. In combination, this increases the affinity of
the protein-carbohydrate interaction by several orders of magnitude for biological processes that they
are involved in. The observation that all resonances are in slow exchange during the titration suggests
that the Kd is likely to be sub-micro molar. EtMIC3 possesses seven MAR domains, five of which
are believed to contain the carbohydrate binding sequence, and hence could potentially allow it to bind
extremely tightly to the glycan ligand on the host cell surface.
The titration of N-acetylneuraminic acid (Neu5Ac) also exhibited slow exchange for all resonances.
Interestingly, however, the protein only reached saturation with about 25 molar excess of ligand. This
is unusual because complexes in slow exchange on the NMR chemical shift time scale usually have
a high affinity, and this saturates at 1:1 ratio. However, one explanation might be that in solution,
Neu5Ac is in equilibrium between the a and b-anomeric conformation (Figure 4.7, left), with only 5%
being the a-anomers [251]. On the other hand, all sialic acid-linked oligosaccharides are generated by
different a-linkages from the C2 carbon to the next sugar residue, most commonly the C3 or C6 position
of galactose, therefore they are all in the a form (Figure 4.7, middle and right). The differences in
affinity observed between Neu5Ac monomers and the sialyl-trisaccharides therefore might be explained
by specificity of EtMIC3_MAR1b for the a-anomeric form of sialic acid. Such specificity has been
described in other sialic acid binding proteins [252]. This conformational selection mechanism in
combination with a small population of ligand in the a-anomeric form could lead to a slow apparent
on rate for EtMIC3_MAR1b, hence slow exchange was observed whilst excess ligand was needed to
reach saturation. A similar observation was made for the bronchodilator drug theophylline binding to its
in vitro selected RNA aptamer [253].
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Figure 4.7: (Left) Sialic acid anomers in equilibrium in solution and the structure of the α2,3 (middle) and
α2,6-sialyl-N-acetyllactosamine (Neu5Ac-Gal-GlcNAc) (right).
About 20% of the amide peaks shifted significantly upon ligand binding, i.e. experience a change
in chemical environment in the bound conformation. Carbohydrate binding proteins generally do not
undergo large conformational changes when binding to sugar [211]. Since the carbohydrate ligand is in
direct contact with only a few residues at the binding site, the rest of the peak shifts could be the result
of small local conformational changes occurring near the binding site.
Furthermore, the saturated protein spectra for the sialylated ligands were very similar (Figure 4.8), with
most of the peaks superimposing exactly. This suggests that the binding site of EtMIC3_MAR1b domain
is interacting mainly with the sialic acid moiety which is common in all ligands, whilst the other sugar
units, possibly further away from the binding site, have minimal effects on the chemical shifts of the
protein.
4.4.2 2,3 vs 2,6-linked carbohydrates
Overlay of the a2,3 versus a2,6 spectra for sialyl-N-acetyllactosamine and sialyl-N-acetyllactose showed
interesting differences in the chemical shifts of two particular peaks (Figure 4.8). The peaks were
assigned to Thr 88 and Arg 89 after backbone assignment of the ligand-bound protein (next chapter).
This suggested that Thr 88 and Arg 89 are probably in the proximity of the glycosidic linkage between
the C2 carbon of sialic acid and C3 or C6 of galactose. Since C6 is out of the pyranose ring, the
a2,6-linkage extends the galactose further away from the sialic acid than the a2,3-linkage which could
explain the chemical shift differences.
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Figure 4.8: Overlay of 1H-15N HSQCs of EtMIC3_MAR1b titrated with α2,3-sialyl-N-acetyllactosamine
versus α2,6-sialyl-N-acetyllactosamine (top), and α2,3-sialyl-N-acetyllactose versus α2,6-sialyl-N-acetyllactose
(bottom). The spectra of the α2,6-ligand complex are shown in red and the α2,3-ligand complex are shown in
black. Most of the amide peaks overlay well but the amide of Thr 88 and Arg 89 shows clear differences in both
overlay spectra.
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4.4.3 Chemical shift mapping
Since most peaks has identical chemical shifts for the complex of EtMIC3_MAR1b with a2,3- and
a2,6-sialyl-N-acetyllactosamine (Figure 4.8), further 3D experiments were ran on the complex of EtMIC3_MAR1b
and a2,6-sialyl-N-acetyllactosamine to obtain the resonance assignment of EtMIC3_MAR1b in the
bound form (see Chapter 5 for details).
In an attempt to localise residues involved in carbohydrate binding, the chemical shift changes upon
addition of a2,6-sialyl-N-acetyllactosamine were analysed in more detail. The weighted chemical shift
change showed three regions with the most significant chemical shift changes upon ligand binding
(Figure 4.9). These included residues Cys 28 - Gly 29, Lys 46 - Glu 47, Ser 80 - Gly 81, Ser 83 -
Thr 88, which had weighted chemical shift changes of 5 or above. Chemical shift mapping on the 3D
structure showed that Cys28 and Gly29 are located in a loop after the 1st a-helix; Lys 46 - Gly 47 is
located at the end of b1 and Ser 80 - Gly 81 is located in a loop before the b5 and Ser 83 - Thr 88 is
located on b5 (Figure 4.10, top). These residues are situated next to the proposed sialic acid binding site
(TSHLT) from residue 84 to 88 and are highlighted in the surface representation of the structure (Figure
4.10, bottom).
These results show that the proposed ligand binding site residues 84 to 88 on b5 exhibited significant
chemical shift changes. Furthermore, the loops on either side of b5 and some residues of the 1st
helix also experience large changes in chemical environment upon ligand binding. Chemical shift is
a very sensitive parameter and this result has highlighted a broad region of chemical shift changes. The
chemical shift changes could be a result of direct interaction with the carbohydrate ligand or protein
conformational changes. This ambiguity can be resolved by inter-molecular NOE data and also by
determining the structure of the complex. The former are described in the following section and the
latter in chapter 5 (section 5.3.3).
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Figure 4.9: The weighted chemical shift change of each amino acid residue upon binding to
α2,6-sialyl-N-acetyllactosamine.
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Figure 4.10: Chemical shift mapping for the interaction of recombinant EtMIC3_MAR1b with
α2,6-sialyl-N-acetyllactosamine. Cartoon (top) and surface representation (bottom) of EtMIC3_MAR1b with
residues coloured pink to red according to the extent of chemical shift perturbation of backbone amide in the
presence of α2,6-sialyl-N-acetyllactosamine. The most significant chemical shift changes were observed for
residues Cys 28 - Gly 29, Lys46 - Glu 47, Ser 80 - Gly 81 and Ser 83 - Thr 88 which are indicated in the top
figure. In the bottom figure, the chemical shift mapping highlight an area (colour in red) localised next to the
proposed sialic acid binding site (area within the black line).
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4.4.4 Inter-molecular NOEs
A total of 17 and 19 NOE cross-peaks were observed in the spectra of the a2,3 and a2,6 complex
respectively. The two spectra had similar NOE cross-peaks patterns, with only 4 peaks not being
common to both spectra (highlighted in the red box in Figure 4.11). The majority of the NOE cross-peaks
were below 4.7 ppm, with 3 peaks to a ligand 1H resonance frequency at 2.15 ppm. This is expected to
be the methyl group of sialic acid. About 10 NOE cross-peaks resonate between 3 and 4.7 ppm, which
are characteristic of the protons within the pyranose rings in sialic acid, galactose or glucosamine or
the glycerol sidechain of sialic acid. Interestingly, 6 cross-peaks are observed above 7 ppm. These are
possibly hydroxyls on the carbohydrate, amide of sialic acid or from water molecules at the binding site.
Water molecules are known to be involved in protein-carbohydrate interactions. The crystal structure of
TgMIC1-a2,3/ a2,6-sialyl-N-acetyllactosamine complex has shown that protein-carbohydrate contacts
are mediated by water molecules coordinated with hydrogen bond networks. Similar water molecules
which are not exchanged with the bulk solvent could be present in the EtMIC3-carbohydrate complexes,
resulting in these NOE cross-peaks.
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Figure 4.11: The methyl region of the 3D 13C filtered NOESY spectrum of the EtMIC3_MAR1b in complex
with α2,3-sialyl-N-acetyllactosamine (Left) and α2,6-sialyl-N-acetyllactosamine (Right). Spectra are a projection
of all planes of the 3D experiment showing the two proton axes. Regions of the spectra where methyl protons,
carbohydrate ring or sidechain protons and NH or hydroxyl groups are observed are indicated in brackets. The 4
NOEs which differed in the two ligand bound complex are shown in red boxes.
4.5 Summary
• Ligand titration monitored by 2D 1H-15N HSQC spectra identified sialic-acid containing glycans
as the ligands of EtMIC3_MAR1b, and the complex exhibited slow chemical exchange in solution.
• Chemical shift mapping was carried out and identified regions between Cys 28 - Gly 29, Lys 46 -
Glu47 and Ser 80 - Thr 88 that experience the largest chemical shift changes upon ligand binding.
• For the ligands studied in this project, measuring inter-molecular NOEs was possible because of
the high affinity of EtMIC3_MAR1b for its ligands a2,3/ a2,6-sialyl-N-acetyllactosamine.
• Inter-molecular NOE cross-peaks were observed from 3D-filtered NOESY experiment. They were
identified as resonances from the methyl group of sialic acid, and carbohydrate ring protons on
the carbohydrate ligand or glycerol sidechain of sialic acid to the 1st and 3rd regions identified by
the chemical shift mapping, suggesting intimate contacts with these areas. A number of signals to
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putative water molecules were identified.
The slow exchange regime and detection of intermolecular NOEs suggests determining the NMR structure
of the complex is feasible. This is pursued in the next chapter.
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Chapter 5
Structure determination of
EtMIC3_MAR1b complex
5.1 Introduction
Experiments in the previous chapter has shown the interaction of EtMIC3_MAR1b and sialylated oligosaccharides
ligands. The following chapter describes the structural characterisation of this interaction by NMR and
molecular docking, which is outlined in the sections below.
5.1.1 Protein assignment, structure calculation
First of all the structure of EtMIC3_MAR1b in the ligand-bound conformation was determined by NMR.
Since the complex is in the slow exchange regime, a new set of NMR triple resonance experiments with
a sample of the complex (13C/15N-EtMIC3_MAR1b with unlabelled a2,6-sialyl-N-acetyllactosamine)
was recorded. All resonances of the protein were re-assigned and subsequently the protein structure in
the bound conformation was calculated.
5.1.2 Assignment of carbohydrate ligand
All the resonances of the carbohydrate ligand must ideally be assigned as well for NOE-based structural
determination. Like the isotopically labelled protein,13C labelled ligands are desirable for the chemical
shift assignments of the bound ligands. However, they are not readily available commercially and tailor
made synthesis of 13C labelled carbohydrate ligands were too costly to be purchased. Hence unlabelled
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sialyl-carbohydrate ligands were used.
To assign the unlabelled carbohydrate ligands, isotope-filtered 2D 1H -1H COSY, TOCSY and NOESY
experiments with different lengths of spin locks/ mixing times were tested. However, once bound to the
protein, the 600 Da carbohydrate ligand tumbled much slower in solution with an apparent molecular
weight 13 kDa. This caused rapid decay of magnetisation, reducing resolution and sensitivity of the
TOCSY experiments in particular. The lack of correlations for the peaks for the bound ligand made
assignment of the bound ligand practically impossible. Some signals were observed for the unbound
ligand, possibly a minority population in the sample.
5.1.3 Assignments of inter-molecular NOEs
Unambiguous assignment of the intermolecular NOE cross-peaks in the 3D filtered-NOESY spectra was
achieved in the F2 and F3 dimensions (C and H resonances of the protein) but not in the F1 dimension
(H resonances of the ligand) because of lack of assignment of the carbohydrate ligand. NOE-based
structure calculation was therefore not possible. Nonetheless, the interaction data presented provided
important information about the complex. These information were used to drive the docking process
in HADDOCK (High Ambiguity Driven biomolecular DOCKing) to generate a structural model of the
complex.
5.1.4 HADDOCK (High Ambiguity Driven protein-protein Docking)
HADDOCK is a docking program for modelling protein-protein or protein-ligand complexes. Structural
determination of protein complexes by NMR and X-ray crystallography is often difficult and limited
by problems such as protein size and dynamics. However, NMR is well suited for characterising
interactions. A wide range of techniques have been developed to characterise protein interactions.
This includes chemical shift mapping, H/D exchange, cross-saturation [254], residual dipolar couplings
(RDCs), paramagnetic site-directed spin labelling and diffusion anisotropy. Furthermore, biophysical
methods like small angle X-ray scattering (SAXS) and cryo-electron microscopy (cryoEM) [255, 256]
and biochemical data including bioinformatics predictions, mutagenesis data and cross-linking are also
very useful for characterising interactions. HADDOCK was developed to incorporate these interaction
data as Ambiguous Interaction Restraints (AIRs) to drive the docking process [255, 256]. It is more
commonly used for protein-protein and protein-DNA/RNA docking but it has been used for protein-carbohydrate
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docking as well [257]. The project setup described in the Materials and method section below was
modified for docking protein-carbohydrate complexes (personal communication, Alexandre Bonvin).
5.1.4.1 Docking Protocol
In general, the docking process consisted of three stages: (i) randomization of orientations and rigid
body energy minimization (EM), (ii) semi-rigid simulated annealing in torsion angle space (TAD-SA),
and (iii) final refinement in Cartesian space with explicit solvent.
In the first stage of Rigid body EM, the two molecules are positioned at 150 Å from each other in
space and each molecule is randomly rotated around its center of mass. Four cycles of orientational
optimization are performed in which each molecule in turn is allowed to rotate to minimize the intermolecular
energy function. Then both translations and rotations are allowed, and the two molecules are docked
by rigid body EM. 1000 complex conformations are calculated and the best 200 solutions in terms of
intermolecular energies are refined in the next stage.
In the next stage of TAD simulated annealing and finally water refinement, the residues at the interface
(side chains and backbone) can be allowed to move to optimise the interface packing. The resulting
structures are then subjected to 200 steps of steepest descent EM. Finally, a gentle refinement in a 8 Å
shell of TIP3P water molecules is carried out.
The final structures are clustered using the pairwise backbone RMSD at the interface. A cluster is
defined as an ensemble of at least two conformations displaying an iRMSD (backbone RMSD at the
interface) smaller than a user defined value (e.g. 7.5 Å for protein-protein interaction, much less for
protein-carbohydrate interaction). The resulting clusters are analysed and ranked according to their
average interaction energies (sum of Eelec, Evdw, EACS) and their average buried surface area.
5.2 Materials and methods
5.2.1 EtMIC3_MAR1b structure in the bound form
5.2.1.1 Sample preparation and NMR experiments
A uniformly 13C,15N labelled sample of EtMIC3_MAR1b with 1:1 ratio of a2,6-sialyl-N-acetyllactosamine
was prepared as described in (section 2.2.2, 2.2.3 and section 4.3.1). The NMR experiments used
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for structural calculation are listed in Table 5.1 below. Most experiments were recorded on a Bruker
Avance III 600 MHz magnet equipped with TXI cryoprobe, except the NOESY experiments which
were acquired on a Bruker Avance II 800 MHz magnet equipped with TXI cryoprobe. The NOESY
mixing time was set to 100 ms. All spectra were referenced in the direct 1H dimension according to the
resonance frequency of the water peak and in the indirect, i.e. heteronuclear dimension using frequency
ratios [224].
Experiment Nucleus Complex point Spectral width (Hz) Field strength (MHz)
HSQC 1H 1024 6510.42 500
15N 128 1388.89
HNCACB 1H 512 6510.42 500
15N 34 1388.89
13C 59 8333.33
CBCA(CO)NH 1H 512 6510.42 500
15N 34 1388.89
13C 55 8333.33
HN(CA)CO 1H 512 6510.42 500
15N 34 1388.89
13C 55 1666.67
HNCO 1H 512 6510.42 500
15N 34 1388.89
13C 55 1666.67
HBHA(CBCACO)NH 1H 512 6510.42 500
15N 34 1388.89
1H (indirect) 60 3001.20
H(C)CH-TOCSY 1H 512 6250 500
13C 35 4401.41
1H (indirect) 120 4752.85
(H)CCH-TOCSY 13C 120 8810.57 500
13C (J-coupled) 34 3144.65
1H 512 6250
(H)CC(CO)NH 1H 512 6510.42 500
15N 34 1388.89
13C 60 11947.43
15N NOESY-HSQC 1H 1024 10416.67 800
15N 40 2222.22
1H (indirect) 140 10416.67
13C NOESY-HMQC 1H 1024 10000 800
13C 39 14084.51
1H (indirect) 130 10000
3D filtered 13C NOESY 1H 1024 10000 800
13C 40 14084.51
1H (indirect) 125 10000
Table 5.1: List of parameters used in all NMR experiments for the EtMIC3 MAR1b sample in complexed
with 2,6 sialyl-N-acetyllactosamine. All spectra were recorded at 303 K.
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5.2.2 pH titration
A sample of 15N- labelled EtMIC3_MAR1b was prepared in 50 mM NaCl, 20 mM NaPO4, pH 7, as
described in Chapter 2. A series of 2D 1H-15N HSQC spectra were recorded at varying sample pH values
(between 4.5 and 7). The pH of sample was adjusted by addition of hydrochloric acid to the sample in
between each HSQC experiment.
5.2.2.1 Protein resonance assignment and structural calculation
The assignments and structural calculation procedures was carried out as described for the EtMIC3_MAR1b
apo structure in Chapter 3 .
5.2.3 HADDOCK
5.2.3.1 Preparing input-files
For the protein component of the complex, an ensemble of the 10 lowest energy structure of EtMIC3_MAR1b
in the ligand-bound form calculated in ARIA was used in the dock. The SEGIDs (a four character long
string at columns 73 - 76 in the PDB format) were removed from all the structure PDB files.
Two sialyl-carbohydrates, a2,3-sialyl-N-acetyllactosamine and a2,6-sialyl-N-acetyllactosamine, were
chosen for the dock. The structures of the carbohydrate were generated from the GlyCaNS webserver
(personal communications, Alexandre Bonvin). The output files from the webserver contained a pdb
(protein data bank format) file which contains the atomic coordinates, a psf (protein structure file)
containing the atomic connectivity information and the CNS topology (.top) and parameters (.param)
files for the carbohydrate. The dihedral angles of the glycosidic linkage: phi (φ ), psi (ψ) and omega (ω)
were either specified or set as default.
To create a structural ensemble for each ligand, explicit solvent refinement run in HADDOCK was
performed using an initial structure from the GlyCaNS webserver. Specifically, the number of steps for
the heating phase was set to 100; the number of steps for 300 K sampling phase was set to 20000; and the
number of steps for the cooling phase was set to 500. 20 structures were generated and 10 distinctively
different structures were selected manually to form the ensemble of structures for the dock.
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5.2.3.2 Project Setup
After the new run was generated, the carbohydrate pdb and psf files were manually copied into the
/begin folder, together with the file_B.list file which specifies all the pdb file names of the carbohydrate
ligand. These files are needed to create 10 initial pdbs which contain both the protein and carbohydrate,
separated 150 Å apart to start the rigid body energy minimization step.
Since the standard HADDOCK run does not contain the topology and parameter files for carbohydrate,
the CNS topology (.top) and parameter (.param) files which were generated from the GlyCaNS server
were copied into the /toppar folder in each new run.
The ring carbons of Neu5Ac, Gal and Glu were set as fixed in the torsiontop.cns file, to avoid problems
during the torsion angle simulated annealing step (TAD-SA). During TAD-SA, flexibility was allowed
for the amino acid side chains in the first round of semi-flexible SA and both protein backbone and the
side chains in the second. The ligand was allowed to be fully flexible in both rounds.
5.2.3.3 Distance Restraints
A number of restraints including inter-molecular NOEs, hydrogen bonds and ambiguous interaction
restraints (AIRs) derived from chemical shift changes were tested for the dock. These included the
inter-molecular NOEs-derived restraint from Leu 24 Hd, Thr 84 Hg, His 86 Hd, Ser 87 Hd and Thr 88
Hg2 to either the methyl, amide or ring protons of Neu5Ac and restraints between Thr 88 and Arg 89 to
the galactose sugar based on the observed chemical shift differences of Thr 88 and Arg 89 amide protons
in the HSQC spectra of the a2,3-linked and 2,6-linked ligand titration (section 4.4.3). These are listed
in the Table 5.4.
5.2.3.4 Clustering and analysis of docking data
The clustering of the water refined structures were carried out according to the HADDOCK protocol;
different distance cut-off distances were tested for an optimal value of 1 Å.
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5.3 Results
5.3.1 pH titration
From the backbone assignment of EtMIC3_MAR1b used for structure determination (Chapter 3), several
backbone amide peaks were found missing in the 1H-15N HSQC spectra recorded at pH 6.5, particularly
from the fifth b-sheet. Therefore a pH titration between pH 4.5 to 7 was carried out to test whether more
peaks were observed at other pH values. Changes in the peaks can easily be distinguished in the overlay
of the spectra (Figure 5.1). Several extra peaks were observed at pH 5.5, which could be the missing
amide peaks from the fifth b-sheet. Consequently, the experiments recorded for structural determination
of the EtMIC3_MAR1b in complex were recorded at pH 5.5.
Figure 5.1: Overlay of 1H-15N HSQCs of EtMIC3_MAR1b at pH 7 (pink) and pH 5.5 (black). Some extra peaks
at pH 5.5 are indicated with arrows.
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5.3.2 EtMIC3_MAR1b structure in the bound form
5.3.2.1 Chemical shift assignments
Automatic backbone assignment carried out using MARS successfully assigned the majority of the
residues in the initial run. The C-terminal region of the protein (Glu 111 to Pro 123) were once again
absent from amide-detected spectra and therefore were not assigned. This region was also missing in the
backbone assignment of the apo protein, and was thought to be unstructured. After manual checking of
the picked peaks and distinguishing overlapping peaks from different spin systems, the final backbone
assignments were complete excluding the C-terminal region. The fifth b sheet region which was missing
in the apo protein assignment was assigned, this due to the lower pH value of the complex sample.
Sidechain assignments proceeded using the TOCSY and NOESY spectra. In noisy or highly overlapped
area of the spectra, assignments of the apo protein were referred to, which speed up the assignment
process. Sidechain assignment were almost complete for all the residues with backbone assignment,
including all aromatic residues. Excluding prolines, other missing assignments includes NHe of Gln 14
and 94; NHe and Hg of Gln 43; NHe and NHh of Arg 10, 76 and 89; NHh of Arg 49; NHd and NHe of
His 86; NHd and Cg of Asn 103 and NHz of all lysine residues. These sidechain groups of Arg, His and
Lys are commonly surface exposed and signals are not observable for protons in rapid exchange with
the solvent. Similar to the apo protein, the sidechain of Arg 35 was fully assigned, an indication that
the sidechain of Arg 35 is buried within the hydrophobic core of the protein. The Cα and Cβ resonances
of all cysteine residues were characteristic of the oxidised form [228]. Long range NOEs across the
disulphide bonds were also observed, confirming the pairing of the cysteines in the folded protein.
An annotated 1H-15N-HSQC showing all backbone and sidechain amide resonance assignments is provided
in Figure 5.2.
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Figure 5.2: 1H-15N HSQC of EtMIC3_MAR1b in the ligand bound form. Backbone amide resonances are
labelled with assigned residue number.
5.3.2.2 NMR-derived restraints for structure calculation
5.3.2.2.1 NOE-derived restraints Automatic peak picking of the NOESY spectra generated 2 peak
lists, after manually removing peaks due to noise and artefacts thoroughly, the resulting 15N and 13C-
NOESY peak lists contained 1225 and 1970 peaks respectively. The frequency window tolerance for
automatic NOE assignment was set to 0.05 ppm for direct and indirect proton dimensions, 0.3 ppm for
15N and 0.6 ppm for the 13C dimensions.
5.3.2.2.2 Dihedral restraints A total of 224 TALOS-derived dihedral angles (φ andψ) were included
in the structure calculation. The C-terminal residues Lys 108 to Ala 116 were classified as dynamic and
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residues Thr 117 to Pro 123 have no prediction because of missing assignments. 16 residues (Leu 4,
Cys 12, Gly 23, Tyr 27, Gly 29, Lys 38, Asn 40, Ser 41, Gln 44, Lys 46, Ile 52, Gly 64, Ser 80, Ser 85,
Thr 88, Pro 90) were defined as ambiguous and therefore not used for structural calculation. Excluding
these regions and the first residue (Ala 1), prediction for the rest of the residues were classified as good
predictions and were thus implemented in ARIA. The minimum error of all and restraints was set to be
25° or two standard deviations of the prediction, whichever was greater.
5.3.2.3 Structure calculation
A total of 10 rounds of ARIA were carried out. NOE and dihedral violations from initial runs were
improved by removing peaks due to noise and artefacts in the NOESY peak list. Using the structure from
the initial ARIA runs, 22 hydrogen bonds within the two helices (from residues Thr 3 - Ser 22 and Glu
92 - Lys 101) and 3 pairs of hydrogen bonds between the anti-parallel b sheets (between the backbone
N-H and C=O groups of residues Tyr 33 and Tyr 51; and Arg 35 and Arg 49) were identified and used as
restraints in the structure calculation in the later runs of ARIA calculation. Pairs of disulphide bonded
cysteines including C12 - C50, C20 - C28, C65 - C75, and C69 - C105 were confirmed by manually
assigned NOE peaks and used in the later stage of calculation. In the final round of ARIA, there were
2.5±0.5 NOE violations above 0.5 Å and 4.5±1.5 dihedral violations above 5 Å in the 10 lowest energy
structures.
The 10 lowest energy structures are shown in Figure 5.3. Regions with secondary structure converge
well, but one of the loops is not very well defined. The structural ensemble from ARIA showed good
convergence between models with an RMSD of 0.29±0.06 Å over backbone atoms and 0.67 ±0.07 Å
over all heavy atoms within secondary structure. Detailed statistics of the structure are listed in Table
5.2 and a list of the restraints are given in Table 5.3. A total of 2708 restraints were used for the structure
calculation, including 1356 unambiguous and 409 ambiguous NOE-derived restraints.
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Figure 5.3: Backbone traces of the 10 lowest energy structures of EtMIC3_MAR1b in the bound form.
Number of experimental Restraints
NOE-derived 1765
Ambiguous 409
Unambiguous 1356
Intra-residue 585
Sequential 283
Medium range (1> |i− j| ≤ 4) 141
Long range (|i− j|> 4) 347
TALOS-derived dihedral angles (φ and ψ) 224
Hydrogen bonds 30
Total number of restraints used 2019
Table 5.2: Experimental restraints used for structure calculation of the EtMIC3_MAR1b bound form.
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RMSD from experimental restraints
Distance (Å) 0.111±0.003
Dihedral angle (º) 1.50±0.18
RMSD from idealised covalent geometry
Bonds (Å) 0.0057±0.00017
Angles (Å) 0.72±0.01
Improper (Å) 2.25±0.11
Coordinate RMSD Coordinate RMSD (Å)
Backbone atoms in secondary structure 0.29±0.058
Heavy atoms in secondary structure 0.67±0.0647
Energies (kcal ·mol−1)
Etotal -3682.54±79.69
ENOE 734.20±39.04
Ebond 52.79±3.32
Eangle 230.35±9.33
Eimproper 653.32±68.88
Edihedral 590.66±8.98
Evdw -980.75±12.15
Eelec -4228.9±98.224
Table 5.3: Structural statistics of the 10 lowest energy structure of EtMIC3_MAR1b in the ligand bound form.
5.3.2.4 Structure validation
The EtMIC3_MAR1b was submitted to the Protein Structure Validation Suite (PSVS) (http://psbs-1_3.nesg.org).
The built-in module Procheck [230] gave a Z-score of -2.4 when only phi/psi angles are included, and
a Z-score of -4.2 when all dihedral angles are included. The Ramachandran plot [231] of the structure
ensemble is shown in Figure 5.4. It shows that 81.2% of the residues fall within the most favoured
regions, 17.3% in additionally allowed regions and 1.5% in generously allowed and none in disallowed
regions. Several residues at the C-terminus are either in the generously allowed or disallowed regions,
but this region is poorly defined by the NMR data and is likely to be unstructured.
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Figure 5.4: Ramachandran plot of the 10 lowest energy structure ensemble of EtMIC3_MAR1b.
5.3.2.5 Structural features and comparison to the unbound structure
The structure of EtMIC3_MAR1b in the bound state is reminiscent of the previously determined apo
structure. The position of the short 2nd helix is shifted slightly nearer to the 1st helix, and the loop
regions aligned less well compared to the regions with secondary structure. The two structures aligned
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with an RMSD value of 1.46 over all backbone atoms (Figure 5.5). The secondary structures aligned well
in the two structures, but the loops are not very well aligned. No significant changes were observed in the
ligand binding site in the bound structure. A ’preformed’ binding pocket is common for carbohydrate-binding
proteins where a large change in conformation upon binding is rare.
Figure 5.5: Alignment of the cartoon representation of EtMIC3_MAR1b apo and ligand bound structure. The
C-terminus residues 111-123 are not shown.
5.3.3 Assigning intermolecular NOEs
After re-assigning EtMIC3_MAR1b in the bound form, it was possible to assign the protein resonances
of the inter-molecular NOEs from the 3D 13C F1-filtered, F3-edited NOESY-HSQC spectra by matching
the resonances on the 13C and protein H dimension to the chemical shifts of EtMIC3_MAR1b in the
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bound form. The assignments showed that the inter-molecular NOE cross peaks arise from Leu 24 Hd,
Thr 84 Hg, His 86 Hd, Ser 87 Hd and Thr 88 Hg2 in both spectra (Figure 5.6). Interestingly, apart from
residues from the 5th b sheet, 84TSHLT88, thought to be the sialic acid binding site, NOE cross-peaks
to both Hδ protons of Leu 24 were also detected. The two Hδ protons have slightly different chemical
shifts, and exhibit a different NOE pattern towards the carbohydrate ligand. One of the protons has a
stronger NOE peak towards the methyl group (assumed to be from sialic acid), whilst the other proton
has a weaker NOE signal to the methyl, but stronger peaks to a few ring or sidechain protons. This
shows that this pair of protons are in very close proximity to the ligand. This is discussed further in the
complex model (section 5.3.4.3).
An additional assignment for the hydroxyl proton of Tyr 27 was made after the initial HADDOCK model
was calculated. The sidechain of Tyr 27 is very close to the sialic acid binding site in the structure (Figure
X). In the 13C-NOESY He strip of Tyr 27, a NOE cross peak at 9 ppm was found which matched the
chemical shift of the peak from the 3D filtered NOESY spectra. Since the 3D filtered NOESY spectrum
contained both an15N and 13C filter, no NH peaks should be present, therefore it is likely that the peak
belongs to an OH group.
The chemical shift mapping data (section 4.4.3) results have shown that a number of protein residues
exhibit significant chemical shift change upon ligand binding, namely Cys 28 - Gly 29, Lys 46 - Glu 47,
Ser 80 - Gly 81, Ser 83 - Thr 88. Intermolecular NOE assignments have shown that Ser 83 - Thr 88 is
at the binding site of the complex, whilst Cys 28 - Gly 29, Lys 46 - Glu 47, Ser 80 - Gly 81 are located
away from the ligand binding site. Chemical shift changes at these residues were possibly a result of
small conformational changes during binding rather than direct contact with the ligand (Figure 4.10).
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Figure 5.6: The assigned methyl region of the 3D 13C F1-filtered, F3-edited NOESY- HSQC spectra of the
EtMIC3_MAR1b in complex with α2,3-sialyl-N-acetyllactosamine (Left) and α2,6-sialyl-N-acetyllactosamine
(Right). Spectra are a projection of all planes of the 3D experiment. Only a section of the full spectra is shown
illustrating the 4 NOEs (in red boxes) which differed in the α2,3 and α2,6- linked carbohydrate bound complex.
5.3.4 HADDOCK model
5.3.4.1 Defining the structure of carbohydrate ligand
In this project, the protein structure was well defined using the 10 lowest energy structural ensemble
of EtMIC3_MAR1b in the ligand bound form calculated from ARIA. However, because of lack of
assignment, the carbohydrate ligand conformation in the bound form was not known. Two methods
described below were tested to define the carbohydrate conformation for HADDOCK.
5.3.4.1.1 Dock using 1 ligand with defined glycosidic dihedral angles The first method was to
define the glycosidic dehedral angles of the ligand in the dock. The glycosidic dihedral angles was
either from the energy minimised structure generated by the GlyCaNS server or the lowest energy
conformation of the free carbohydrate in solution [258, 259, 260]. By allowing full flexibility during
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HADDOCK, this method was tried to see whether the carbohydrate would adopt a new conformation
during the docking process, because it is known that carbohydrate ligands do not often bind in the lowest
energy conformation [261]. Furthermore, This tested whether any particular conformation, presumably
complementary to the ligand binding site on the protein, is favoured during the docking process.
The result showed little differences in the carbohydrate conformation before and after the dock. The
total energy of the complexes with different ligand conformation was also similar. This showed that the
conformation which the carbohydrate could explore was limited during the docking process. Moreover,
the energy differences upon binding to the protein with a slightly different conformation were not large
enough to direct the result of the dock to any particular conformation.
5.3.4.1.2 Dock with an ensemble of ligand conformations To explore a wider range of ligand
conformation, an ensemble of ligand structures were used for the dock. This was done using the
explicit water refinement step in HADDOCK. Using 1 initial structure, generated by any of the methods
mentioned above, 20 structures were generated by HADDOCK. From these 20 structures, the 10 most
differing structures were selected manually for the protein-ligand dock. An example of an ensemble of
the a2,3- sialyl-N-acetyllactosamine structure is shown in Figure 5.7.
Figure 5.7: Ensemble of the 10 α2,3- sialyl-N-acetyllactosamine structure generated by the explicit water
refinement step in HADDOCK.
5.3.4.2 Defining distance restraints
In this project, three pieces of information were available about the EtMIC3_MAR1b- carbohydrate
complex. First of all the chemical shift mapping data presented in Chapter 5 (section 5.3.2); secondly,
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the inter-molecular NOE data described in the previous section; and lastly, insight of the complex based
on homology to the TgMIC1, where a crystal structure of the MAR2 domain with a2,3- and a2,6-
sialyl-N-acetyllactosamine is available.
5.3.4.2.1 Intermolecular NOEs Since the carbohydrate was unassigned, the distance restraints were
defined between the protein atom and ambiguously to any of either the methyl, amide or any ring/
sidechain protons of sialic acid (Table 5.4). This distance defined was between 3.5 Å and 5 Å. These
restraints were not defined to the galactose or glucosamine residues because this might be too non-specific.
By homology to the TgMIC1 MAR2 domain, and interaction data described in Chapter 3, EtMIC3_MAR1b
is believed to bind to sialic acid. Therefore the inter-molecular NOEs were specified only to sialic acid.
5.3.4.2.2 Ligand titration data Comparison of the 1H-15N HSQC spectra of a2,3- and a2,6-sialyl-ligands
bound EtMIC3 (section 4.4.2) identified that Thr 88 and Arg 89 showed different chemical shifts. The
a2,6-linkage has an extra carbon in between the two carbohydrate rings, and positions the galactose
further away from the sialic acid. Examining the equivalent residues in the crystal structure of TgMIC1
MAR2, Thr 88 and Arg 89 should be positioned closest to the Neu5Ac-Gal glycosidic linkage and
the galactose ring. Furthermore, Thr 88 did not give NOE signals to the methyl protons of the sialic
acid (Figure 5.6), which supports the idea that it is nearer to the galactose rather than the sialic acid
residue. When this distance restraint was included in HADDOCK, it was defined as follows: the r6
summed distance between all hydrogens of Thr 88 and galactose is a maximum of 2 Å. This is the upper
distance limit for ambiguous interaction restraints (where no atom is specified in the restraint). This
is because when many distances are be summed, the effective distance will be much shorter than the
shortest distance entering the sum ( de f f = [Sum(1/r6)]−1/6 ).
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Amino acid atoms Carbohydrate atoms Distance/Å Error (+)/Å Error (-) /Å
Inter-molecular NOEs
His 86 Hd any H of Neu5Ac 3.5 1.5 0.0
Leu 24 Hg any methyl proton of Neu5Ac 3.5 1.5 0.0
Leu 24 Hg any ring or sidechain proton of Neu5Ac 3.5 1.5 0.0
Ser 87 Hg any ring or sidechain proton of Neu5Ac 3.5 1.5 0.0
Ser 88 Hg any ring or sidechain proton of Neu5Ac 3.5 1.5 0.0
Thr 84 Hg any methyl proton of Neu5Ac 3.5 1.5 0.0
Ligand titration data
Thr 88 any atom of Gal 2.0 0.0 0.0
Arg 89 any atom of Gal 2.0 0.0 0.0
Table 5.4: A list of restraints for the docking of EtMIC3_MAR1b and α2,3- and α2,6- sialyl-N-acetyllactosamine.
5.3.4.3 Structures
The final 200 water refined docked structures were clustered using the pairwise RMSD at the interface.
The resulting clusters are analysed and ranked according to their average interaction energies and average
buried surface area. The lowest energy structures of the best cluster for the complex of EtMIC3_MAR1b
with a2,3 or a2,6-sialyl-N-acetyllactosamine are presented below.
First of all the binding site surfaces of EtMIC3_MAR1b and TgMIC1 MAR2 in complex with a2,3-
sialyl-N-acetyllactosamine are shown in Figure 5.8. In general both ligand binding sites are broad
and flat, which is common for carbohydrate binding proteins. In comparison, in the EtMIC3_MAR1b
complex, the extended helix a1 creates a deeper pocket for the N-acetyl group of sialic acid.
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Figure 5.8: Structures of the α2,3- sialyl-N-acetyllactosamine bound complex of EtMIC3_MAR1b (left,
HADDOCK model) and TgMIC1 MAR2 (right, crystal structure, PDB code: 2JHD). The proteins are shown
in surface representation in brown (EtMIC3_MAR1b) and red (TgMIC1 MAR2). The area in green marks the
ligand binding site. For the TgMIC1 MAR2 complex structure, only the sialic acid and galactose was shown
because the glucosamine residue is missing in the electron density map.
Secondly, the binding sites of the complex models are represented in detail in Figure 5.9 The structures
show that in both the a2,3 and a2,6-sialyl-N-acetyllactosamine complexes (a, b and c, d), the sialic acid
moiety was closest to the protein binding site whilst the galactose and glucosamine sugars are further
away, making little contact with the protein. In solution, these two residues might be flexible and adopt
many conformations.
In addition to the active site TxH motif found in MAR2 domains, the MAR1 family also possess an
extended first helix and loop. In EtMIC3_MAR1b, the sidechains of Leu 24 and Tyr 27 from this
’MAR1 insertion’, and Thr 84 from the TxH motif make several intimate contacts with the N-acetyl
group of sialic acid. A number of inter-molecular NOEs were observed from these sidechain protons
to the methyl group shown in Figure 5.6 and represented with dashed lines in Figure 5.9 (a and c).
These interactions explain why EtMIC3 cannot recognise the glycolyl-form of sialic acid (NeuGc) as the
additional hydroxyl group would not be accommodated without significant rearrangement. Compared
to the EtMIC3_MAR1b domain, the TgMIC1 MAR2 binding site presents a shallower pocket for the
N-acetyl group of sialic acid (Figure 5.9, e) with the sidechains of Lys 200, Arg 201 and Tyr 203.
In EtMIC3_MAR1b, two leucine residues, Leu 24 and 87 are in direct contact with the sialic acid
glycerol side chain (C7-C9). Several inter-molecular NOEs to the carbohydrate ring or sialic acid
glycerol sidechain protons were observed (Figure 5.6), although they could not be unambiguously
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assigned, these are likely to be to sialic acid because the galactose ring is much further away from
the two leucine sidechains. These two leucines are not conserved in TgMIC1 MAR2, instead Tyr 203 is
closest to the sialic acid glycerol sidechain.
Figure 5.9 b, d and f) shows the position of Thr 88 and Arg 89 in the complex model of EtMIC3_MAR1b.
They are not in direct contact with sialic acid, but instead closer to the sialic acid-galactose glycosidic
linkage and the galactose residue. In the crystal structure of TgMIC1 MAR2, two glutamic acid residues
Glu 205 and 206 are involved in several water-mediated interactions with the galactose residue of the
a2,3-ligand. Both the inter-molecular NOE pattern to the sidechain of Thr 88, and the backbone amide
chemical shifts were different in complexes of the a2,3- and a2,6-ligand. These could be related to the
position of the galactose ring. However, the HADDOCK model did not reveal a precise docking position
for the galactose and this might be the case in solution as well.
No distance restraint was specified for the glucosamine residue for the EtMIC3 dock. In the crystal
structure, no electron density was observed for the glucosamine ring. Glycoarray data also showed that
EtMIC3 does not bind to glucosamine alone. It is therefore likely that the glucosamine is mobile in
solution. The glucosamine group is shown in Figure 5.9 but it is worth noting that the diagram does not
indicate a precise conformation or position for this ring.
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Figure 5.9: The binding site of the docked structure of EtMIC3_MAR1b with α2,3-sialyl-N-acetyllactosamine
(a and b, shown in yellow) and α2,6-sialyl-N-acetyllactosamine (c and d, shown in orange). The amino acid
sidechains near the acetyl group of sialic acid are coloured in green and shown in sticks. Dashed lines in a) and c)
show the NOE interaction between the methyl group of sialic acid and the sidechain of Leu 24 and Thr 84. The
Crystal structure of TgMIC1 MAR2 in complex with α2,3-sialyl-N-acetyllactosamine (e and f) are shown in the
same view as comparison.
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5.4 Summary
• EtMIC3_MAR1b in the bound conformation with a2,6-sialyl-N-acetyllactosamine was determined.
• The inter-molecular NOE was unambiguously assigned to the protons from EtMIC3_MAR1b.
• HADDOCK was used to model the EtMIC3_MAR1b-ligand complex. Ligand titration data and
inter-molecular NOE were used as distance restraints for the dock. The programme successfully
docked the carbohydrate in the binding site of EtMIC3_MAR1b. However, the conformation of
the carbohydrate ligand was poorly defined. The position of sialic acid was consistent because
of the inter-molecular NOE distance specified to it, but the position of galactose and glucosamine
was not precise; these residues are likely to be flexible in solution.
• Nonetheless the structure model showed the interactions between the ligand and Leu 24 and Tyr
27 from the extended helix of MAR1 domain which was not shown in the crystal structure of
TgMIC1. The model also illustrates why EtMIC3 cannot recognise the glycolyl-form of sialic
acid.
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Chapter 6
Summary and future perspectives for
work on EtMIC3
The following section summarises the work presented in the previous chapters. A number of future
perspectives on the work on EtMIC3 is then discussed. At the end of this chapter, preliminary data on
the protection experiments (using EtMIC3 as recombinant vaccine) by our collaborator Janene Bumstead
is presented.
6.1 Summary
6.1.1 Eimeria tenella microneme protein 3
Eimeria tenella is one of the most common obligate intracellular Apicomplexan parasites which causes
coccidiosis in chicken. Other members of Apicomplexa include other parasites of medical and/or
veterinary importance including Plasmodium spp., Toxoplasma gondii, and Neospora caninum. They
are defined by their apical complex, which allow them to invade by active penetration of the host cell
membrane. Apicomplexan parasites possess two specialised secretory organelles, the micronemes and
the rhoptries. Microneme proteins are released onto the parasite surface just before invasion of host
cells. EtMIC3 is one of the microneme proteins from Eimeria tenella and plays important roles in host
cell recognition, attachment and penetration during invasion.
124
6.1.2 Solution structure of EtMIC3 MAR domain
The second MAR domain of EtMIC3 (EtMIC3_MAR1b), containing the MAR domain conserved sialic
acid binding motif S/TxHxT, was successfully cloned, expressed and purified. The sample was highly
soluble, mono-dispersed and homogeneous in solution. This allow successful chemical shift assignment
and structure determination by NMR. Despite a sequence identity of 28%, the calculated structure
shows remarkable resemblance to the MAR domain from TgMIC1, which consist of a distorted b-barrel
structure flanked by a pair of anti-parallel a-helices. About 15 residues at the C-terminus were poorly
defined in the structure and this region is considered to be unstructured. Alignment with the structure
of the MAR2 domain of TgMIC1 revealed that EtMIC3_MAR1b contains a prominent extension to the
first helix and subsequent loop, which is stablised and pinned together by an extra disulphide bond,
exclusive to the MAR1 family. It was later confirmed that this extension creates additional contact to the
carbohydrate ligand, which might have contributed to EtMIC3’s high affinity towards sialyl-glycans.
6.1.3 Interaction of EtMIC3 and sialyl-glycan ligand
Based on collaborative biochemical and glycoarray data, several Neu5Ac terminating-ligands were
selected and their interaction with EtMIC3_MAR1b were characterised by NMR. Ligand titration confirmed
that EtMIC3_MAR1b binds to sialyl-ligands, and the interaction is in the slow exchange regime, commonly
exhibited by high affinity complexes. Chemical shift mapping was used to localise residues involved in
ligand binding. A number of areas exhibited significant chemical shift changes, some of which are
located away from the sialic acid binding motif on the 5th b-sheet. The ambiguity of the chemical shift
mapping data was resolved by measuring the inter-molecular NOEs of two EtMIC3_MAR1b-carbohydrate
complexes (a2,3- and 2,6-sialyl-N-acetyllactosamine).
6.1.4 HADDOCK model of EtMIC3-glycan complex
To produce an atomic model of the complex, the structure of EtMIC3_MAR1b in the bound form was
solved, this allowed assignment of the inter-molecular NOEs to the protein. NOEs to the sialic acid
binding motif TSHLT, as well as Leu 24 and Tyr 27 from the extended first helix were observed. The
carbohydrate ligand was not assigned because of lack of 13C labelled ligand and 1H - 1H homonuclear
experiment failed at the molecular weight of the complex. The HADDOCK approach was then used to
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produce a complex model using the chemical shift data and inter-molecular NOEs. The carbohydrate
ligand was successfully docked to the sialic acid binding motif on the 5th b-sheet. The complex model
illustrates the interaction of the ligand with sidechain resides from both the sialic acid binding motif Thr
84 - Thr 88 and the extended helix Leu 24 and Tyr 27. The position of the sialic acid N-acetyl group
within the binding site was well defined and explains the selectivity of EtMIC3 against the glycolyl
form of sialic acid. However, the conformation of the trisaccharide ligand was not well defined in
the docked structures. The carbohydrate conformation in the outputted complex did not deviate much
from the initial inputted structure. Furthermore, ligands of different conformation were able to dock
to the binding site without large energy differences, indicating the program was not able to produce a
’correct’ ligand conformation based on shape complementarity at the protein binding site. HADDOCK
is generally regarded as very useful in modelling protein-protein complexes, but the conformation of
globular proteins are more rigid compared to carbohydrates (excluding small changes of sidechains
residues at the interface during binding). This affects the accuracy of the protein-carbohydrate complex
models generated using HADDOCK without the bound conformation of the ligand.
6.2 Future perspectives
New constructs
The major obstacle in the project was the assignment of the unlabelled carbohydrate ligand. Because
of the size of the complex (about 14 kDa), 1H - 1H homonuclear experiments (COSY,TOCSY and
NOESY) did not give rise to signals of the carbohydrate in the bound conformation. Re-cloning the
EtMIC3_MAR1b domain to remove the C-terminus flexible region will reduce the molecular weight of
the complex. This increases the tumbling rate of the complex in solution and possibly yields signals in
the homonuclear experiments.
Crystallography
The HADDOCK model presented have shown that the interaction of the MAR domain and carbohydrate
ligand of EtMIC3 is very similar to TgMIC1. However, glycoarray results have shown that EtMIC3
preferentially binds to some sialyl-ligand with higher affinity and that the specificity of EtMIC3 is
different from that of TgMIC1 (TgMIC1 has a preference for the a2,3-linkage over the a2,6-linkage, but
this is not observed for EtMIC3 in the glycoarray and NMR data). The crystal structure of TgMIC1-ligand
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complex have shown that the MAR domain interaction with sialyl-ligand involves a number of water
molecules and the interaction with the a2,3- and a2,6-linked only differs in a couple of hydrogen bonds.
A high resolution crystal structure would be useful to differentiate these differences for EtMIC3-ligand
complexes. New crystallisation experiments could be done using the re-cloned EtMIC3_MAR1b construct.
The removal of the flexible C-terminal region should increase the chances of success in crystallisation
trials.
Full length EtMIC3
Apart from studying the MAR1b domain, further work could be done on constructs with tandem MAR
domains or the full length protein. A construct containing 5 MAR domains (MAR1a, MAR1b, MAR1d
and MAR1e, residue 1-198, 750-921) was produced and used in the biochemical and glycoarray analysis.
As expected, the 5MAR protein showed stronger signal in the glycoarray compared to MAR1b domain
only (section 4.2.1). Since five of the seven MAR repeats in the full length protein contain the sialic acid
binding motif TSHLT, structural determination would be useful to explore the spatial arrangement of all
the active sites in the full length protein.
Mutagenesis
Work from this project have identified residues that are involves in ligand binding in EtMIC3_MAR1b;
mutagenesis experiments could be used to test the improtance of equivalent residues in other MAR
domains in EtMIC3 or other MAR domain containing proteins in Apicomplexa.
Affinity
Further work could be done to investigate the binding kinetics of EtMIC3 and sialyl-ligands. In this
project, NMR and glycoarray were used to characterise the affinity of EtMIC3 towards different carbohydrate
ligands. ITC was attempted to measure the kinetics of EtMIC3 and a2,3- and 2,6-sialyl-N-acetyllactosamine,
but the results were noisy and not always reproducible. Surface Plasmon resonances (SPR) is another
common biophysical method to characterise protein-ligand kinetics which could be tried to characterise
the EtMIC3-ligand interaction.
6.3 Protection experiments of EtMIC3
To determine whether immunisation with EtMIC3 could induce protection against parasite infection, in
vivo vaccination and challenge experiments were carried out by Janene Bumstead (Institute of Animal
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Health) in chickens by immunising them with purified recombinant protein or DNA of EtMIC3_MAR1c
and EtMIC3_MAR5. Five independent experiments were carried out and in each of these statistically
significant reductions in oocyst shedding following challenge infection were observed in vaccinated
groups of birds compared to control groups (data from two independent experiments are shown in Figure
6.1). Whilst these are small-scale experiments, the consistency of the trials and level of efficacy (around
50% reduction in oocyst shedding following vaccination) are higher than seen in many studies with
other antigens, indicating that EtMIC3 should be considered as a good candidate antigen for future
recombinant vaccine development.
Rotational treatment with anticoccidial drugs and commercial live vaccines are currently the best way
to control infection within chicken flocks. Due to the high expense of scaling-up the production of
live parasite vaccine, there have been a number of recent efforts to develop subunit and recombinant
coccidiosis vaccines using both DNA and protein based antigens [262, 263, 264, 265]. However, few
have been successful and much work needs to be done to identify appropriate antigens and the optimal
mode of delivery. The role of EtMIC3 in targeting host sialyl glycan in the early stages of invasion and
its prominent location at the host-parasite interface suggests that it may serve as an effective vaccine
antigen.
Figure 6.1: Vaccination trials of EtMIC3 carried out by Janene Bumstead, recombinant proteins provided by
Livia Lai. Left) Immunisation with recombinantly-expressed EtMIC3_MAR1c-thioredoxin protein resulted in an
overall reduction in oocyst output after challenge of 54% compared to treatment with the thioredoxin protein
alone. Right) DNA immunisation with pcDNA3.1 vector containing EtMIC3_MAR5 or EtMIC3_MAR1c resulted
in an overall reduction in oocyst output after challenge of 48-51% respectively compared to treatment with the
pcDNA3.1 vector alone.
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Chapter 7
Other Work: EtMIC4/5 complex
7.1 Introduction
Apicomplexan parasites secret an number of microneme proteins during invasion. Apart from EtMIC3,
EtMIC4 and EtMIC5 are two microneme proteins expressed by Eimeria tenella during invasion. EtMIC4
is a 240 kDa protein containing 31 EGF domains (22 of which have key residues characteristic of calcium
binding EGF domains [266]), 16 TSP-1 domains, followed by a short transmembrane region and a
C-terminal tail [267, 268]. EtMIC5 is a 100 kDa soluble protein with 11 Apple domains, similar to
the binding domain of blood coagulation factor XI and plasma pre-kallikrein (PK) [269, 270, 271].
A EtMIC4/5 complex has previously been described and purified from Eimeria oocyst lysate. It was
reported to form a large multimeric complex of over 2 MDa in size [197], with a proposed stoichiometry
of [EtMIC4]8[EtMIC5]4 (octamer of EtMIC4 bind non-covalently to a tetramer of EtMIC5).
The structure of one of the Apple domains of EtMIC5 was solved by NMR spectroscopy [272], however,
no structural studies have been published on the whole EtMIC4/5 complex so far. This chapter describes
the purification of the native EtMIC4/5 complex using a lactose-affinity purification protocol, characterisation
of its size and stochiometry and visualization of the complex by single particle electron microscopy.
7.1.1 Materials and methods
7.1.1.1 Published purification protocol
The native EtMIC4/5 complex was purified from parasite oocysts according to the published protocol
[197]. A culture of 109 fully sporulated E. tenella oocysts (Houghton strain) prepared with standard
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protocol [6] was suspended in 50 ml of 40 mM Tris, pH 8 and lysed by vortexing with glass beads,
followed by three rounds of freeze-thawing. The lysate was then centrifuged at 5,000 g for 5 minutes.
DNaseI (0.2 mg/ml) was added to the lysate and incubated for 1 hour at 37 ºC, followed by centrifugation
at 5,000 g for 5 minutes. The supernatant of the lysate was filtered through a 2.5 µm filter. The lysate
was then loaded onto a Q Sepharose column (GE Healthcare) equilibrated with 40 mM Tris, pH 8.0, and
eluted in a linear 0 to 1 M NaCl gradient in the same buffer. The fractions containing the target proteins
were then purified by gel filtration using a Sephacryl S-300 column and then a Superose 6 PC 3.2/30
column (Amersham Biosciences). The fractions containing the target protein were assayed for EtMIC4
and EtMIC5 by SDS-PAGE followed by silver staining or Western blotting throughout the purification.
7.1.1.2 New lactose-affinity purification protocol
A culture of 109 fully sporulated E. tenella oocysts prepared by Janene Bumstead (Institute of Animal
Health) was lysed by vortexing with glass beads. The lysate was suspended in binding buffer (40 mM
Tris, 100 mM KCl, pH 8) and centrifuged at 18,000 g for 30 minutes. 5 ml lactose agarose resin
(SIGMA®) equilibrated with binding buffer was added to the supernatant and allowed to bind for 30
minutes on a rocking platform at 4 ºC. The resin was then loaded on a 5 ml column and lysate allowed
to flow through. The resin was washed with three column volumes of binding buffer. The bound
protein was eluted with 0.2 M lactose dissolved in binding buffer. The eluted protein was identified
by SDS-PAGE followed by silver staining and Western blotting. The eluted protein was concentrated
to 1 ml and buffer exchanged twice with 40 mM Tris, 100 mM KCl, pH 8. It was then dialysed twice
against 2 L of buffer to remove remaining free lactose. The yield of one sample preparation was about 1
mg.
7.1.1.3 Electrospray Mass Spectrometry
The lactose-affinity purified sample was buffer exchanged six times using a vivaspin 30 kDa MWCO
centrifugal concentrator (Sartorius) into 100 mM ammonium acetate buffer, pH 8. The sample was
analysed on the Qstar nano-electrospray mass spectrometer by Laura Lane, University of Cambridge.
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7.1.1.4 Carbohydrate binding of the EtMIC4/5/7 complex
To characterise the sugar binding profile of the EtMIC4/5/7 complex in detail, glycoarray analysis was
carried out by Liu Yan, Imperial College London. The complex was tested with a set of comprehensive
Gal-terminating sequences, including Lac/LacNAc, gangliosides and N-glycan related sequences. The
results were compared to the 5th apple domain (Ap5) of TgMIC4 (which is a homologue of EtMIC5)
which was found to bind to terminal galactose.
7.1.1.5 Electron microscopy
2 µl of purified native EtMIC4/5/7 complex at 150 µg/ml in a buffer of 40 mM Tris, , pH 8, 100 mM KCl
was applied to a glow-discharged continuous carbon coated copper grid (TAAB, UK). It is then treated
with a 2% solution of uranyl acetate, blotted with filter paper and air dried. Microscopy was performed
on a Technai 12 electron microscope. Images were taken with a 1k x 1k CCD camera.
7.1.2 Results
7.1.2.1 New purification strategy for EtMIC4/5 complex
The EtMIC4/5 complex was first purified by Periz et. al [197] by ion-exchange chromatography and a
series of gel filtration. Having purified some EtMIC4/5 complex using that protocol, we have identified
a few drawbacks in the protocol. Firstly, filtering with a 2.5 µm was difficult after 5 minutes of
centrifugation at 5000 g; secondly, the final yield of the complex was low because of the multiple
purification steps; thirdly, the purified complex was contaminated with large aggregated proteins which
eluted at the same fraction from the gel filtration (visualised by negative-stain electron micrographs, data
not shown). An easier purification protocol was therefore needed to obtain a pure sample with higher
yield.
Lactose-affinity purification was first used to purify TgMIC1/4/6 complex from Toxoplasma lysate by
Lourenco et. al [80]. When TgMIC1/4/6 complex was first described, TgMIC1 was thought to be a
lactose binding protein. Since then, TgMIC1 C-terminal was found to have no sugar binding ability
[199] and TgMIC1 N-terminal was found to bind to sialic acid [201]. TgMIC4, containing 6 Apple
domains, is now recognised as the lactose binding protein within the complex, and recent findings have
identified the active site in the fifth Apple domain (Ben Cowper, personal communication). EtMIC5 is
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the homologue of TgMIC4 and it contains 11 Apple domains. EtMIC5, like other microneme proteins,
is expected to function as an adhesin during host invasion. It is therefore thought to bind to lactose via
its Apple domains.
In an attempt to produce a more homogenous sample of EtMIC4/5, a lactose-affinity purification protocol
was tested and the eluted fraction on a SDS-PAGE is shown in Figure 7.1. Three bands were observed
at molecular weights of 240 kDa, 100 kDa and 17 kDa. The 240kDa band was expected to be EtMIC4
and the 100kDa band was expected to be EtMIC5.
Figure 7.1: EtMIC4/5 complex purified by lactose agarose. The expected position of EtMIC4, EtMIC5 and an
unexpected band which was identified as EtMIC7 (below) are indicated.
7.1.3 Characterisation of EtMIC4/5 complex
7.1.3.1 Identifying the protein subunits
To confirm the identity of the 3 bands purified from lactose-affinity purification, the eluted proteins were
blotted with anti-EtMIC4 and anti-EtMIC5 antibodies (by Janene Bumstead, Institute of Animal Health,
UK). The 240 kDa band was recognised by the EtMIC4 antibodies and the 100 kDa band was recognised
by the EtMIC5 antibodies (Figure 7.2), the 17 kDa band was not recognised by either antibodies.
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Figure 7.2: Western blot of the complex with rabbit anti-EtMIC4 and anti-EtMIC5 by Janene Bumstead, Institute
of Aminal Health.
The three gel bands were sent for protein identification by mass spectrometry (Mass Spec. facility,
Institute of Animal Health, UK), revealing the 240 kDa band to be EtMIC4, the 100 kDa band as EtMIC5
and the 17 kDa band as a protein named EtMIC7. Protein N-terminal sequencing further confirmed the
protein mass spectrometry results (data not shown). EtMIC7 was identified from previous studies of E.
tenella expressed sequence tags (ESTs) derived from a merozoite cDNA library [273, 274]. Database
searches with EtMIC7 revealed homology to an E. acervulina antigen, but no other significant matches
to any other Apicomplexan or other protein sequences.
EtMIC7 was reported as one of the 10 most abundant ESTs from E. tenella merozoites, which also
include EtMIC4, EtMIC5, EtMIC1 and EtMIC2 (Table 7.1) [273]. EtMIC1 and 2 are the homologes
to TgMIC2 and M2AP (MIC2-associate protein) which form a multimeric complex [275, 195]. It is
possible that EtMIC7 is associated with the EtMIC4/5 complex and therefore a similar expression level
is observed for all three microneme proteins. Previous studies of the EtMIC4/5 complex [197] did not
describe the presence of EtMIC7 in the complex, but the EtMIC complex purified following the protocol
in [197] also yielded a complex containing EtMIC7 (data not shown). Therefore EtMIC7 may associate
with the EtMIC4/5 complex rather than binding to lactose independently.
To test whether EtMIC7 binds to lactose, recombinant expression trials in E. coli were attempted,
however, no folded protein was produced successfully in the pET-32 system. Other expression systems
in E. coli or eukaryotic systems could be tested in the future for characterisation of EtMIC7.
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E. tenella merozoite cDNA library
Rank Gene/ Putative ID No. ESTs %
1 EtMIC1 microneme protein 20 4.07
2 Ubiquitin 10 2.04
3 Ubiquitin 9 1.83
4 Actin 8 1.63
5 EtMIC7 microneme protein 8 1.63
6 Heat shock protein 90 8 1.63
7 Surface antigen 8 1.63
8 EtMIC4 microneme protein 7 1.42
9 EtMIC5 microneme protein 7 1.42
10 EtMIC2 microneme protein 6 1.22
11 Ribosomal protein L11 6 1.22
12 Phosphatidic acid phosphatase 6 1.22
Table 7.1: Comparison of most abundant ESTs from E. tenella merozoites [273].
7.1.3.2 Analysis of size and stoichiometry of the complex
To characterise the size and stoichiometry of the lactose-affinity purified complex, it was analysed by
native protein gel and electrospray mass spectrometry.
Native Gel
The purified complex run on a native gradient gel (3-12%) showed two main bands, at about 450 kDa and
240 kDa (Figure 7.3, left). After incubation with urea or GCl, the 440 kDa, 240 kDa bands (indicated
with arrows) and another band running at about 100 kDa were observed. From the native gel the highest
molecular weight species of the complex was about 440 kDa. Since the theoretical molecular weight
of EtMIC4 is about 240 kDa and EtMIC5 is about 100 kDa, a complex with a [EtMIC4]1[EtMIC5]2
stoichiometry will be approximately 440 kDa in size. The 240 kDa band in the native sample could be
dimers of EtMIC5 which were pulled down via lactose binding or monomeric EtMIC4 dissociated from
the complex.
Incubation with urea and GCl did not seem to disrupt all of the 440 kDa complex. To investigate whether
inter-molecular disulphide bonds are present, samples with or without 1 mM DTT added (reduced or
non-reduced) were run on a denaturing SDS gel (Figure 7.3, right). In both conditions, bands around
240 kDa and 100 kDa were observed. Therefore there is no evidence of inter-molecular disulphide bonds
within the EtMIC4/5 complex.
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Figure 7.3: (Left) 3-12% Bis-Tris Native gel of the native EtMIC4/5 complex, and after incubation with 8 M urea
or 6 M guanidine hydrochloride. The 440, 240 and 100 kDa bands are indicated with arrows. (Right) SDS-PAGE
with EtMIC4/5/7 and TgMIC1/4/6 complex in reducing and non-reducing conditions, showing no inter-molecular
disulphide bonds within these complexes.
Electrospray Mass Spectrometry
Mass spectrometry analysis of the intact complex under native conditions was carried out to investigate
the total molecular weight of the complex and its subunits [276, 277, 278] (by Laura Lane, University of
Cambridge). The results identified a 430 kDa species (H) expected to be the complex with a [EtMIC4]1[EtMIC5]2
stoichiometry (Figure 7.4, top). The species at 200 kDa (G) was expected to be EtMIC4, while species
(A, B and C) were EtMIC7 and species (D and E) were EtMIC5. The species at 107 kDa (series
F) corresponds to approximately the combined molecular weight of EtMIC5 and EtMIC7 (91.7kDa +
16kDa = 107.7kDa). Tandem MS/MS analysis of the 107 kDa species identified a 16 kDa component
(Figure 7.4, bottom), which suggest that it is a complex of EtMIC5 and EtMIC7.
In conclusion, the stoichiometry of the whole complex according to the experimental results above is
[EtMIC4]1[EtMIC5/7]2. However, further analysis is needed to prove the interaction between EtMIC5
and EtMIC7. As mentioned above, recombinantly expressed folded samples of both EtMIC7 and
EtMIC5 would be invaluable to further investigation of this complex. Unfortunately, like EtMIC7,
recombinant expression of EtMIC5 apple domains in E. coli was unsuccessful, except for the 9th apple
domain which did not bind to lactose [272].
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Figure 7.4: Mass spectrometry analysis of the intact complex under native conditions by Laura Lane, University
of Cambridge. (Top) Nano-electrospray mass spectra. The spectra reveal three series of peaks (A, B and C),
about 16 kDa in mass, which matched the mass of EtMIC7; series D and E, around 91 kDa corresponded to the
mass of EtMIC5; series F matched the combined molecular weight of EtMIC5 and EtMIC7 (91.7kDa + 16kDa =
107.7kDa); series G matches the mass of EtMIC4 at 200 kDa; finally series H was the highest molecular weight
species observed and would match the mass of a complex with a [EtMIC4]1[EtMIC5]2 stoichiometry (Bottom)
Tandem MS/MS analysis of the F series from the top spectra, purple, 107 kDa species. 16 kDa species were
identified, as series A, B and C, confirming the presence of a subcomplex consisting of EtMIC5 and EtMIC7.
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7.1.3.3 Glycosylation of EtMIC4/5/7 complex
Glycosylation of the native EtMIC4, 5 and 7 was detected using Gelcode glycosylation detection kit
(Thermo Scientific) according to the manufacturer’s instructions and resulted in positive identification
of EtMIC4 glycosylation (Figure 7.5). A recent paper identified the genes for four enzymes that are
involved in the biosynthesis of O-linked GalNAc and are upregulated during macrogamete development
in E. tenella [279], whilst GalNAc-transferase (EtGalNAc-T), the enzyme responsible for the O-linked
transfer of GalNAc to proteins, is upregulated in the unsporulated and sporulated oocyst stages. These
are thought to be important for the synthesis of O-linked glycoproteins that form the oocyst wall. EGF
and TSP domains have distinct O-linked glycosylation patterns including O-glucose, O-fucose and
O-mannose [280]. EtMIC4 might contain such O-linked glycosylation amongst its 31 EGF domains
and 12 TSP domains. From the protein sequence there are 5 potential O-glucose and 12 O-fucose sites,
but no predicted O-mannose sites in the sequence. Mass spectrometry analysis could potentially confirm
and identify the glycosylation on EtMIC4 in the future.
Figure 7.5: Silver and Glyco stained SDS gel of EtMIC4/5/7 and TgMIC1/4/6. A positive band was shown for
EtMIC4.
7.1.3.4 Carbohydrate binding of the EtMIC4/5/7 complex
To characterise the carbohydrate binding profile of the EtMIC4/5/7 complex in detail, glycoarray analysis
was carried by Liu Yan, Imperial College London. The complex was tested with a set of comprehensive
Gal-terminating sequences, including Lac/LacNAc, gangliosides and N-glycan related sequences. The
results were compared to the 5th apple domain (Ap5) of TgMIC4 (which is a homologue of EtMIC5)
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which was found to bind to terminal galactose.
The EtMIC4/5 complex binds selectively to Gal-terminating oligosaccharide probes in the microarray
(Figure 7.6). This is in sharp contrast to EtMIC3, which binds selectively to sialylated oligosaccharide
probes. Interestingly, although sharing the same Lac/LacNAc-binding property, EtMIC4/5 and TgMIC4-Ap5
have different binding characteristics according to the microarray results. EtMIC4/5 has a preference for
type 2 backbone sequences (Gal1-4GlcNAc-) over type 1 sequences (Gal1-3GlcNAc-) and ganglioside
related sequences (Gal1-3GalNAc-). In contrast, TgMIC4-Ap5 binds preferentially to ganglioside related
sequences (Figure 7.6, probe 12-16). Although good binding was observed with short Lac/LacNAc
sequence, there was little or no binding to Gal-terminating complex type N-glycans. This difference
might relate to the different host and tissue tropism of E. tenella and T. gondii.
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Comparisons of binding specificities of EtMIC4/5 and TgMIC4-Ap5 
with 16 Gal-terminating oligosaccharide probes in microarrays 
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Figure 7.6: Comparisons of binding specificities of EtMIC4/5/7 and TgMIC4-Ap5 with 16 Gal-terminating
oligosaccharide probes in microarrays by Liu Yan, Imperial College London.
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7.1.3.5 Electron microscopy
Negative stained EM pictures of the freshly purified complex shows intact round particles with diameter
about 20 nm (Figure 7.7, top), which shows that the complex forms a compact structure. However
most images have a noisy background. The complex was prone to disintegration when stored at 4 ºC
or after freeze-thawing. Images taken a few days after purification show that various smaller particles
appear over time, including “doughnut-like” and hexameric rings particles (Figure 7.7, middle). The
disintegrated complex sample was very heterogeneous, which limited the possibility of doing single
particle 3D structure reconstruction of the complex.
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Figure 7.7: Negative stained electron micrographs. (Top) Intact EtMIC4/5/7 complex at 26x magnification.
(Middle) Part disintegrated complex at 21x magnification. (Bottom) Low magnification image showing patches
of heavily stained area.
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7.1.4 Summary
To summarise the work on the EtMIC4/5/7 complex:
• A lactose-affinity chromatography protocol was used to purify the EtMIC complex from E. tenella
sporulated oocyst lysate. The eluent contains EtMIC5 which has 11 Apple domains [270], EtMIC4
which is a 240 kDa protein known to associate with EtMIC5, and a newly identified component
of the complex EtMIC7.
• Native gel electrophoresis and mass spectrometry analysis indicated that the full complex was
about 450 kDa in size. A species at 107 kDa was identified in the mass spectrometry results and
could be a 1:1 complex of EtMIC5 (100 kDa) and EtMIC7 (17 kDa). The proposed stoichiometry
of the complex is [EtMIC4]1[EtMIC5/7]2.
• Glycosylation was detected on the complex but further work is needed to identify the composition
of the glycosylation.
• Carbohydrate microarrays revealed that the EtMIC4/5/7 complex targets Gal1-4GlcNAc- sequences
which is in contrast with TgMIC4 Apple 5 domain which binds preferentially to Gal1-3GalNAc-
terminated sequences.
• Electron microscopy revealed a compact complex of about 20 nm in diameter. However single
particle 3D structure reconstruction of the complex was limited by sample heterogeneity.
Further work is needed to establish whether EtMIC7 binds to lactose alone, to identify the lactose
binding domain of EtMIC5 and the interactions between each protein component in the EtMIC4/5/7
complex. Furthermore, glycosylation on the native complex could be analysed in greater detail.
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.1 Molecular Biology
.1.1 Polymerase Chain Reaction
.1.1.1 PCR reaction mixture
Components Volume (μl)
PCR Grade water 28.6
10X Buffer * 5
dNTPs (final concentration 0.2mM) 5
MgCl2 (final concentration 1mM) 2
DNA template (plasmid) 1
5’ primer 4
3’ primer 4
KOD polymerase (Merck) 0.4
Total volume 50
*10X = 1.2 M Tris-HCl, 100 mM KCl, 60 mM (NH4)2SO4, 1% Triton X-100, 0.01% BSA, pH 8.0
Table 2: PCR reaction recipe for KOD polymerase (Merck)
.1.1.2 PCR protocol
25 cycles:
Denature 15 secs, 98ºC
Anneal 5 secs, (primers melting temperature -5)ºC
Extend 40 secs, 72ºC
Table 3: PCR protocol
.2 Buffer Recipes
.2.1 Media
Minimal (M9) media per litre:
• 6 g Na2HPO4
• 3 g KH2PO4
• 0.5 g NaCl and autoclave;
Filter-sterilise (with filter membrane pore size of 0.2 mM) and add the following:
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• 2 ml MgSO4 (1 mM)
• 10 L CaCl2
• 1ml FeSO4 (0.01 M)
• 1ml vitamin stock (1000X)
• 1ml micronutrients stock (1000X)
• 0.7 g NH4Cl
• 2 g glucose
Vitamin stock (1000X):
• 0.4g Choline chloride
• 0.5g Folic acid
• 0.5g Pantothenic acid
• 0.5g Nicotinamide
• 1.0g Myo-inositol
• 0.5g Pyridoxal HCl
• 0.5g Thiamine HCl
• 0.05g Riboflavin
• 1.0g Biotin
Micronutrients stock (1000X):
• 3 mM Amm. Molybdate
• 0.4 mM H3BO3
• 0.3 mM CoCl2
• 0.1 mM CuSO4
• 0.8 mM MnCl2
• 0.1 mM ZnSO4
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.2.2 Antibiotic stock solution
For 1000X solutions:
• Carbenicilin 50 mg/ml in H2O
• Kanamycin 15 mg/ml in H2O
• Tetracycline 12.5 mg/ml in 70% EtOH
Filter sterilise and store at -20ºC.
.2.3 Purification buffer
Lysis buffer
• 50 mM Tris-HCl, pH 8, 300 mM NaCl
• 1 tablet Complete® EDTA-free protease inhibitor cocktail (Roche)
• 6 mg/ml DNaseI
Nickel affinity purification buffer
• Binding buffer: 50 mM Tris-HCl, pH 8, 300 mM NaCl
• Wash buffer 1: 50 mM Tris-HCl, pH 8, 300 mM NaCl, 5 mM imidazole
• Wash buffer 2: 50 mM Tris-HCl, pH 8, 300 mM NaCl, 10 mM imidazole
• Wash buffer 3: 50 mM Tris-HCl, pH 8, 300 mM NaCl, 15 mM imidazole
• Elution buffer: 50 mM Tris-HCl, pH 8, 300 mM NaCl, 250 mM imidazole
Factor Xa cleavage buffer
• 50 mM Tris-HCl, pH 8, 100 mM NaCl, 5 mM CaCl2
Gel filtration buffer
• 50 mM Tris-HCl, pH 8, 300 mM NaCl
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NMR sample buffer
• 20 mM NaPO4, pH 6.5 or pH 5.5, 50 mM NaCl
• Complete® EDTA-freeprotease inhibitor cocktail (Roche)
• 0.01% Sodium azide
• 10% D2O
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.3 Glycoarray data of EtMIC3_MAR5 and TgMIC1_MARR
 
Position Probe designation** Sequence 
EtMIC3 
binding 
TgMIC1 
binding 
Non-sialylated  (neutral and sulphated) 
1 Lac Galß-4Glc-DH  -   -  
2 Lac-AO Galß-4Glc-AO 336  127  
3 LacNAc(1-3) Galß-3GlcNAc-DH  -   -  
4 LacNAc(1-3)-AO Galß-3GlcNAc-AO  -   -  
5 LacNAc Galß-4GlcNAc-DH 
                 
31   -  
6 LacNAc-AO Galß-4GlcNAc-AO 179  54  
7 LNT Galß-3GlcNAcß-3Galß-4Glc-DH  -   -  
8 LNnT Galß-4GlcNAcß-3Galß-4Glc-DH  -   -  
9 Paragloboside Galß-4GlcNAcß-3Galß-4Glcß-Cer 33   -  
10 LNFP-II 
Galß-3GlcNAcß-3Galß-4Glc-DH 
      │ 
 Fucα-4  -   -  
11 LNFP-III 
Galß-4GlcNAcß-3Galß-4Glc-DH 
      │ 
 Fucα-3  -   -  
12 SU(3')-LNFP-II 
SU-3Galß-3GlcNAcß-4Galß-4Glc-DH  
            │ 
       Fucα-4  -   -  
13 SU(6')-LNFP-II 
SU-6Galß-3GlcNAcß-3Galß-4Glc-DH 
          │ 
     Fucα-4  -   -  
14 SU(3')-LNFP-III 
SU-3Galß-4GlcNAcß-3Galß-4Glc-DH 
            │ 
       Fucα-3  -   -  
15 SU(6')-LNFP-III 
SU-6Galß-4GlcNAcß-3Galß-4Glc-DH 
            │ 
       Fucα-3  -   -  
16 SU(3',6)-LNFP-III 
         SU-6 
            │ 
SU-3Galß-4GlcNAcß-3Galß-4Glc-DH 
            │ 
       Fucα-3  -   -  
17 Man9GN2 
 Manα-2Manα-6 
            │ 
Manα-2Manα-3Manα-6 
                 │ 
                 Manß-4GlcNAcß-4GlcNAc-DH 
                 │ 
Manα-2Manα-2Manα-3  -   -  
18 NA2 
Galß-4GlcNAcß-2Manα-6  
                    │  
                    Manß-4GlcNAcß-4GlcNAc-DH 
                    │  
Galß-4GlcNAcß-2Manα-3  -   -  
2-3-linked sialyl 
19 NeuAcα-(3')Lac NeuAcα-3Galß-4Glc-DH 4,635  2,298  
20 NeuAcα-(3')Lac-AO NeuAcα-3Galß-4Glc-AO 6,260  4,734  
21 Neu4,5Ac-(3')Lac Neu4,5Acα-3Galß-4Glc-DH  -  23  
22 Neu4,5Ac-(3')Lac-AO Neu4,5Acα-3Galß-4Glc-AO  -  621  
23 Neuα-(3')Lac Neuα-3Galß-4Glc-DH 326  74  
24 Neuα-(3')Lac-AO Neuα-3Galß-4Glc-AO 437   -  
25 NeuAcß-(3')Lac NeuAcß-3Galß-4Glc-DH  -   -  
26 NeuAcß-(3')Lac-AO NeuAcß-3Galß-4Glc-AO 6   -  
27 NeuAcα-(3')LN1-3 NeuAcα-3Galß-3GlcNAc-DH 10,717  3,820  
28 NeuAcα-(3')LN1-3-AO NeuAcα-3Galß-3GlcNAc-AO 19,612  11,214  
29 NeuAcα-(3')LN NeuAcα-3Galß-4GlcNAc-DH 6,175  2,628  
30 NeuAcα-(3')LN-AO NeuAcα-3Galß-4GlcNAc-AO 13,499  8,872  
31 SA(3')-Lea-Tri 
NeuAcα-3Galß-3GlcNAc-DH 
              │ 
         Fucα-4 11,667  2,207  
32 SA(3')-Lea-Tri-AO 
NeuAcα-3Galß-3GlcNAc-AO 
              │ 
         Fucα-4 10,736  3,304  
33 SA(3')-Lex-Tri 
NeuAcα-3Galß-4GlcNAc-DH 
              │ 
         Fucα-3 6,342  1,117  
34 SA(3')-Lex-Tri-AO 
NeuAcα-3Galß-4GlcNAc-AO 
              │ 
         Fucα-3 7,566  1,795  
35 GSC-105 
NeuAcα-3Galß-4GlcNAcß-3Galß-Cer36 
              │ 
         Fucα-3 1,861  132  
36 GSC-177 
NeuGcα-3Galβ-4GlcNAcβ-3Galß-Cer36    
              │  
         Fucα-3 33  1,899  
Figure 8: Carbohydrate microarray analysis of recombinant EtMIC3_MAR5 and TgMIC1_MARR using 115
lipid-linked oligosaccharide probes (Data from Liu Yan, Imperial College London)[1].
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